1. Cell Cycle/DNA Damage
    Cytoskeleton
  2. Microtubule/Tubulin

Docetaxel 

Cat. No.: HY-B0011 Purity: 99.80%
Data Sheet SDS Handling Instructions

Docetaxel is a semi-synthetic taxane analogue, acts as a microtubule stabilizer.

For research use only. We do not sell to patients.
Docetaxel Chemical Structure

Docetaxel Chemical Structure

CAS No. : 114977-28-5

Size Price Stock Quantity
Free Sample (0.5-1 mg)   Apply now  
10 mM * 1 mL in DMSO $66 In-stock
100 mg $60 In-stock
200 mg $85 In-stock
500 mg   Get quote  
1 g   Get quote  

* Please select Quantity before adding items.

Other Forms of Docetaxel:

Top Publications Citing Use of Products

    Docetaxel purchased from MCE. Usage Cited in: Oncotarget. 2016 May 17;7(20):28891-902.

    Western blot analyses for Brachyury and AR expression in prostate cell lines treated with Docetaxel (Doc) or with Cabazitaxel (Cab). Graphs represent the densimetric semi-quantification of western blot images.
    • Biological Activity

    • Protocol

    • Technical Information

    • Purity & Documentation

    • References

    Description

    Docetaxel is a semi-synthetic taxane analogue, acts as a microtubule stabilizer.

    IC50 & Target

    Microtubule[1]

    In Vitro

    Docetaxel (DOC) and Glufosfamide (GLU) single and combined treatments affect the cells viability in a dose-dependent manner. The IC50 of GLU are 70±4 µM and 86.8±8 µM in PC-3 and LNCaP cells; respectively. While, the IC50 of Docetaxel alone is found to be 3.08±0.4 nM and 1.46±0.2 nM in PC-3 and LNCaP cells; respectively. The co-treatment of GLU with Docetaxel is found to synergize the cytotoxicity and the IC50 values are decreased to be 2.7±0.1 nM and 0.75±0.3 nM in PC-3 and LNCaP cells; respectively[1]. IC50 of NCI-H460 to Docetaxel at 24 h is 116 nM and at 72 h is 30 nM. According to data reported in DTP Data Search, the mean IC50 of NCI-60 cell panel to Docetaxel is 14-34 nM[2].

    In Vivo

    In female mice, the Docetaxel-induced intestinal apoptosis in the 14-hours after light on (HALO) group is significantly greater than that in the 2-HALO group. Bax expression is significantly elevated by Docetaxel in the 2-HALO group, but not in the 14-HALO group. On the other hand, cleaved Caspase-3 expression is significantly elevated by Docetaxel in the 14-HALO group, but not in the 2-HALO group. The expressions of Wee1 and phosphorylated CKD1 are significantly elevated after dosing of Docetaxel at 14 HALO, but not at 2 HALO. In addition, Docetaxel significantly reduces survivin expression in the 14-HALO group but not in the 2-HALO group. The survivin expression level in the Docetaxel-treated 14-HALO group is significantly smaller than that in the drug-treated 2-HALO group[3]. Piperine (PIP) is administrated via intravenous bolus at 3.5 mg/kg and via oral administration at 35 mg/kg and 3.5 mg/kg, while Docetaxel (DOX) is intravenously administrated at 7 mg/kg to Sprague-Daley rats. The co-administrations of PIP at 35 mg/kg via oral administration and Docetaxel at 7 mg/kg via intravenous bolus administration in Sprague-Dawley rats. The combination use of PIP and Docetaxel results in a synergic increase of both their in vivo exposure[4].

    Clinical Trial
    NCT Number Sponsor Condition Start Date Phase
    NCT01110291 University of Turku|Sanofi|Turku University Hospital|Vaasa Central Hospital, Vaasa, Finland|medbase Oy Ltd CYP3A Phenotyping|CYP3A5 and MDR1 Genotyping|Docetaxel Toxicity|Associations Between Genetic Data and Docetaxel Toxicity April 2003
    NCT00675545 National University Hospital, Singapore Hormone-Refractory Prostate Cancer May 2007 Phase 2
    NCT00630110 Nereus Pharmaceuticals, Inc. Cancer February 2008 Phase 1|Phase 2
    NCT00795171 Medical University of Vienna Hormone Refractory Prostate Cancer November 2008 Phase 2
    NCT00606814 Infinity Pharmaceuticals, Inc. Solid Tumors December 2007 Phase 1
    NCT02442531 Cristal Therapeutics Cancer|Metastatic Cancer|Solid Tumors August 2015 Phase 1
    NCT01949519 Medical University of South Carolina|National Cancer Institute (NCI) Adenocarcinoma of the Prostate November 2013 Phase 1
    NCT00714376 CHU de Quebec-Universite Laval Prostate Cancer May 2008 Phase 2
    NCT00703378 National University Hospital, Singapore Solid Tumors May 2006 Phase 1|Phase 2
    NCT01837667 Lixte Biotechnology Holdings, Inc. Tumors|Neoplasms|Cancer February 2013 Phase 1
    NCT01254513 UNICANCER Prostate Cancer November 2010 Phase 2
    NCT00248703 Oslo University Hospital|University of Tromso|Helse Stavanger HF|Sorlandet Hospital HF|Sykehuset Innlandet HF|Ullevaal University Hospital|Sykehuset i Vestfold HF|Sykehuset Ostfold|Alesund Hospital Breast Cancer October 2003 Phase 2
    NCT00440128 GlaxoSmithKline Nausea and Vomiting, Chemotherapy-Induced May 2007 Phase 1
    NCT00030407 Barbara Ann Karmanos Cancer Institute|National Cancer Institute (NCI) Lung Cancer October 2001 Phase 2
    NCT00169000 Dartmouth-Hitchcock Medical Center|Hoffmann-La Roche Metastatic Breast Cancer January 2003 Phase 1
    NCT00935961 Memorial Sloan Kettering Cancer Center|Novartis Pharmaceuticals HEAD & NECK Cancer July 2009 Phase 1
    NCT00995761 Gyeongsang National University Hospital Non-small Cell Lung Cancer October 2009 Phase 2
    NCT00832338 Emory University|Sanofi Breast Neoplasms|Breast Cancer|Cancer of the Breast April 2009 Phase 2
    NCT00294385 Central European Cooperative Oncology Group Breast Cancer June 2002 Phase 3
    NCT01693432 Hallym University Medical Center|Jeil Pharmaceutical Co., Ltd. Esophageal Neoplasms November 2011 Phase 2
    NCT00539968 Merck Sharp & Dohme Corp. Prostate Cancer|Breast Cancer|Ovarian Cancer|Lung Cancer|Gastric Cancer June 2007 Phase 1|Phase 2
    NCT00582634 University of Wisconsin, Madison Non Small Cell Lung Cancer September 2004 Phase 2
    NCT00080665 Sidney Kimmel Comprehensive Cancer Center|National Cancer Institute (NCI) Breast Cancer December 2003 Phase 1
    NCT01362400 Infinity Pharmaceuticals, Inc. Non Small Cell Lung Cancer May 2011 Phase 2
    NCT02274610 Samyang Biopharmaceuticals Corporation Solid Tumor November 2014 Phase 1
    NCT01256359 University of Oxford Melanoma October 2010 Phase 2
    NCT01741155 Spectrum Pharmaceuticals, Inc Non Small Cell Lung Cancer (NSCLC) May 2013 Phase 2
    NCT00212095 National University Hospital, Singapore Metastatic Breast Cancer June 2005 Phase 2
    NCT02024841 The University of Hong Kong|Taiho Pharmaceutical Co., Ltd. Gastric Cancer|Peritoneal Carcinomatosis December 2013 Phase 1
    NCT00474669 James Graham Brown Cancer Center|University of Louisville Ovarian Carcinoma June 2007 Phase 1
    NCT02490475 Hoffmann-La Roche Solid Tumor February 2004 Phase 1
    NCT02376296 Saladax Biomedical, Inc.|UPMC CancerCenter Prostate Cancer February 2015
    NCT01957007 OncoMed Pharmaceuticals, Inc. Solid Tumors September 2013 Phase 1
    NCT00253318 M.D. Anderson Cancer Center|Novartis Pharmaceuticals Breast Cancer November 2005 Phase 1
    NCT01825265 M.D. Anderson Cancer Center|Novartis Pharmaceuticals Breast Cancer November 2005 Phase 2
    NCT00227721 Robert Morris|National Cancer Institute (NCI)|Barbara Ann Karmanos Cancer Institute Ovarian Cancer|Peritoneal Cavity Cancer February 2004 Phase 2
    NCT00525005 Hallym University Medical Center|Asan Medical Center|Sanofi Stomach Neoplasms August 2007 Phase 2
    NCT02547987 Mothaffar Rimawi|Baylor Breast Care Center Breast Cancer September 2015 Phase 2
    NCT00123929 Hospital San Carlos, Madrid|UNC Lineberger Comprehensive Cancer Center Breast Cancer January 2005 Phase 2
    NCT01685489 Bastyr University|University of Washington|Fred Hutchinson Cancer Research Center Prostatic Neoplasms May 2013 Phase 1
    NCT02289378 Sixth Affiliated Hospital, Sun Yat-sen University Docetaxel, Oxaliplatin and Fluorouracil November 2014 Phase 2
    NCT02378389 Jiangsu HengRui Medicine Co., Ltd. HER2 Positive Gastric Cancer September 2014 Phase 1
    NCT01611961 Shenyang Pharmaceutical University Advanced Cancer August 2012 Phase 1
    NCT01044485 Centre Georges Francois Leclerc|GlaxoSmithKline|Sanofi Metastatic Breast Cancer November 2008 Phase 1|Phase 2
    NCT03159143 University of Pittsburgh|Sanofi-Synthelabo Metastatic Transitional Cell Cancer of the Urothelial Tract December 17, 2004 Phase 2
    NCT00614835 Memorial Sloan Kettering Cancer Center Uterine Leiomyosarcoma|Uterine Cancer August 2001
    NCT00287885 Masonic Cancer Center, University of Minnesota Cervical Cancer|Endometrial Cancer|Fallopian Tube Cancer|Ovarian Cancer|Peritoneal Cavity Cancer|Sarcoma|Vaginal Cancer|Vulvar Cancer March 2004 Phase 1
    NCT01560663 Hospital General Universitario Gregorio Marañon|UNC Lineberger Comprehensive Cancer Center|Hospital Universitario Ramon y Cajal|Hospital San Carlos, Madrid|Centro Nacional de Investigaciones Oncologicas CARLOS III Breast Cancer|Breast Cancer Stage II-III January 2012
    NCT00697437 National University Hospital, Singapore Solid Tumors October 2006 Phase 2
    NCT00113347 M.D. Anderson Cancer Center|Aventis Pharmaceuticals|Genentech, Inc. Head and Neck Cancer April 2005 Phase 1
    NCT00005096 Dana-Farber Cancer Institute|National Cancer Institute (NCI)|Rhone-Poulenc Rorer Prostate Cancer December 1999 Phase 2
    NCT00293085 Central European Cooperative Oncology Group Non-Small Cell Lung Cancer December 2001 Phase 2
    NCT00496795 University of Bergen|Haukeland University Hospital Stage III Breast Cancer AJCC V7 September 2007 Phase 2
    NCT03147963 Zhejiang Cancer Hospital Breast Cancer December 20, 2015 Phase 2
    NCT00183872 University of Southern California|Sanofi Gastric Cancer|Esophageal Neoplasms April 14, 2005 Phase 2
    NCT01312311 Samsung Medical Center Nasopharyngeal Cancer July 2006 Phase 2
    NCT01183364 Synta Pharmaceuticals Corp. Solid Tumor Malignancies July 2010 Phase 1
    NCT00430651 Hellenic Oncology Research Group|University Hospital of Crete Non-Small Cell Lung Cancer July 2004 Phase 3
    NCT02083536 University of Miami Ovarian Cancer|Ovarian Carcinoma|Recurrent Ovarian Cancer|Recurrent Ovarian Carcinoma May 2014 Phase 1
    NCT00714246 Milton S. Hershey Medical Center|Sanofi Non Small Cell Lung Cancer October 2008 Phase 1|Phase 2
    NCT02504489 BeyondSpring Pharmaceuticals Inc. Non-Small Cell Lung Cancer June 2016 Phase 3
    NCT03043989 Sidney Kimmel Comprehensive Cancer Center Prostate Cancer March 21, 2017 Phase 1
    NCT01380275 National Cancer Center, Korea Sarcoma April 2008 Phase 2
    NCT00511576 Mirati Therapeutics Inc. Breast Cancer|Lung Cancer|Pulmonary Cancer|Non-Small-Cell Lung Carcinoma|Prostate Cancer|Prostatic Cancer|Gastric Cancer|Stomach Cancer August 2007 Phase 1
    NCT00983047 Biotech Pharmaceutical Co., Ltd. Advanced Non-Small Cell Lung Cancer August 2009 Phase 2
    NCT00645333 University of Michigan Cancer Center|Baylor College of Medicine|Ohio State University|Dana-Farber Cancer Institute|Weill Medical College of Cornell University|Merck Sharp & Dohme Corp. Metastatic Breast Cancer March 2008 Phase 1|Phase 2
    NCT01238055 Samsung Medical Center Advanced Gastric Cancer November 2008 Phase 2
    NCT01071928 Hoosier Cancer Research Network|Novartis Pharmaceuticals Urothelial Carcinoma June 2010 Phase 2
    NCT00684099 Hellenic Oncology Research Group|University Hospital of Crete Non Small Cell Lung Cancer May 2006 Phase 1|Phase 2
    NCT00862134 Proacta, Incorporated Non-Small Cell Lung Cancer March 2009 Phase 2
    NCT00052169 NSABP Foundation Inc|AstraZeneca Breast Neoplasms January 2003 Phase 2
    NCT00976976 Asan Medical Center Resected Advanced Gastric Cancer May 2007 Phase 2
    NCT00248560 Barbara Ann Karmanos Cancer Institute|National Cancer Institute (NCI) Head and Neck Cancer January 2005 Phase 2
    NCT01660399 Tianjin Medical University Cancer Institute and Hospital Squamous Cell Lung Cancer August 2012 Phase 2
    NCT00428922 Bhuvaneswari Ramaswamy|Genentech, Inc.|Case Comprehensive Cancer Center|University of Pittsburgh|Ohio State University Comprehensive Cancer Center Breast Cancer June 14, 2007 Phase 2
    NCT01567163 Eli Lilly and Company Malignant Solid Tumor July 2012 Phase 2
    NCT00008411 M.D. Anderson Cancer Center|National Cancer Institute (NCI) Breast Cancer December 1999 Phase 3
    NCT02639858 Samyang Biopharmaceuticals Corporation Head and Neck Squamous Cell Carcinoma October 2015 Phase 2
    NCT01921673 Asan Medical Center|Novartis Pharmaceuticals Gastric Cancer August 2013 Phase 1|Phase 2
    NCT00450008 The Methodist Hospital System|Bayer Prostatic Neoplasms December 2006 Phase 2
    NCT00888108 Abbott|Genentech, Inc. Solid Tumor July 2009 Phase 1
    NCT00944424 King Faisal Specialist Hospital & Research Center Breast Cancer July 2009 Phase 3
    NCT02364362 Jiangsu HengRui Medicine Co., Ltd.|Shanghai Pulmonary Hospital, Shanghai, China Non-Small Cell Lung Cancer (NSCLC) November 2014 Phase 1
    NCT00318890 University of Alabama at Birmingham|Aventis Pharmaceuticals Cancer of Head and Neck|Head Cancer|Head and Neck Cancer|Neck Cancer|Neck Neoplasms October 2002 Phase 1|Phase 2
    NCT01798485 Synta Pharmaceuticals Corp. Non-Small-Cell Lung Adenocarcinoma|Non-small Cell Lung Cancer Stage IIIB|Non-small Cell Lung Cancer Stage IV|Non-small Cell Lung Cancer Metastatic April 2013 Phase 3
    NCT03069937 Medical University of South Carolina|Ferring Pharmaceuticals Metastatic Prostatic Adenocarcinoma March 1, 2017 Phase 2
    NCT00030420 Barbara Ann Karmanos Cancer Institute|National Cancer Institute (NCI) Lung Cancer October 2001 Phase 2
    NCT01907308 University of Colorado, Denver|Amgen Urothelial Carcinoma February 2014 Phase 2
    NCT02225405 M.D. Anderson Cancer Center|Boehringer Ingelheim Lung Cancer April 2015 Phase 1
    NCT02346370 Halozyme Therapeutics Non-small Cell Lung Cancer November 30, 2014 Phase 1
    NCT00258284 Barbara Ann Karmanos Cancer Institute|National Cancer Institute (NCI) Prostate Cancer August 2003 Phase 2
    NCT01561456 Axelar AB Non-small-cell Lung Cancer|Squamous Cell Carcinoma|Adenocarcinoma of the Lung December 2011 Phase 2
    NCT01442909 Taipei Veterans General Hospital, Taiwan Non-small-cell Lung Cancer March 2008 Phase 4
    NCT01172028 University of Arizona|National Cancer Institute (NCI) Breast Cancer|Esophageal Cancer|Gastric Cancer|Head and Neck Cancer|Lung Cancer|Ovarian Cancer|Prostate Cancer September 2005 Phase 1
    NCT02026921 Nordic Society for Gynaecologic Oncology Ovarian Epithelial Cancer Recurrent June 2004 Phase 2
    NCT00075374 Case Comprehensive Cancer Center|National Cancer Institute (NCI) Lung Cancer October 2003 Phase 2
    NCT01755923 Peking Union Medical College Hospital Non-small Cell Lung Cancer December 2012 Phase 2
    NCT00905983 Hospital Arnau de Vilanova Carcinoma, Non-Small-Cell Lung October 2007 Phase 2
    NCT02128906 University of Pittsburgh Squamous Cell Carcinoma December 2013 Phase 2
    NCT02718820 Medical University of Vienna Head and Neck Carcinoma March 2016 Phase 1|Phase 2
    NCT01106352 Bayer Bone Metastases|Castration-Resistant Prostate Cancer July 2010 Phase 1|Phase 2
    NCT01882985 University of California, Irvine Adenocarcinoma of the Prostate|Recurrent Prostate Cancer|Stage I Prostate Cancer|Stage IIA Prostate Cancer|Stage IIB Prostate Cancer|Stage III Prostate Cancer December 2010 Phase 2
    NCT00048087 M.D. Anderson Cancer Center|AstraZeneca|Aventis Pharmaceuticals Non-small Cell Lung Cancer August 2002 Phase 2
    NCT02137083 Fudan University Metastatic Breast Cancer April 2014 Phase 2
    NCT00541099 Barbara Ann Karmanos Cancer Institute|National Cancer Institute (NCI) Lung Cancer January 2008 Phase 2
    NCT00216112 Daniela Matei, MD|Novartis Pharmaceuticals|Sanofi|Walther Cancer Institute|Hoosier Cancer Research Network Ovarian Cancer December 2003 Phase 2
    NCT00169520 GlaxoSmithKline Solid Tumor Cancer June 2004 Phase 1
    NCT00890825 AstraZeneca Non Small Cell Lung Cancer April 2009 Phase 2
    NCT00406276 Emory University Lung Cancer November 2006 Phase 1|Phase 2
    NCT00741195 Hellenic Oncology Research Group Non-small-cell Lung Cancer April 2008 Phase 2
    NCT00201708 Ohio State University Comprehensive Cancer Center Breast Cancer October 2004 Phase 2
    NCT01540110 National Cancer Centre, Singapore Breast Cancer August 2010 Phase 2
    NCT01103791 Samyang Biopharmaceuticals Corporation Advanced Solid Malignancies April 2010 Phase 1
    NCT00801801 Francisco Robert,MD|Sanofi|Bayer|University of Alabama at Birmingham Non Squamous Cell Lung Cancer|Non Small Cell Lung Cancer January 2008 Phase 2
    NCT00695994 National University Hospital, Singapore Non Small Cell Lung Cancer|Breast Cancer October 2006 Phase 2
    NCT00880334 Dana-Farber Cancer Institute|Brigham and Women's Hospital|Beth Israel Deaconess Medical Center|Massachusetts General Hospital|AstraZeneca Transitional Cell Carcinoma|Bladder Cancer September 2006 Phase 2
    NCT00712504 Pfizer Advanced Solid Tumors|Non Small Cell Lung Cancer July 2004 Phase 1
    NCT01479036 Xijing Hospital Breast Cancer October 2011 Phase 3
    NCT02110992 University of Cincinnati Head and Neck Cancer April 2014 Phase 1
    NCT02793765 The University of Texas Health Science Center, Houston Prostate Cancer December 2016 Phase 2
    NCT00906061 Hospital Arnau de Vilanova Carcinoma, Non-Small-Cell Lung October 2007 Phase 2
    NCT00375999 Yonsei University Stomach Neoplasms September 2006 Phase 2
    NCT02985021 Seattle Institute for Biomedical and Clinical Research|Prostate Cancer Foundation|VA Puget Sound Health Care System Hormone-Resistant Prostate Cancer|Metastatic Prostate Carcinoma|Recurrent Prostate Carcinoma|Stage IV Prostate Cancer November 2016 Phase 2
    NCT00514540 M.D. Anderson Cancer Center Prostate Cancer May 2006 Phase 2
    NCT00565227 University of Michigan Cancer Center Non-Small-Cell Lung Carcinoma|Prostate Cancer|Bladder Cancer|Urothelial Carcinoma April 2007 Phase 1
    NCT00041093 Gynecologic Oncology Group|National Cancer Institute (NCI) Cervical Squamous Cell Carcinoma, Not Otherwise Specified|Recurrent Cervical Carcinoma June 2002 Phase 2
    NCT00669162 University of Kansas Medical Center Prostate Cancer August 2012 Phase 1|Phase 2
    NCT02027376 Spanish Breast Cancer Research Group|Novartis Advanced Breast Cancer May 2014 Phase 1
    NCT01876251 Pfizer Breast Cancer Metastatic November 2013 Phase 1
    NCT00883675 Michael Mann|Sanofi|Maestro Clinical, Inc. Non-small Cell Lung Cancer May 2009 Phase 4
    NCT01658462 Centre Oscar Lambret|Boehringer Ingelheim Breast Cancer May 2013 Phase 2
    NCT01773785 Spectrum Pharmaceuticals, Inc Biliary Cancer April 2013 Phase 2
    NCT01019798 Taipei Medical University Hospital|Pfizer|TTY Biopharm Non Small Cell Lung Cancer January 2009 Phase 2
    NCT00172380 National Taiwan University Hospital NSCLC February 2005 Phase 2
    NCT00664170 Mast Therapeutics, Inc. Advanced Cancer April 2008 Phase 1
    NCT02776137 Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University Head-and-neck Cancer|Squamous Cell Carcinoma June 2016 Phase 2
    NCT00103389 Medigen Biotechnology Corporation|Progen Pharmaceuticals Lung Cancer February 2004 Phase 2
    NCT00485485 M.D. Anderson Cancer Center|Novartis Head and Neck Cancer|Squamous Cell Cancer January 2007 Phase 2
    NCT00321646 Mary-Ellen Taplin, MD|Beth Israel Deaconess Medical Center|Duke University|Genentech, Inc.|Sanofi|Dana-Farber Cancer Institute Prostate Cancer|Adenocarcinoma of the Prostate June 2006 Phase 2
    NCT01652469 European Thoracic Oncology Platform|Biodesix Inc. Carcinoma, Non-Small-Cell Lung August 2012 Phase 3
    NCT03209206 Seoul National University Hospital Urothelial Carcinoma July 8, 2017 Phase 2
    NCT00137761 Dana-Farber Cancer Institute|Massachusetts General Hospital|Beth Israel Deaconess Medical Center|Brigham and Women's Hospital Metastatic Pancreatic Carcinoma October 2004 Phase 2
    NCT00280735 UNC Lineberger Comprehensive Cancer Center|Aventis Pharmaceuticals Lung Cancer May 2004 Phase 2
    NCT01469598 Samsung Medical Center Metastatic Carcinoma|Recurrent Esophageal Squamous Cell Carcinoma August 2011 Phase 2
    NCT01083589 M.D. Anderson Cancer Center|Novartis Non-small Cell Lung Cancer January 2005 Phase 2
    NCT02793219 The University of Texas Health Science Center, Houston Prostate Cancer December 2016 Phase 2
    NCT02451865 Jonsson Comprehensive Cancer Center|National Cancer Institute (NCI) Recurrent Non-Small Cell Lung Carcinoma|Stage IV Non-Small Cell Lung Cancer June 2016 Phase 1
    NCT03041181 Greg Durm, MD|Hoosier Cancer Research Network|Bristol-Myers Squibb Non-Squamous Non-Small Cell Lung Cancer (NSCLC)|Adenocarcinoma of the Lung|Lung Cancer January 27, 2017 Phase 2
    NCT02358473 Kyowa Kirin Pharmaceutical Development, Inc. Non-Small Cell Lung Cancer January 2015 Phase 1
    NCT00653848 Scandinavian Prostate Cancer Group|Sanofi Prostate Cancer May 2007 Phase 3
    NCT01204099 Cascadian Therapeutics Inc. Non Small Cell Lung Cancer (NSCLC)|Squamous Cell Carcinoma of the Head and Neck (SCCHN) September 2010 Phase 1|Phase 2
    NCT03127319 Affiliated Hospital of Hebei University Non-squamous Non-small Cell Lung Cancer May 2017 Phase 2
    NCT00193037 SCRI Development Innovations, LLC|Ortho Biotech, Inc.|Aventis Pharmaceuticals Breast Cancer February 2001 Phase 2
    NCT00755157 University Hospital of Crete Small Cell Lung Cancer April 2008 Phase 2
    NCT01054313 M.D. Anderson Cancer Center Advanced Cancer January 2010 Phase 1
    NCT00805012 Seoul National University Hospital|Clinical Research Center for Solid Tumor, Korea Head and Neck Squamous Cell Carcinoma December 2008 Phase 2
    NCT00137436 Pfizer Prostatic Neoplasms October 2005 Phase 1|Phase 2
    NCT02448290 Samsung Medical Center Gastric Adenocarcinoma November 12, 2014 Phase 2
    NCT00047255 Jonsson Comprehensive Cancer Center|National Cancer Institute (NCI) Breast Cancer May 2002 Phase 3
    NCT01935778 Asan Medical Center Gastric Cancer, Adjuvant Chemotherapy, XO September 2013 Phase 3
    NCT02252913 Hutchison Medipharma Limited|AstraZeneca Gastric Cancer September 2014 Phase 1
    NCT00511446 Martin-Luther-Universität Halle-Wittenberg Stomach Neoplasms August 2007 Phase 2
    NCT02691871 Cancer Institute and Hospital, Chinese Academy of Medical Sciences|Jiangsu HengRui Medicine Co., Ltd. Lung Adenocarcinoma February 2016 Phase 1
    NCT00482274 OHSU Knight Cancer Institute|National Cancer Institute (NCI) Prostate Cancer May 2007 Phase 2
    NCT01418001 Memorial Sloan Kettering Cancer Center|National Comprehensive Cancer Network|University of California, Los Angeles|Washington University School of Medicine|Northwestern University Sarcoma|Leiomyosarcoma|Malignant Peripheral Nerve Sheath Tumor|Malignant Fibrous|Histiocytoma/Undifferentiated Pleomorphic Sarcoma August 2011 Phase 1|Phase 2
    NCT00582582 University of Wisconsin, Madison|Sanofi|Genzyme, a Sanofi Company Prostate Cancer April 2002 Phase 2
    NCT01076335 M.D. Anderson Cancer Center|National Cancer Institute (NCI) Prostate Cancer May 2005 Phase 2
    NCT01711112 Samsung Medical Center Bladder Cancer August 2010 Phase 2
    NCT01705483 Astellas Pharma Global Development, Inc.|Astellas Pharma Inc Pharmacokinetics of ASP9853|Non-hematologic Malignancies August 2012 Phase 1
    NCT00390429 University of California, Davis|National Cancer Institute (NCI)|Genentech, Inc.|Aventis Pharmaceuticals Lung Cancer|Unspecified Adult Solid Tumor, Protocol Specific July 2002 Phase 1|Phase 2
    NCT00290693 University of Miami Pancreatic Cancer June 2004 Phase 2
    NCT02775006 The Netherlands Cancer Institute|Dutch Society of Physicians for Pulmonology and Tuberculosis Carcinoma, Non-small Cell Lung May 2016 Phase 3
    NCT00728663 Swiss Group for Clinical Cancer Research Prostate Cancer June 2008 Phase 2
    NCT00080678 M.D. Anderson Cancer Center|National Cancer Institute (NCI) Metastatic Cancer|Prostate Cancer May 2003 Phase 2
    NCT00980382 National Cancer Center, Korea Stomach Neoplasms September 2004 Phase 1|Phase 2
    NCT00431054 M.D. Anderson Cancer Center|Keryx Biopharmaceuticals Ovarian Cancer February 2007 Phase 1
    NCT00805194 Boehringer Ingelheim Carcinoma, Non-Small-Cell Lung December 3, 2008 Phase 3
    NCT00148070 University of Michigan Cancer Center|Aventis Pharmaceuticals|Rhone-Poulenc Rorer Metastatic Breast Cancer March 1999 Phase 2
    NCT00521274 The Methodist Hospital System|Oxford BioMedica Prostatic Neoplasms August 2007 Phase 2
    NCT00861471 New York University School of Medicine|Novartis Prostate Cancer|Prostatic Neoplasms May 2005 Phase 1|Phase 2
    NCT01747707 Chinese Academy of Medical Sciences Gastric Cancer|Gastroesophageal Junction Cancer September 2012 Phase 2
    NCT00088907 National Cancer Institute (NCI) Recurrent Head and Neck Cancer|Metastatic Head and Neck Cancer August 2004 Phase 3
    NCT00982436 University of Vermont Head and Neck Neoplasms September 2009 Phase 1|Phase 2
    NCT01446731 Inge Marie Svane|Herlev Hospital Prostatic Neoplasms October 2011 Phase 2
    NCT02973789 NovoCure Ltd. Nonsmall Cell Lung Cancer December 2016 Phase 3
    NCT00504257 H. Lee Moffitt Cancer Center and Research Institute|National Cancer Institute (NCI)|Genentech, Inc.|Sanofi Fallopian Tube Cancer|Ovarian Cancer|Malignant Tumor of Peritoneum March 2007 Phase 2
    NCT00587145 National Cancer Center, Korea Stomach Neoplasms May 2006 Phase 2
    NCT00390416 Memorial Sloan Kettering Cancer Center|Sanofi|Genentech, Inc. Stomach Neoplasms|Esophageal Neoplasms October 2006 Phase 2
    NCT00268918 Dana-Farber Cancer Institute|Brigham and Women's Hospital|Massachusetts General Hospital Ovarian Cancer|Endometrial Cancer|Cervical Cancer|Fallopian Tube Cancer|Peritoneal Cancer|Breast Cancer September 2005 Phase 1
    NCT02041351 Centro Universitario contra el Cáncer Metastatic Breast Cancer November 2013 Phase 2
    NCT00692900 University of Pittsburgh|Sanofi Ovarian Cancer|Peritoneal Cancer|Fallopian Tube Cancer December 2008 Phase 1
    NCT01351597 Korean Breast Cancer Study Group Recurrent Breast Cancer|Metastatic Breast Cancer April 2011 Phase 2
    NCT00975767 Mirati Therapeutics Inc. Advanced Malignancies, Non-small Cell Lung Cancer August 2009 Phase 1
    NCT00025493 Southwest Oncology Group|National Cancer Institute (NCI) Breast Cancer October 2001 Phase 2
    NCT01905657 Merck Sharp & Dohme Corp. Non Small Cell Lung Cancer (NSCLC) August 9, 2013 Phase 2|Phase 3
    NCT00193180 SCRI Development Innovations, LLC|Novartis|Aventis Pharmaceuticals Breast Cancer May 2005 Phase 2
    NCT00574769 University of Southern California|Novartis|Genentech, Inc. Prostate Cancer February 17, 2010 Phase 1|Phase 2
    NCT00647426 Abramson Cancer Center of the University of Pennsylvania Non-Small Cell Lung Cancer November 2007 Phase 2
    NCT00517829 US Oncology Research|ImClone LLC|Sanofi Gastric Cancer Adenocarcinoma Metastatic July 2007 Phase 2
    NCT01803503 National University Hospital, Singapore Solid Tumors|Breast Cancer|Non-small Cell Lung Cancer|Prostate Cancer|Gastric Cancer May 2013 Phase 2
    NCT02574598 Instituto Nacional de Cancerologia de Mexico Carcinoma, Non-Small-Cell Lung June 2016 Phase 2
    NCT03137004 Fujian Cancer Hospital Advanced Gastric Cancer June 1, 2017 Phase 2
    NCT02813785 Hoffmann-La Roche Carcinoma, Non-Small-Cell Lung July 31, 2016 Phase 3
    NCT00870714 Kansas City Veteran Affairs Medical Center|Sanofi Prostate Cancer September 2004
    NCT00201812 Ohio State University Comprehensive Cancer Center|Immunex Corporation Tumors November 2000 Phase 1
    NCT00697060 AmpliMed Corporation Carcinoma, Non-Small-Cell Lung August 2010 Phase 2
    NCT00042939 Eastern Cooperative Oncology Group|National Cancer Institute (NCI) Pancreatic Cancer July 2003 Phase 2
    NCT00003565 Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI) Bladder Cancer|Breast Cancer|Head and Neck Cancer|Lung Cancer|Unspecified Adult Solid Tumor, Protocol Specific September 1998 Phase 2
    NCT00354601 Wake Forest University Health Sciences|National Cancer Institute (NCI) Fallopian Tube Cancer|Ovarian Cancer|Peritoneal Cavity Cancer January 2006 Phase 2
    NCT00876460 Boehringer Ingelheim Carcinoma, Non-Small-Cell Lung March 2009 Phase 1
    NCT00348816 The University of Texas Health Science Center at San Antonio Prostate Cancer May 2006 Phase 2
    NCT01780545 Noah Hahn, M.D.|OncoGenex Technologies|Hoosier Cancer Research Network Bladder Cancer|Urothelial Carcinoma April 2013 Phase 2
    NCT00287768 Japan Clinical Cancer Research Organization|Korean Cancer Study Group Gastric Cancer March 2006 Phase 3
    NCT02144194 Cancer Research Group - Collaborative Group, Beirut, Lebanon. Breast Cancer March 2012 Phase 2
    NCT00331682 National Cancer Institute (NCI) Adenocarcinoma of the Pancreas|Recurrent Pancreatic Cancer|Stage IV Pancreatic Cancer March 2006 Phase 2
    NCT00231465 H. Lee Moffitt Cancer Center and Research Institute|AstraZeneca Non-Small Cell Lung Cancer July 2003 Phase 2
    NCT01352494 Korean Breast Cancer Study Group Breast Cancer Stage II|Breast Cancer Stage III May 2011 Phase 2
    NCT02922777 University of Texas Southwestern Medical Center|Texas Tech University Health Sciences Center|BerGenBio ASA Non-Small Cell Lung Carcinoma November 2016 Phase 1
    NCT02057107 University of Pittsburgh Recurrent|Head and Neck Cancer May 2013 Phase 2
    NCT00584012 University of Iowa Any Cancer|Breast Cancer April 2004 Phase 1|Phase 2
    NCT00426127 University of Iowa|Aventis Pharmaceuticals Pancreatic Cancer November 2006 Phase 2
    NCT00076310 M.D. Anderson Cancer Center|Aventis Pharmaceuticals|Genentech, Inc. Head and Neck Cancer January 2004 Phase 2
    NCT00021242 Children's Oncology Group|National Cancer Institute (NCI) Leukemia August 2002 Phase 2
    NCT00678626 Pfizer Breast Cancer April 2009 Phase 2
    NCT00091442 Johnson & Johnson Pharmaceutical Research & Development, L.L.C. Breast Cancer September 2004 Phase 3
    NCT02780778 Tianjin Medical University Cancer Institute and Hospital Non-small Cell Lung Cancer May 2016 Phase 2|Phase 3
    NCT02779608 Fudan University Stomach Neoplasms|Peritoneal Metastasis January 20, 2017 Phase 2
    NCT00217672 Translational Oncology Research International|National Cancer Institute (NCI)|University of California, Los Angeles Breast Cancer May 2005 Phase 2
    NCT00327288 AmpliMed Corporation Non-small Cell Lung Cancer|Breast Cancer|Prostate Cancer October 2005 Phase 1
    NCT00059943 Memorial Sloan Kettering Cancer Center|National Cancer Institute (NCI) Breast Cancer|Lung Cancer|Prostate Cancer September 2002 Phase 2
    NCT00069160 National Cancer Institute (NCI)|National Institutes of Health Clinical Center (CC) Lung Neoplasms|Ovarian Neoplasms|Cervix Neoplasms|Renal Neoplasms September 2003 Phase 2
    NCT02884479 SciClone Pharmaceuticals International (Cayman) Development Limited|Parexel|National Cheng-Kung University Hospital|SciClone Pharmaceuticals Advanced Solid Tumor|Non-Small Cell Lung Cancer August 2016 Phase 1|Phase 2
    NCT02171676 Boehringer Ingelheim Neoplasms May 2005 Phase 1
    NCT00177255 University of Pittsburgh|Aventis Pharmaceuticals|Roche Pharma AG Cancer April 2005 Phase 2
    NCT00274456 Celgene Corporation Metastatic Breast Cancer November 2005 Phase 2
    NCT02004769 Sun Yat-sen University|Fudan University|307 Hospital of PLA|Shandong Tumor Hospital|Tongji Hospital|West China Hospital|Shandong Provincial Hospital|Second Affiliated Hospital of Suzhou University|Tianjin Medical University General Hospital|Second Affiliated Hospital, School of Medicine, Zhejiang University|Sixth Affiliated Hospital, Sun Yat-sen University|Nanfang Hospital of Southern Medical University Stomach Neoplasms|Neoplasms Metastasis|ERBB2 Gene Amplification November 2013 Phase 2
    NCT01229605 Tufts Medical Center Breast Cancer October 2010 Phase 2
    NCT01671332 University of Wisconsin, Madison|Medical College of Wisconsin|Optimum Therapeutics, LLC|Ohio State University Carcinoma, Non Small Cell Lung June 2012 Phase 2
    NCT01009775 Astellas Pharma Inc Melanoma November 2009 Phase 2
    NCT00054275 Paula Silverman, MD|National Cancer Institute (NCI)|Case Comprehensive Cancer Center Breast Cancer December 2002 Phase 2
    NCT01468532 Barbara Ann Karmanos Cancer Institute|National Cancer Institute (NCI) Adenocarcinoma of the Prostate|Hormone-resistant Prostate Cancer|Recurrent Prostate Cancer|Stage IV Prostate Cancer October 2011 Phase 1|Phase 2
    NCT00356941 Masonic Cancer Center, University of Minnesota Lung Cancer April 2006 Phase 1
    NCT01999673 Peregrine Pharmaceuticals Non-Small-Cell Lung Cancer Stage IIIB|Non-Small-Cell Lung Cancer Stage IV|Non-Small-Cell Lung Cancer Metastatic|Carcinoma, Non-Small-Cell Lung|Non-Small Cell Lung Cancer|Non-Small-Cell Lung Carcinoma|Nonsmall Cell Lung Cancer December 2013 Phase 3
    NCT00193024 SCRI Development Innovations, LLC|Aventis Pharmaceuticals|Pharmacia and Upjohn Breast Cancer September 2001 Phase 2
    NCT00432315 Sanofi Carcinoma, Squamous Cell May 2001 Phase 2
    NCT00313482 Veeda Oncology|Bayer Hormone Refractory Prostate Cancer April 2006 Phase 2
    NCT01527487 SCRI Development Innovations, LLC|Eisai Inc. HER2 Negative Breast Cancer June 2012 Phase 2
    NCT00217581 Barbara Ann Karmanos Cancer Institute|National Cancer Institute (NCI) Esophageal Cancer|Gastric Cancer October 2004 Phase 2
    NCT00479089 M.D. Anderson Cancer Center|AstraZeneca Bladder Cancer February 2004 Phase 2
    NCT01619813 Canadian Cancer Trials Group|Oncolytics Biotech Prostate Cancer July 2012 Phase 2
    NCT01038804 Astellas Pharma Inc Breast Cancer December 2009 Phase 2
    NCT00378573 Sanofi Non-small Cell Lung Cancer January 2007 Phase 2
    NCT00541281 Cliniques universitaires Saint-Luc- Université Catholique de Louvain|Sanofi Hormone Resistant Prostate Cancer|Metastatic Prostate Cancer December 2003 Phase 2
    NCT00525642 Fudan University Breast Neoplasms|Adjuvant|Chemotherapy June 2003 Phase 2|Phase 3
    NCT00137813 Dana-Farber Cancer Institute|Brigham and Women's Hospital|Massachusetts General Hospital|Beth Israel Deaconess Medical Center|Genentech, Inc.|Sanofi Esophageal Cancer|Gastric Cancer August 2004 Phase 2
    NCT00288444 Emory University|Aventis Pharmaceuticals|Schering-Plough Lung Cancer|Soft Tissue Sarcoma|Colorectal Carcinoma|Breast Cancer|Prostate Cancer January 2006 Phase 1
    NCT00571675 Ascenta Therapeutics Hormone Refractory Prostate Cancer October 2007 Phase 2
    NCT01836120 Hebei Tumor Hospital Gastric Cancer April 2013 Phase 2
    NCT00754351 University Hospital of Crete Breast Cancer September 2008 Phase 2
    NCT00285415 Carilion Clinic|Sanofi Advanced Endometrial Adenocarcinoma, Stage III A, B, C April 2005 Phase 2
    NCT00258765 Novartis Pharmaceuticals|Novartis Prostate Cancer May 2006 Phase 2
    NCT00132639 Haruhiko Fukuda|Ministry of Health, Labour and Welfare, Japan|Japan Clinical Oncology Group Pulmonary Neoplasms October 2002 Phase 2
    NCT00377559 Catharina Ziekenhuis Eindhoven|Cephalon|Sanofi Breast Cancer|Neoplasm Metastasis May 2006 Phase 2
    NCT02531737 University Hospital, Limoges|Boehringer Ingelheim Lung Neoplasms September 2015 Phase 2
    NCT02134990 Oshadi Drug Administration Carcinoma, Non-Small-Cell Lung June 2014 Phase 2
    NCT00216138 Hoosier Cancer Research Network|Sanofi|Hoffmann-La Roche|Walther Cancer Institute Head and Neck Cancer March 2004 Phase 2
    NCT00565448 Sanofi Nasopharyngeal Neoplasms|Carcinoma November 2007 Phase 2
    NCT03218826 National Cancer Institute (NCI) Advanced Malignant Solid Neoplasm|Estrogen Receptor Negative|Estrogen Receptor Positive|HER2/Neu Negative|Metastatic Malignant Solid Neoplasm|Progesterone Receptor Negative|PTEN Gene Mutation|Triple-Negative Breast Carcinoma|Unresectable Solid Neoplasm March 16, 2018 Phase 1
    NCT01824901 ECOG-ACRIN Cancer Research Group|National Cancer Institute (NCI)|Eastern Cooperative Oncology Group Recurrent Non-small Cell Lung Cancer|Squamous Cell Lung Cancer September 2013 Phase 1|Phase 2
    NCT00617669 AstraZeneca Prostate Cancer January 2008 Phase 3
    NCT00452556 Nova Scotia Cancer Centre Prostatic Neoplasms May 2007 Phase 2
    NCT02766140 Jiangsu HengRui Medicine Co., Ltd.|Shanghai Pulmonary Hospital, Shanghai, China Non Squamous Non Small Cell Lung June 2016 Phase 3
    NCT01777945 Hoffmann-La Roche Breast Cancer December 2012
    NCT02864394 Merck Sharp & Dohme Corp. Carcinoma, Non-Small-Cell Lung September 7, 2016 Phase 3
    NCT00621049 SCRI Development Innovations, LLC|Genentech, Inc.|Sanofi Non-Small Cell Lung Cancer December 2007 Phase 2
    NCT01350817 University Hospital, Limoges|Hoffmann-La Roche Non Small Cell Lung Cancer May 2011 Phase 2
    NCT00439270 Bristol-Myers Squibb Metastatic Prostate Cancer July 2007 Phase 1|Phase 2
    NCT00484666 Carilion Clinic|GlaxoSmithKline Ovarian Cancer May 2008 Phase 2
    NCT00543829 German Breast Group Breast Neoplasms April 1998 Phase 2
    NCT02127372 Duke University Non-small Cell Lung Cancer November 2004 Phase 1|Phase 2
    NCT00532441 Gabi Chiorean, MD|Sanofi|OSI Pharmaceuticals|Hoosier Cancer Research Network Hepatocellular Carcinoma September 2007 Phase 2
    NCT00577356 Benaroya Research Institute|Cell Genesys|Sanofi Prostate Cancer February 2008 Phase 2
    NCT00354562 Abbott Lung Cancer|Non-Small Cell Lung Cancer February 2007 Phase 1|Phase 2
    NCT00087035 Jonsson Comprehensive Cancer Center|National Cancer Institute (NCI) Prostate Cancer May 2004 Phase 2
    NCT00916123 Weill Medical College of Cornell University Prostate Cancer May 2009 Phase 1
    NCT00134056 Southwest Oncology Group|National Cancer Institute (NCI) Metastatic Cancer|Prostate Cancer August 2006 Phase 3
    NCT01907685 Sanofi Advanced Neoplastic Disease June 2006 Phase 1
    NCT01673867 Bristol-Myers Squibb Non-Squamous Cell Non-small Cell Lung Cancer November 2, 2012 Phase 3
    NCT00080626 Sidney Kimmel Comprehensive Cancer Center|National Cancer Institute (NCI) Breast Cancer July 2003 Phase 2
    NCT01348126 Synta Pharmaceuticals Corp. Non-small Cell Lung Cancer Stage IIIB|Non-small Cell Lung Cancer Stage IV|Non-small Cell Lung Cancer Metastatic May 2011 Phase 2|Phase 3
    NCT00179309 National Cancer Institute (NCI)|National Institutes of Health Clinical Center (CC) Breast Cancer September 2005 Phase 2
    NCT01653158 Pfizer Advanced Non-Hematologic Malignancies March 2005 Phase 1
    NCT00524810 ARCAGY/ GINECO GROUP Metastatic Breast Cancer February 2004 Phase 2
    NCT00675597 Memorial Sloan Kettering Cancer Center|Sanofi Lung Cancer May 2008
    NCT00074022 National Cancer Institute (NCI) Recurrent Non-small Cell Lung Cancer|Recurrent Prostate Cancer|Stage III Prostate Cancer|Stage IIIA Non-small Cell Lung Cancer|Stage IIIB Non-small Cell Lung Cancer|Stage IV Non-small Cell Lung Cancer|Stage IV Prostate Cancer|Unspecified Adult Solid Tumor, Protocol Specific October 2003 Phase 1|Phase 2
    NCT00256282 University of California, Irvine|Bayer Metastatic Melanoma April 2003 Phase 2
    NCT00669370 University of Turku|Sanofi Stomach Neoplasms June 2006 Phase 2
    NCT00166881 National Taiwan University Hospital|Far Eastern Memorial Hospital Gastric Cancer June 2000 Phase 2
    NCT01485926 Cancer Trials Ireland Breast Cancer October 2010 Phase 2
    NCT02959749 Qingdao Central Hospital Progression Free Survival August 2015 Phase 2|Phase 3
    NCT01148615 Sanofi|Regeneron Pharmaceuticals Neoplasm Malignant July 2010 Phase 1
    NCT00598858 John P. Fruehauf|Sanofi|University of California, Irvine Prostate Cancer|Adenocarcinoma of the Prostate|Stage I Prostate Cancer|Stage II Prostate Cancer January 2009 Phase 2
    NCT01642004 Bristol-Myers Squibb Squamous Cell Non-small Cell Lung Cancer October 16, 2012 Phase 3
    NCT00661778 Hoffmann-La Roche Non-small Cell Lung Cancer July 2007 Phase 2
    NCT00049296 Case Comprehensive Cancer Center|National Cancer Institute (NCI) Cancer July 2002 Phase 1
    NCT00783471 Hellenic Cooperative Oncology Group Advanced Non-Small Cell Lung Cancer November 2008 Phase 2
    NCT00619996 Italian Trial in Medical Oncology Prostate Cancer March 2007 Phase 2
    NCT02565901 University of Washington|National Cancer Institute (NCI) Castration Levels of Testosterone|Hormone-Resistant Prostate Cancer|Metastatic Prostate Carcinoma|Prostate Carcinoma Metastatic in the Bone|PSA Progression|Recurrent Prostate Carcinoma|Stage IV Prostate Cancer February 2016 Phase 1|Phase 2
    NCT00845884 Rabin Medical Center Advanced Gastric Cancer February 2009 Phase 1|Phase 2
    NCT00357747 NCIC Clinical Trials Group|Canadian Cancer Trials Group Unspecified Adult Solid Tumor, Protocol Specific April 2005 Phase 1
    NCT00198237 Indiana University School of Medicine|Aventis Pharmaceuticals|Indiana University Breast Cancer March 2003 Phase 2
    NCT01107444 Eli Lilly and Company Non Small Cell Lung Cancer May 2010 Phase 2
    NCT00049088 National Cancer Institute (NCI) Unspecified Adult Solid Tumor, Protocol Specific August 2002 Phase 1
    NCT02524275 University of Nebraska|National Cancer Institute (NCI) Head and Neck Squamous Cell Carcinoma March 2015 Phase 2
    NCT00551577 University Hospital, Bonn|Sanofi Ovarian Neoplasms March 2003 Phase 2
    NCT00142571 Memorial Sloan Kettering Cancer Center|Connective Tissue Oncology Society|M.D. Anderson Cancer Center|Massachusetts General Hospital|Mayo Clinic|University of Michigan Cancer Center Sarcoma, Soft Tissue January 2003 Phase 3
    NCT00461344 Sanofi Ductal Carcinoma July 2004 Phase 2
    NCT02536495 Erin Bertino|Karyopharm Therapeutics Inc|Ohio State University Comprehensive Cancer Center Recurrent Squamous Cell Lung Carcinoma|Stage IV Squamous Cell Lung Carcinoma September 2015 Phase 1|Phase 2
    NCT01094288 Millennium Pharmaceuticals, Inc.|Takeda Advanced Solid Tumors|Adenocarcinoma of the Prostate September 2010 Phase 1
    NCT00840125 Meir Medical Center Non-Small Cell Lung Cancer February 2009 Phase 2
    NCT01084655 Millennium Pharmaceuticals, Inc. Prostate Cancer July 2010 Phase 1|Phase 2
    NCT00072033 Swiss Group for Clinical Cancer Research Esophageal Cancer March 2003 Phase 2
    NCT00979641 Tampere University Hospital|Oulu University Hospital|Turku University Hospital Neoplasms January 2009 Phase 2
    NCT00707473 M.D. Anderson Cancer Center Paranasal Sinus Neoplasms|Squamous Cell Carcinoma June 2008 Phase 2
    NCT00271505 M.D. Anderson Cancer Center|Genentech, Inc. Non-Small Cell Lung Cancer December 2005 Phase 2
    NCT00253370 National Cancer Institute (NCI) Adenocarcinoma of the Gastroesophageal Junction|Metastatic Gastric Cancer|Advanced Unresectable Gastric Cancer October 2005 Phase 2
    NCT00679341 Hoffmann-La Roche Breast Cancer September 2008 Phase 2
    NCT00276055 New Mexico Cancer Care Alliance Sarcoma November 2005 Phase 1
    NCT00145418 Oncology Specialists, S.C.|Sanofi-Synthelabo Carcinoma, Non-Small-Cell Lung February 2005 Phase 2
    NCT00066456 Gynecologic Oncology Group|National Cancer Institute (NCI) Fallopian Tube Carcinoma|Primary Peritoneal Carcinoma|Recurrent Ovarian Carcinoma|Stage III Ovarian Cancer|Stage IV Ovarian Cancer September 2003 Phase 1
    NCT00526110 M.D. Anderson Cancer Center|Sanofi-Synthelabo Gastrointestinal Diseases August 2004 Phase 1|Phase 2
    NCT00786682 University of Medicine and Dentistry of New Jersey|National Cancer Institute (NCI)|Rutgers, The State University of New Jersey Prostate Cancer December 2008 Phase 2
    NCT00065182 GlaxoSmithKline Non-Small-Cell Lung Cancer|Lung Cancer, Non-Small Cell August 2003 Phase 2
    NCT02598895 University of Washington|National Cancer Institute (NCI) Castration Levels of Testosterone|Hormone-Resistant Prostate Cancer|Metastatic Prostate Carcinoma|Prostate Carcinoma Metastatic in the Bone|Recurrent Prostate Carcinoma|Stage IV Prostate Cancer January 2016
    NCT02643407 Guangdong Association of Clinical Trials Non-Small Cell Lung Cancer October 2015 Phase 3
    NCT01126008 Samsung Medical Center Head and Neck Cancer December 2009 Phase 2
    NCT00441922 Hellenic Oncology Research Group|University Hospital of Crete Non Small Cell Lung Cancer January 2003 Phase 3
    NCT01206036 Central European Society for Anticancer Drug Research Prostatic Neoplasms July 2010 Phase 1|Phase 2
    NCT00206518 Mothaffar Rimawi|Baylor College of Medicine|Baylor Breast Care Center Breast Cancer September 2004 Phase 2
    NCT00687440 Merck Sharp & Dohme Corp.|MDS Pharma Services Breast Neoplasm May 18, 2005 Phase 2
    NCT03093272 Dana-Farber Cancer Institute|Janssen Pharmaceutica Prostate Cancer June 30, 2017 Phase 2
    NCT00448734 Poniard Pharmaceuticals Hormone Refractory Prostate Cancer June 2006 Phase 1|Phase 2
    NCT00118131 University of Medicine and Dentistry of New Jersey|National Cancer Institute (NCI)|Aventis Pharmaceuticals|Rutgers, The State University of New Jersey Lung Cancer December 2003 Phase 2
    NCT00980603 National Cancer Center, Korea|Seoul National University Bundang Hospital|Chungbuk National University Hospital|Gachon University Gil Medical Center Gastric Cancer November 2008 Phase 2
    NCT03228186 University of Michigan Cancer Center Non-small Cell Lung Cancer September 1, 2017 Phase 2
    NCT00544960 Ascenta Therapeutics Non-small Cell Lung Cancer September 2007 Phase 2
    NCT00908336 Hospital Arnau de Vilanova Non-Small Cell Lung Cancer March 2009 Phase 2
    NCT00686985 Jeroen Bosch Ziekenhuis Small Cell Lung Cancer September 2007 Phase 2
    NCT00085358 National Cancer Institute (NCI) Brenner Tumor|Fallopian Tube Cancer|Ovarian Carcinosarcoma|Ovarian Clear Cell Cystadenocarcinoma|Ovarian Endometrioid Adenocarcinoma|Ovarian Mixed Epithelial Carcinoma|Ovarian Mucinous Cystadenocarcinoma|Ovarian Serous Cystadenocarcinoma|Ovarian Undifferentiated Adenocarcinoma|Primary Peritoneal Cavity Cancer|Stage II Ovarian Epithelial Cancer|Stage III Ovarian Epithelial Cancer|Stage IV Ovarian Epithelial Cancer May 2004 Phase 1
    NCT00276549 Case Comprehensive Cancer Center|National Cancer Institute (NCI) Prostate Cancer October 2005 Phase 2
    NCT02787473 First People's Hospital of Hangzhou Squamous Cell Lung Cancer October 2016 Phase 2
    NCT01234051 Korean South West Oncology Group Biliary Tract Cancer November 2010 Phase 2
    NCT02191059 Shandong Cancer Hospital and Institute Non Small Cell Lung Cancer July 2014 Phase 2
    NCT02036359 National Taiwan University Hospital Non-small Cell Lung Cancer(NSCLC) May 2012 Phase 2
    NCT00758732 Hellenic Oncology Research Group|University Hospital of Crete Ovarian Cancer October 2005 Phase 2
    NCT03154983 Zhou Fuxiang|Zhongnan Hospital Metastatic Gastric Cancer May 20, 2017 Phase 2
    NCT01932580 McGill University Gastric Adenocarcinoma|Esophageal Adenocarcinoma August 2013 Phase 2
    NCT00139269 Dana-Farber Cancer Institute|Brigham and Women's Hospital|Sanofi Advanced Squamous Cell Carcinoma|Squamous Cell Carcinoma of Head and Neck|SSCHN February 1998 Phase 1|Phase 2
    NCT00183794 University of Southern California|Aventis Pharmaceuticals|Eli Lilly and Company Ovarian Carcinoma|Peritoneal Neoplasms November 2002 Phase 2
    NCT00301808 Barbara Ann Karmanos Cancer Institute|National Cancer Institute (NCI) Lung Cancer November 2005 Phase 2
    NCT02642042 National Cancer Institute (NCI) KRAS Gene Mutation|Recurrent Non-Small Cell Lung Carcinoma|Stage IV Non-Small Cell Lung Cancer AJCC v7 July 18, 2016 Phase 2
    NCT01718353 Sanofi Prostate Cancer Metastatic March 2013 Phase 2
    NCT00312377 Genzyme, a Sanofi Company|Sanofi Non-small Cell Lung Cancer|Lung Cancer May 2006 Phase 3
    NCT00941330 Emory University|Pfizer Breast Cancer July 2009 Phase 2
    NCT00988208 Celgene Prostate Cancer November 11, 2009 Phase 3
    NCT01025349 Taipei Medical University Hospital Metastatic Breast Cancer January 2005 Phase 2
    NCT01933932 AstraZeneca Locally Advanced or Metastatic Non Small Cell Lung Cancer Stage IIIb - IV September 2013 Phase 3
    NCT01356303 National Guard Health Affairs Non-small Cell Lung Cancer Metastatic March 2009 Phase 2
    NCT02146222 University of Wisconsin, Madison|Tyrogenex|National Cancer Institute (NCI) Unspecified Adult Solid Tumor, Protocol Specific September 2014 Phase 1
    NCT00343239 Sanofi Stomach Neoplasms June 2006 Phase 2
    NCT01957995 University of Southern California|Jina Pharmaceuticals, Inc.|National Cancer Institute (NCI) Unspecified Adult Solid Tumor, Protocol Specific November 8, 2013 Phase 1
    NCT00364611 Sanofi Breast Cancer August 2006 Phase 2
    NCT02522910 Yonsei University NSCLC (Non-Small Cell Lung Cancer) August 2015 Phase 1|Phase 2
    NCT00382720 Sanofi Stomach Neoplasms September 2006 Phase 2
    NCT00587431 Memorial Sloan Kettering Cancer Center Prostate Cancer July 2003 Phase 2
    NCT01938456 GlaxoSmithKline Lung Cancer, Non-Small Cell October 2013 Phase 1
    NCT01903993 Hoffmann-La Roche Non-Small Cell Lung Cancer August 5, 2013 Phase 2
    NCT01138163 Peregrine Pharmaceuticals Non-small-cell Lung Cancer June 2010 Phase 2
    NCT00084825 M.D. Anderson Cancer Center|National Cancer Institute (NCI) Metastatic Cancer|Prostate Cancer May 2003 Phase 2
    NCT01646125 Novartis Pharmaceuticals|Novartis Advanced Non Small Cell Lung Cancer (NSCLC) November 2012 Phase 2
    NCT00320749 Tony Bekaii-Saab|University of Michigan Cancer Center|Ohio State University Comprehensive Cancer Center Pancreatic Cancer December 2005 Phase 1
    NCT00225420 UNC Lineberger Comprehensive Cancer Center|Sanofi Prostate Cancer August 2005 Phase 1|Phase 2
    NCT02649855 National Cancer Institute (NCI)|National Institutes of Health Clinical Center (CC) Prostate Cancer|Prostate Neoplasms|Neoplasms, Prostatic January 4, 2016 Phase 2
    NCT00912444 Shanghai Jiao Tong University School of Medicine Breast Cancer July 2009 Phase 3
    NCT00076388 AstraZeneca Non-Small-Cell Lung Carcinoma February 2004 Phase 3
    NCT00887809 Memorial Sloan Kettering Cancer Center|Genentech, Inc. Sarcoma|Leiomyosarcoma|Malignant Fibrous|Histiocytoma|Angiosarcoma April 2009 Phase 2
    NCT00079118 Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI) Breast Cancer April 2004 Phase 2
    NCT03071042 Sir Run Run Shaw Hospital|Jiangsu HengRui Medicine Co., Ltd. Metastatic Gastric Adenocarcinoma October 2015 Phase 1
    NCT00500110 M.D. Anderson Cancer Center|Novartis Pharmaceuticals Prostate Cancer June 2003 Phase 2
    NCT00436501 National Cancer Institute (NCI) Fallopian Tube Cancer|Malignant Tumor of Peritoneum|Recurrent Ovarian Epithelial Cancer January 2007 Phase 1|Phase 2
    NCT00401765 Centocor, Inc. Prostatic Neoplasms September 2005 Phase 1
    NCT00689156 Danish Breast Cancer Cooperative Group|Fonden Til Fremme af Klinisk- Eksperimentel Cancerforskning|Sanofi|Dako Breast Neoplasms June 2008 Phase 3
    NCT01379807 Grupo Gallego de Investigaciones Oncologicas|Amgen|Trial Form Support S.L. Gastric Adenocarcinoma|Gastroesophageal Junction Adenocarcinoma December 2010 Phase 2
    NCT02360501 Sun Yat-sen University Nasopharyngeal Neoplasms January 2008 Phase 2
    NCT00114218 Gynecologic Oncology Group|National Cancer Institute (NCI) Recurrent Uterine Corpus Sarcoma|Uterine Carcinosarcoma March 2005 Phase 2
    NCT02469116 Washington University School of Medicine|Sanofi Ovarian Cancer January 2006 Phase 2
    NCT00996333 Columbia University|Sanofi Metastatic Pancreatic Cancer June 2003 Phase 2
    NCT00459186 Dana-Farber Cancer Institute|Novartis|Massachusetts General Hospital|Beth Israel Deaconess Medical Center|Oregon Health and Science University Metastatic, Androgen Independent Prostate Cancer|Prostate Cancer November 2005 Phase 1|Phase 2
    NCT02300298 Boehringer Ingelheim Carcinoma, Non-Small-Cell Lung December 2014 Phase 1
    NCT00713219 Memorial Sloan Kettering Cancer Center|Oncology/Hematology West Head and Neck Cancer July 2008 Phase 2
    NCT00074204 Case Comprehensive Cancer Center|National Cancer Institute (NCI) Lung Cancer October 2003 Phase 3
    NCT00215709 Geriatric Oncology Consortium|Sanofi Prostate Cancer July 2004 Phase 1
    NCT02007148 International Group of Endovascular Oncology Gastric Adenocarcinoma,|Gastroesophageal-junction Adenocarcinoma November 2013 Phase 2
    NCT02831491 Eli Lilly and Company Stage IV Non-small Cell Lung Cancer November 2016 Phase 2
    NCT00005963 Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI) Breast Cancer November 2000 Phase 2
    NCT02596256 Chinese PLA General Hospital Gastric Cancer April 2016 Phase 2
    NCT00819728 Sanofi Carcinoma, Non-Small-Cell Lung June 2000 Phase 2
    NCT00116142 Dana-Farber Cancer Institute|Sanofi Prostate Cancer June 2005 Phase 3
    NCT00312208 Sanofi|Cancer International Research Group (CIRG) Breast Cancer November 2001 Phase 3
    NCT02393209 Millennium Pharmaceuticals, Inc.|Takeda Non-small Cell Lung Cancer June 2015 Phase 1|Phase 2
    NCT02179567 Hellenic Oncology Research Group NSCLC March 2010 Phase 2
    NCT00405951 Gemin X|Teva Pharmaceutical Industries Lung Cancer October 2006 Phase 1|Phase 2
    NCT02249702 Mario Negri Institute for Pharmacological Research|PharmaMar Leiomyosarcoma April 2010 Phase 2
    NCT00006010 Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI) Liver Cancer September 2001 Phase 2
    NCT00176631 Rutgers, The State University of New Jersey|National Cancer Institute (NCI) Prostate Cancer September 2007 Phase 2
    NCT00054457 Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI) Esophageal Cancer|Gastric Cancer September 2003 Phase 2
    NCT00738387 Novartis Pharmaceuticals|Novartis Non-Small Cell Lung Cancer December 2008 Phase 3
    NCT00268840 ARCAGY/ GINECO GROUP Pancreatic Neoplasms|Biliary Tract Neoplasms August 2001 Phase 2
    NCT00533533 Samsung Medical Center Gastric Cancer January 2006 Phase 1|Phase 2
    NCT00055861 National Cancer Institute (NCI) Recurrent Breast Cancer|Stage IV Breast Cancer July 2002 Phase 2
    NCT01245543 Daiichi Sankyo Inc. Solid Tumors November 2010 Phase 1
    NCT00494338 Sanofi Metastatic Prostate Cancer November 2004 Phase 2
    NCT01087580 Northwestern University|Genzyme, a Sanofi Company PROSTATE CANCER March 2011 Phase 2
    NCT00134706 Dana-Farber Cancer Institute|Bristol-Myers Squibb|Beth Israel Deaconess Medical Center|Lowell General Hospital|Massachusetts General Hospital|Oregon Health and Science University|Wentworth-Douglass Hospital Prostate Cancer January 2004 Phase 2
    NCT00125411 Agennix Tumors March 2007 Phase 1
    NCT00214864 Cancer Research Network|Hoffmann-La Roche Metastatic Breast Cancer December 2002 Phase 2
    NCT01577654 Endocyte Non Small Cell Lung Cancer March 2011 Phase 2
    NCT00401323 Sanofi Head and Neck Neoplasms|Neoplasm Recurrence, Local|Neoplasm Metastasis January 1998 Phase 2|Phase 3
    NCT00378404 Susanne Arnold|Kentucky Lung Cancer Research Program|University of Kentucky Non-Small Cell Lung Cancer November 2004 Phase 1
    NCT01710592 Cancer Trials Ireland Gastro Oesophageal Cancer May 2007 Phase 2
    NCT02685267 Prostate Cancer Clinical Trials Consortium|University of Chicago|Astellas Pharma Inc Prostate Cancer February 2016 Phase 2
    NCT00055770 National Cancer Institute (NCI) Recurrent Salivary Gland Cancer|Recurrent Squamous Cell Carcinoma of the Hypopharynx|Recurrent Squamous Cell Carcinoma of the Larynx|Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity|Recurrent Squamous Cell Carcinoma of the Nasopharynx|Recurrent Squamous Cell Carcinoma of the Oropharynx|Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity|Salivary Gland Squamous Cell Carcinoma|Stage III Salivary Gland Cancer|Stage III Squamous Cell Carcinoma of the Hypopharynx|Sta October 2002 Phase 1|Phase 2
    NCT02035527 Ohio State University Comprehensive Cancer Center|National Comprehensive Cancer Network Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma|Recurrent Metastatic Squamous Neck Cancer With Occult Primary|Recurrent Salivary Gland Cancer|Recurrent Squamous Cell Carcinoma of the Hypopharynx|Recurrent Squamous Cell Carcinoma of the Larynx|Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity|Recurrent Squamous Cell Carcinoma of the Nasopharynx|Recurrent Squamous Cell Carcinoma of the Oropharynx|Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Na April 14, 2014 Phase 1|Phase 2
    NCT00394433 Dana-Farber Cancer Institute|Brigham and Women's Hospital|Massachusetts General Hospital|Genentech, Inc. Esophageal Cancer|Stomach Cancer September 2006 Phase 2
    NCT02445586 Hoffmann-La Roche Breast Cancer August 17, 2015 Phase 4
    NCT02257619 Incyte Corporation Non-Small Cell Lung Cancer June 2014 Phase 2
    NCT00705315 Hellenic Oncology Research Group Breast Cancer May 2008 Phase 1|Phase 2
    NCT02036060 Spanish Oncology Genito-Urinary Group Metastatic Prostate Cancer February 2014 Phase 2
    NCT02549677 Ruijin Hospital Breast Neoplasms October 2015 Phase 4
    NCT01437449 Stanford University Head and Neck Cancer October 2011 Phase 2
    NCT01378091 Columbia University|Celgene Corporation Prostate Cancer August 2005 Phase 1
    NCT00084890 Wake Forest University Health Sciences|National Cancer Institute (NCI) Cervical Cancer November 2003 Phase 1
    NCT00174655 Sanofi Breast Neoplasms June 1998 Phase 3
    NCT01326559 Hong Kong Nasopharyngeal Cancer Study Group Limited|The University of Hong Kong|Sanofi|Merck Sharp & Dohme Corp.|Roche Pharma AG Nasopharyngeal Carcinoma June 2010 Phase 2
    NCT00882310 Columbia University Pancreatic Cancer September 2006 Phase 2
    NCT00251225 University of Pittsburgh|Novartis Pharmaceuticals Prostate Cancer August 2005 Phase 2
    NCT03069820 Second Affiliated Hospital of Nanchang University Liver Injury, Drug-Induced February 10, 2017 Phase 4
    NCT02834403 Angel Augusto Rodriguez, MD|The Methodist Hospital System Metastatic Triple Negative Breast Cancer July 2016 Phase 1
    NCT01562301 M.D. Anderson Cancer Center|National Cancer Institute (NCI)|Nerium Biotechnology Chemotherapeutic Agent Toxicity|Lung Cancer June 2014 Phase 1
    NCT00003900 Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI) Lung Cancer October 1999 Phase 2
    NCT00705822 Sanofi Prostatic Neoplasms August 2006 Phase 3
    NCT00064012 University of Wisconsin, Madison|National Cancer Institute (NCI) Lung Cancer May 2003 Phase 2
    NCT02516670 Sidney Kimmel Comprehensive Cancer Center|National Cancer Institute (NCI) Hormone-Resistant Prostate Cancer|Metastatic Prostate Carcinoma|Stage IV Prostate Cancer June 2016 Phase 2
    NCT00242918 Benaroya Research Institute|AstraZeneca|Sanofi Prostate Cancer May 2003 Phase 2
    NCT01188187 OncoGenex Technologies|Teva Pharmaceutical Industries Prostate Cancer November 2010 Phase 3
    NCT00076024 Pfizer Breast Neoplasms February 2004 Phase 1|Phase 2
    NCT00521521 Sanofi Head and Neck Neoplasms July 2001 Phase 2
    NCT00688740 Sanofi|Cancer International Research Group (CIRG) Breast Cancer June 1997 Phase 3
    NCT00268593 Progen Pharmaceuticals|Northern Sydney and Central Coast Area Health Service|Aventis Pharmaceuticals Prostate Cancer August 2005 Phase 2
    NCT01250717 Beth Israel Deaconess Medical Center|Walter Reed Army Medical Center|Dana-Farber Cancer Institute Prostate Cancer January 2001 Phase 2
    NCT00251433 Novartis Pharmaceuticals|Novartis Neoplasms, Breast September 26, 2005 Phase 1
    NCT00494481 Genzyme, a Sanofi Company|Sanofi Advanced Breast Cancer January 2006 Phase 2
    NCT01719302 University of Vermont|Novartis Stage III Adult Soft Tissue Sarcoma October 2012 Phase 1|Phase 2
    NCT00690300 University of Ulm Pancreas Neoplasms January 2008 Phase 2
    NCT00126230 Gustave Roussy, Cancer Campus, Grand Paris Prostate Cancer January 2004 Phase 2
    NCT00515411 Memorial Sloan Kettering Cancer Center|Sanofi|Roche/Genetech|City of Hope National Medical Center|Piedmont Hospital Research Institute|Medical College of Wisconsin|Queens Health Network|Weill Medical College of Cornell University|Memorial Cancer Institute, Florida|University of Pittsburgh|Long Island Jewish Medical Center|Nebraska Cancer Specialists Methodist Estabrook Cancer Center Gastroesophageal Junction Adenocarcinoma|Gastric Cancer October 2006 Phase 2
    NCT00314782 AstraZeneca Prostate Cancer March 2006 Phase 1
    NCT00703625 Washington University School of Medicine Resistant Solid Malignancies March 8, 2008 Phase 1
    NCT00711243 Northwestern University|National Cancer Institute (NCI) Gastric Cancer|Unspecified Adult Solid Tumor, Protocol Specific March 2005 Phase 1|Phase 2
    NCT03119857 Andreas Josefsson|Göteborg University Prostatic Neoplasms February 2009 Phase 3
    NCT00238407 Swiss Group for Clinical Cancer Research Esophageal Cancer March 2004 Phase 2
    NCT00362882 National Cancer Institute (NCI) Non-small Cell Lung Cancer|Recurrent Non-small Cell Lung Cancer|Stage IV Non-small Cell Lung Cancer July 2006 Phase 2
    NCT01204307 Chang Gung Memorial Hospital|Taiwan Chest Disease Association Advanced Non-Squamous Non-Small Cell Lung Cancer January 2010 Phase 2
    NCT02008227 Hoffmann-La Roche Non-Squamous Non-Small Cell Lung Cancer March 11, 2014 Phase 3
    NCT01540253 Roswell Park Cancer Institute|National Cancer Institute (NCI)|Novartis Unspecified Adult Solid Tumor, Protocol Specific May 2012 Phase 1
    NCT00115635 Herlev Hospital|Sanofi|Eli Lilly and Company Prostate Cancer March 2005 Phase 1|Phase 2
    NCT01932697 Mayo Clinic|National Cancer Institute (NCI) Human Papillomavirus Infection|Stage I Oropharyngeal Squamous Cell Carcinoma|Stage II Oropharyngeal Squamous Cell Carcinoma|Stage III Oropharyngeal Squamous Cell Carcinoma|Stage IVA Oropharyngeal Squamous Cell Carcinoma|Stage IVB Oropharyngeal Squamous Cell Carcinoma September 2013 Phase 2
    NCT00183937 University of Southern California|Millennium Pharmaceuticals, Inc. Prostate Cancer April 2005 Phase 2
    NCT01222312 Krankenhaus Nordwest Non Small Cell Lung Cancer August 2008 Phase 2
    NCT00280098 Sanofi Prostatic Neoplasms January 2006 Phase 4
    NCT00073385 Titan Pharmaceuticals Carcinoma, Non-Small-Cell Lung September 2003 Phase 2
    NCT02502864 H. Lee Moffitt Cancer Center and Research Institute|Saladax Biomedical, Inc. Breast Cancer January 26, 2016 Phase 4
    NCT01911325 Novartis Pharmaceuticals|Novartis Squamous Non-small Cell Lung Cancer October 2013 Phase 1|Phase 2
    NCT00040885 Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI) Anorexia|Cachexia|Fatigue|Lung Cancer October 2002 Phase 3
    NCT03221881 Hebei Medical University Fourth Hospital Breast Cancer January 2015
    NCT00732745 Case Comprehensive Cancer Center|National Cancer Institute (NCI) Adenocarcinoma of the Gastroesophageal Junction|Esophageal Cancer October 2008 Phase 1
    NCT02508246 University of Washington|National Cancer Institute (NCI) Head and Neck Squamous Cell Carcinoma July 22, 2015 Phase 1
    NCT00260026 Memorial Sloan Kettering Cancer Center Non-Small Cell Lung Cancer November 2004 Phase 2
    NCT00003762 Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI) Lung Cancer February 1999 Phase 2
    NCT00193089 SCRI Development Innovations, LLC|Aventis Pharmaceuticals|GlaxoSmithKline Breast Cancer April 2001 Phase 2
    NCT00764166 Assistance Publique - Hôpitaux de Paris|ARTIC group (oncologists and urologists association) Adenocarcinoma of the Prostate June 2003 Phase 3
    NCT01268163 Hospira, now a wholly owned subsidiary of Pfizer Cancer August 2007 Phase 1
    NCT01095302 Sanofi Neoplasms, Malignant May 2010 Phase 1
    NCT00514917 Sanofi Prostatic Neoplasms July 2007 Phase 3
    NCT03154749 Guangdong General Hospital Triple-Negative Breast Cancer September 1, 2016 Phase 2
    NCT02426125 Eli Lilly and Company Urothelial Carcinoma July 2015 Phase 3
    NCT00278460 Wake Forest University Health Sciences|National Cancer Institute (NCI) Lung Cancer November 2000 Phase 2
    NCT03140553 Guangdong General Hospital HER2-Positive Breast Cancer September 1, 2016 Phase 2
    NCT01683994 National Cancer Institute (NCI)|National Institutes of Health Clinical Center (CC) Prostatic Neoplasms September 6, 2012 Phase 1|Phase 2
    NCT02392845 Hospices Civils de Lyon Metastatic Breast Cancer June 2005 Phase 1
    NCT00027885 Case Comprehensive Cancer Center|National Cancer Institute (NCI) Breast Cancer November 2001 Phase 2
    NCT00193050 SCRI Development Innovations, LLC|Pharmacia and Upjohn|Eli Lilly and Company|Aventis Pharmaceuticals Breast Cancer November 2001 Phase 2
    NCT02969473 Zhu Yujia|Sun Yat-sen University Esophageal Neoplasm|Chemoradiation October 2010 Phase 2
    NCT00227669 UNICANCER Sarcoma October 2005 Phase 2
    NCT01939054 Chinese Academy of Medical Sciences|Biotech Pharmaceutical Co., Ltd. Breast Cancer September 2013 Phase 2
    NCT02223884 Yonsei University Malignant Melanoma July 2011 Phase 2
    NCT00808418 Synta Pharmaceuticals Corp. Prostate Cancer November 2008 Phase 1
    NCT01285635 University of Michigan Cancer Center Squamous Cell Carcinoma of the Head and Neck (SCCHN) June 2010 Phase 2
    NCT00088998 Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI) Breast Cancer December 2004 Phase 2
    NCT01567618 Sixth Affiliated Hospital, Sun Yat-sen University Gastric Adenocarcinoma March 2012 Phase 2
    NCT01517009 Jeroen Bosch Ziekenhuis|Eindhoven Cancer Registry Gastric Cancer June 2008 Phase 2
    NCT00793377 German Breast Group|German Adjuvant Breast Cancer Group Primary Breast Cancer Phase 3
    NCT02439346 Bayer Medical Oncology June 15, 2015 Phase 1
    NCT01703091 Eli Lilly and Company Non-small Cell Lung Cancer Metastatic December 2012 Phase 2
    NCT01639131 Sidney Kimmel Comprehensive Cancer Center Metastatic Colorectal Adenocarcinoma August 2012 Phase 2
    NCT00232206 Providence Health & Services|Providence Cancer Center, Earle A. Chiles Research Institute|Sanofi Non-small-Cell Lung Carcinoma May 2005 Phase 2
    NCT00532155 Sanofi|Regeneron Pharmaceuticals Carcinoma|Non Small Cell Lung September 2007 Phase 3
    NCT00159471 University of Southern California|Sanofi Pancreatic Cancer February 2005
    NCT02613507 Bristol-Myers Squibb Non-Small Cell Lung Cancer December 2015 Phase 3
    NCT01194960 Oxford BioMedica|MedSource Hormone Refractory Prostate Cancer August 2010 Phase 2
    NCT01286766 Yonsei University Gastric Cancer September 2009 Phase 2
    NCT00004235 Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI) Esophageal Cancer|Gastric Cancer January 2000 Phase 2
    NCT01368848 Arbeitsgemeinschaft medikamentoese Tumortherapie|Sanofi|Roche Pharma AG NSCLC April 2010 Phase 2
    NCT00966914 BioNumerik Pharmaceuticals, Inc. Non-small Cell Lung Cancer April 2010 Phase 3
    NCT03061643 Samsung Medical Center Prostatic Neoplasm February 8, 2017 Phase 2
    NCT01750281 AstraZeneca Locally Advanced or Metastatic Non Small Cell Lung Cancer Stage IIIb - IV December 18, 2012 Phase 2
    NCT01385228 Daniel George, MD|GlaxoSmithKline|Duke University Prostate Cancer June 2011 Phase 1
    NCT00453635 Hellenic Oncology Research Group|University Hospital of Crete Breast Cancer December 2003 Phase 2
    NCT00070252 National Cancer Institute (NCI) Adult Solid Neoplasm|Inflammatory Breast Carcinoma|Male Breast Carcinoma|Stage IIIA Breast Cancer|Stage IIIB Breast Cancer September 2003 Phase 1|Phase 2
    NCT02633176 Sun Yat-sen University|Chinese Southwest Oncology Group Nasopharyngeal Carcinoma January 2015 Phase 3
    NCT00273546 Sanofi Cancer May 1999 Phase 3
    NCT00833859 H. Lee Moffitt Cancer Center and Research Institute|Sanofi Pancreatic Neoplasms March 2009 Phase 2
    NCT02171741 Boehringer Ingelheim Neoplasms April 2005 Phase 1
    NCT02604342 Hoffmann-La Roche Non-small Cell Lung Cancer November 3, 2015 Phase 3
    NCT00604435 Xijing Hospital Breast Cancer February 2008 Phase 2
    NCT02852798 Jiangsu ShengDiYa Medicine Co., Ltd.|Dongguan People's Hospital Nonsquamous Nonsmall Cell Neoplasm of Lung August 2016
    NCT00075543 Groupe Cooperateur Multidisciplinaire en Oncologie (GERCOR)|National Cancer Institute (NCI) Ovarian Cancer July 2003 Phase 1|Phase 2
    NCT02409199 Shanghai Zhongshan Hospital Gastric Carcinoma June 2015 Phase 2|Phase 3
    NCT01526499 Fudan University Breast Cancer December 2011 Phase 2
    NCT00557206 Minneapolis Veterans Affairs Medical Center|Sanofi Neoplasms|Head and Neck Neoplasms April 2005 Phase 2
    NCT02623153 Tianshu Liu|Shanghai Zhongshan Hospital Gastric Cancer January 2016 Phase 2
    NCT00086333 Seattle Genetics, Inc. Non-Small Cell Lung Carcinoma July 2004 Phase 2
    NCT02799602 Bayer|Orion Corporation, Orion Pharma Prostatic Neoplasms November 30, 2016 Phase 3
    NCT00254384 M.D. Anderson Cancer Center|Sanofi|Genentech, Inc. Lung Cancer October 2005
    NCT03013504 Prestige Biopharma Pte Ltd HER2 Positive Breast Cancer June 2017 Phase 3
    NCT00084435 Southwest Oncology Group|National Cancer Institute (NCI) Head and Neck Cancer July 2005 Phase 2
    NCT00446290 Asan Medical Center Stomach Cancer March 2006 Phase 1
    NCT00601692 Memorial Sloan Kettering Cancer Center|National Cancer Institute (NCI) Esophageal Cancer April 2003 Phase 1
    NCT00536107 AstraZeneca Carcinoma, Non-Small-Cell Lung October 2007 Phase 4
    NCT00069888 Sanofi Prostate Cancer November 2001 Phase 2
    NCT00821912 Karolinska University Hospital Cancer of the Esophagus|Gastric Cardia Carcinoma March 2006 Phase 1|Phase 2
    NCT02283320 BIND Therapeutics KRAS Positive Patients With Non-small Cell Lung Cancer|Squamous Cell Non-small Cell Lung Cancer September 2014 Phase 2
    NCT00183742 University of Southern California|Tibotec Therapeutics, a Division of Ortho Biotech Products, L.P., USA Cancer|Carcinoma December 2000 Phase 1
    NCT00232479 University of Miami|Aventis Pharmaceuticals Breast Cancer September 2005 Phase 2
    NCT00146042 University of Michigan Cancer Center|Genentech, Inc. HER-2 Positive Metastatic Breast Cancer March 1999 Phase 2
    NCT01142778 Hoffmann-La Roche Breast Cancer May 19, 2010 Phase 2
    NCT00442026 Hellenic Oncology Research Group|University Hospital of Crete Non-small-cell Lung Cancer December 2006 Phase 3
    NCT00865982 Charite University, Berlin, Germany|Roche Pharma AG|Sanofi Gastric Cancer|Esophageal Cancer September 2008 Phase 2
    NCT00545246 Sanofi|Regeneron Pharmaceuticals Neoplasms October 2007 Phase 1
    NCT00356122 Sanofi|Genentech, Inc. Non-Small Cell Lung Cancer July 2006 Phase 2
    NCT00201825 Tony Bekaii-Saab|Roche Pharma AG|Ohio State University Comprehensive Cancer Center Lung Cancer|Non-Small-Cell Lung Carcinoma December 2004 Phase 2
    NCT00107510 Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI) Breast Cancer August 2005 Phase 2
    NCT01208480 Severance Hospital Breast Cancer September 2010 Phase 2
    NCT00772681 Sanofi Head and Neck Neoplasms October 2004 Phase 4
    NCT00118053 University of Medicine and Dentistry of New Jersey|National Cancer Institute (NCI)|Aventis Pharmaceuticals|Rutgers, The State University of New Jersey Breast Cancer April 2005 Phase 2
    NCT00151047 University of Michigan Cancer Center Prostate Cancer March 2003 Phase 2
    NCT00872989 Southwest Oncology Group|National Cancer Institute (NCI) Fallopian Tube Cancer|Ovarian Cancer|Primary Peritoneal Cavity Cancer March 2010 Phase 2
    NCT00807261 Asan Medical Center|Severance Hospital|Korea University Anam Hospital|Samsung Medical Center Sarcoma September 2008 Phase 2
    NCT00002825 National Cancer Institute (NCI) Brain and Central Nervous System Tumors|Neuroblastoma|Sarcoma January 1997 Phase 2
    NCT02488564 Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori HER-2 Positive Breast Cancer October 2014 Phase 2
    NCT00429871 Hellenic Oncology Research Group|University Hospital of Crete Breast Cancer May 2002 Phase 3
    NCT02896855 Hoffmann-La Roche Breast Cancer September 13, 2016 Phase 3
    NCT00209092 Emory University|Georgia Center for Oncology Research & Education|Sanofi Breast Cancer August 2006 Phase 2
    NCT02590055 Samsung Medical Center Carcinoma of Unknown Primary October 2015 Phase 2
    NCT00139711 Pfizer Carcinoma, Non-Small-Cell Lung March 2003 Phase 2
    NCT00703326 Eli Lilly and Company Breast Cancer August 2008 Phase 3
    NCT00567190 Genentech, Inc.|Hoffmann-La Roche Metastatic Breast Cancer February 12, 2008 Phase 3
    NCT00591149 University of Kansas Medical Center|Sanofi Head and Neck Cancer|Carcinoma, Squamous June 2007 Phase 2
    NCT00038194 M.D. Anderson Cancer Center|Novartis Prostate Cancer October 2001 Phase 1
    NCT02953340 Spectrum Pharmaceuticals, Inc Neutropenia|Breastcancer April 13, 2017 Phase 3
    NCT01362296 GlaxoSmithKline Lung Cancer, Non-Small Cell September 2011 Phase 2
    NCT00129376 Spanish Breast Cancer Research Group|Sanofi Breast Cancer December 2002 Phase 2
    NCT00733616 Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)|Sanofi|Hoffmann-La Roche Gastric Cancer November 2008 Phase 2
    NCT00041171 Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI) Adult Solid Tumor|Breast Cancer|Head and Neck Cancer|Kidney and Urinary Cancer|Male Reproductive Cancer|Thorax and Respiratory Cancer Phase 3
    NCT00121095 Cytogen Corporation Prostatic Neoplasms July 2005 Phase 1|Phase 2
    NCT00258362 Masonic Cancer Center, University of Minnesota|Sanofi Endometrial Cancer July 2005 Phase 2
    NCT00448097 The Methodist Hospital System|Bristol-Myers Squibb|ImClone LLC Prostatic Neoplasms February 2007 Phase 2
    NCT02401542 BioClin Therapeutics, Inc. Locally Advanced or Metastatic Urothelial Cell Carcinoma|Urinary Bladder Disease|Urological Diseases June 2015 Phase 1|Phase 2
    NCT00151073 University of Michigan Cancer Center|Aventis Pharmaceuticals|Novartis Hormone-Refractory Prostate Cancer April 2002 Phase 2
    NCT02144012 Hoffmann-La Roche Metastatic Breast Cancer June 2014 Phase 3
    NCT02437370 University of California, Davis|Merck Sharp & Dohme Corp. Metastatic Urothelial Carcinoma of the Renal Pelvis and Ureter|Recurrent Bladder Carcinoma|Recurrent Urothelial Carcinoma of the Renal Pelvis and Ureter|Regional Urothelial Carcinoma of the Renal Pelvis and Ureter|Stage III Bladder Urothelial Carcinoma|Stage III Urethral Cancer|Stage IV Bladder Urothelial Carcinoma|Stage IV Urethral Cancer|Urethral Urothelial Carcinoma August 2015 Phase 1
    NCT00683787 Roswell Park Cancer Institute Gastric Cancer May 2008 Phase 2
    NCT02447380 Samsung Medical Center Advanced Gastric Adenocarcinoma March 2017 Phase 2
    NCT00887315 University of Chicago Non-small Cell Lung Cancer April 2009 Phase 2
    NCT00952003 Arbeitsgemeinschaft medikamentoese Tumortherapie|Pfizer|Sanofi|Roche Pharma AG Gastric Cancer|Unresectable July 2009 Phase 2
    NCT01301040 Jules Bordet Institute|Sanofi Breast Cancer March 2011 Phase 2
    NCT00062439 Southwest Oncology Group|National Cancer Institute (NCI)|Eastern Cooperative Oncology Group|American College of Surgeons|North Central Cancer Treatment Group|NCIC Clinical Trials Group|Cancer and Leukemia Group B Lung Cancer July 2003 Phase 2
    NCT00296816 Sanofi Ovarian Cancer March 2006 Phase 2
    NCT00386555 Arog Pharmaceuticals, Inc. Carcinoma, Non-Small-Cell Lung May 2007 Phase 2
    NCT00664105 Vanderbilt-Ingram Cancer Center|National Cancer Institute (NCI) Lung Cancer February 2004 Phase 2
    NCT00377780 Laurence J.C. van Warmerdam|Cephalon|Sanofi|Catharina Ziekenhuis Eindhoven Breast Cancer|Neoplasm Metastasis August 2006 Phase 2
    NCT00480857 University of Michigan Cancer Center|Sanofi Prostate Cancer March 2007 Phase 2
    NCT01593748 Medical University of South Carolina|Novartis Sarcoma May 2012 Phase 2
    NCT00459043 Dana-Farber Cancer Institute|Brigham and Women's Hospital|Massachusetts General Hospital|Loyola University|AstraZeneca Squamous Cell Carcinoma of Head and Neck March 2007 Phase 2
    NCT01038752 Optimum Therapeutics, LLC Non-small Cell Lung Cancer August 2010 Phase 2
    NCT00049283 National Cancer Institute (NCI) Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma|Stage III Squamous Cell Carcinoma of the Hypopharynx|Stage III Squamous Cell Carcinoma of the Larynx|Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity|Stage III Squamous Cell Carcinoma of the Nasopharynx|Stage III Squamous Cell Carcinoma of the Oropharynx|Stage III Verrucous Carcinoma of the Larynx|Stage III Verrucous Carcinoma of the Oral Cavity|Stage IV Squamous Cell Carcinoma of the Hypopharynx|Stage IV Squ September 2002 Phase 1
    NCT02610556 Sun Yat-sen University|Affiliated Tumor Hospital of Guangzhou Medical University|The First Affiliated Hospital of Guangzhou Medical University|The First Affiliated Hospital of Guangdong Pharmaceutical University Nasopharyngeal Carcinoma January 2016 Phase 2
    NCT00193453 SCRI Development Innovations, LLC|Bristol-Myers Squibb Lung Cancer July 2005 Phase 2
    NCT02640898 Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine Gastric Cancer December 2015
    NCT03002064 Sun Yat-sen University Esophagus Cancer|Chemotherapy Effects December 2016 Phase 3
    NCT01041235 Azaya Therapeutics, Inc. Solid Tumor|Breast Cancer|Ovarian Cancer|Pancreatic Cancer|Non-Small Cell Lung December 2009 Phase 1
    NCT00309556 Austrian Breast & Colorectal Cancer Study Group|Amgen|Ebewe Pharma GmbH|Hoffmann-La Roche|Sanofi Breast Cancer February 2005 Phase 3
    NCT00559429 Sidney Kimmel Comprehensive Cancer Center|Sanofi|Cytogen Corporation Prostate Cancer December 2004 Phase 1
    NCT00820872 Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI) Breast Cancer February 2009 Phase 2
    NCT00005908 National Cancer Institute (NCI)|National Institutes of Health Clinical Center (CC) Breast Cancer|Breast Neoplasm June 2000 Phase 2
    NCT00674167 National University Hospital, Singapore Gastric Cancer May 2007 Phase 2
    NCT00527449 Klinikum Weissenfels Primary Breast Cancer May 2006 Phase 2
    NCT01630733 OncoGenex Technologies Non-Small Cell Lung Cancer September 2012 Phase 3
    NCT00942578 National Cancer Institute (NCI)|National Institutes of Health Clinical Center (CC) Metastatic Prostate Cancer July 16, 2009 Phase 2
    NCT00415779 National Cancer Institute, Naples Metastatic Prostate Cancer July 2006 Phase 1
    NCT00996502 Columbia University|Genentech, Inc. Prostate Cancer July 2006 Phase 1|Phase 2
    NCT03150875 Innovent Biologics (Suzhou) Co. Ltd. Non-squamous Cell NSCLC June 2017 Phase 3
    NCT02947061 Chinese Academy of Medical Sciences Breast Cancer Recurrent April 2015 Phase 2
    NCT00095199 Eli Lilly and Company|ImClone LLC Non Small Cell Lung Cancer January 2005 Phase 3
    NCT00424853 Sanofi Carcinoma, Non-Small-Cell Lung May 2005 Phase 2
    NCT00136526 University of Washington|Sanofi Prostate Cancer December 2002 Phase 2
    NCT01251653 Boehringer Ingelheim Neoplasms November 2010
    NCT00917748 Sanofi Prostatic Neoplasms|Breast Cancer June 2009 Phase 3
    NCT00084734 Roswell Park Cancer Institute|National Cancer Institute (NCI) Unspecified Adult Solid Tumor, Protocol Specific May 2002 Phase 1
    NCT00085332 Gynecologic Oncology Group|National Cancer Institute (NCI) Endometrial Cancer July 2004 Phase 2
    NCT00174772 Sanofi Lung Neoplasms March 2004 Phase 2
    NCT00258739 Sanofi Lung Neoplasms October 2001 Phase 2
    NCT00255606 University of Tampere|National Cancer Institute (NCI) Prostate Cancer August 2005 Phase 3
    NCT02288247 Astellas Pharma Europe Ltd.|Medivation, Inc.|Astellas Pharma Inc Metastatic Castration Resistant Prostate Cancer December 1, 2014 Phase 3
    NCT01471470 Asan Medical Center|Roche Pharma AG Advanced Gastric Cancer July 2010 Phase 2
    NCT00723086 Sanofi Therapy, Prostatic Neoplasms May 2005 Phase 2
    NCT02061631 Sanofi Squamous Cell Carcinoma of Head and Neck May 2014 Phase 2
    NCT00833326 Array BioPharma Advanced Cancer January 2009 Phase 1
    NCT00322400 Amgen Locally Recurrent and Metastatic Breast Cancer March 2006 Phase 1
    NCT02668393 Boehringer Ingelheim Carcinoma, Non-Small-Cell Lung March 7, 2016 Phase 1
    NCT00058448 Southwest Oncology Group|National Cancer Institute (NCI)|Eastern Cooperative Oncology Group Penile Cancer October 2004 Phase 2
    NCT00321698 OHSU Knight Cancer Institute Prostate Cancer January 2006 Phase 1|Phase 2
    NCT01608464 King Faisal Specialist Hospital & Research Center Carcinoma of Esophagus May 2012 Phase 2
    NCT00343512 Vanderbilt-Ingram Cancer Center|National Cancer Institute (NCI) Breast Cancer February 2004 Phase 2
    NCT00174707 Sanofi Breast Neoplasms December 1997 Phase 3
    NCT01282463 Eli Lilly and Company Carcinoma of Urinary Tract|Urethral Carcinoma|Carcinoma of Ureter|Carcinoma of Renal Pelvis April 2011 Phase 2
    NCT00430183 Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI)|Eastern Cooperative Oncology Group|NCIC Clinical Trials Group|Southwest Oncology Group Prostate Cancer December 2006 Phase 3
    NCT01145508 National Cancer Institute (NCI) Hormone-Resistant Prostate Cancer|Prostate Adenocarcinoma|Recurrent Prostate Carcinoma|Stage IV Prostate Cancer August 2010 Phase 2
    NCT00478049 AstraZeneca NSCLC September 2005 Phase 3
    NCT01253642 OHSU Knight Cancer Institute|National Cancer Institute (NCI)|The Wayne D. Kuni and Joan E. Kuni Foundation Hormone-Resistant Prostate Cancer|Metastatic Prostatic Adenocarcinoma|Prostate Adenocarcinoma|Recurrent Prostate Carcinoma July 12, 2010 Phase 2
    NCT00003445 Grupo Oncologico Cooperativo del Sur|National Cancer Institute (NCI) Cervical Cancer December 1997 Phase 2
    NCT00132379 Active Biotech AB Carcinoma, Non-Small-Cell Lung November 2005 Phase 1
    NCT00995293 Sanofi Head and Neck Neoplasms August 2009 Phase 3
    NCT00002903 European Organisation for Research and Treatment of Cancer - EORTC Extragonadal Germ Cell Tumor|Ovarian Cancer|Testicular Germ Cell Tumor July 1995 Phase 2
    NCT01624025 Yonsei University Metastatic Advanced Gastric Cancer June 2012 Phase 2
    NCT00281840 Case Comprehensive Cancer Center|National Cancer Institute (NCI) Head and Neck Cancer September 2005 Phase 2
    NCT01004601 Chang Gung Memorial Hospital Non Small Cell Lung Cancer March 2005
    NCT00263016 Sanofi Carcinoma, Non-Small-Cell Lung May 2005 Phase 2
    NCT00063934 National Cancer Institute (NCI) Male Breast Cancer|Stage IIIA Breast Cancer|Stage IIIB Breast Cancer|Stage IIIC Breast Cancer|Stage IV Breast Cancer May 2003 Phase 1|Phase 2
    NCT00041067 Southwest Oncology Group|National Cancer Institute (NCI) Breast Cancer September 2002 Phase 2
    NCT00253344 Case Comprehensive Cancer Center|National Cancer Institute (NCI) Unspecified Adult Solid Tumor, Protocol Specific June 2005 Phase 1
    NCT01126138 Chinese Academy of Medical Sciences|Hoffmann-La Roche Carcinoma, Invasive Ductal, Breast July 2010 Phase 3
    NCT00543387 Merck Sharp & Dohme Corp. Cancer, Neoplasms, Tumors March 2008 Phase 1
    NCT01576029 Sanofi Prostatic Neoplasms August 2012 Phase 2
    NCT00142038 Charite University, Berlin, Germany Stomach Neoplasm|Neoplasm Metastasis March 2004 Phase 2
    NCT00066443 NCIC Clinical Trials Group|Canadian Cancer Trials Group Breast Cancer February 2003 Phase 1|Phase 2
    NCT00099086 David T. Marshall|Medical University of South Carolina Prostate Cancer July 2010 Phase 1
    NCT00004037 Gynecologic Oncology Group|National Cancer Institute (NCI) Ovarian Cancer|Primary Peritoneal Cavity Cancer June 1998 Phase 2
    NCT00264134 Kentuckiana Cancer Institute Non-small Cell Lung Cancer|Extensive Stage Unresectable June 2003 Phase 1|Phase 2
    NCT00216125 Nasser Hanna, M.D.|Sanofi|Walther Cancer Institute|Hoosier Cancer Research Network Non-Small Cell Lung Cancer February 2002 Phase 3
    NCT00345059 National Cancer Institute, Naples Advanced Non-Small Cell Lung Cancer May 2005 Phase 3
    NCT01191216 National Cancer Institute (NCI) Unspecified Adult Solid Tumor, Protocol Specific September 2010 Phase 1
    NCT01266512 Sanofi Lung Neoplasms January 2011 Phase 2
    NCT00503984 University of Miami Prostate Cancer|Pain May 2007 Phase 1|Phase 2
    NCT00658697 Dana-Farber Cancer Institute|Brigham and Women's Hospital|Beth Israel Deaconess Medical Center|Genentech, Inc. Prostate Cancer June 2008 Phase 2
    NCT00118183 National Cancer Institute (NCI) Adenocarcinoma of the Lung|Adenosquamous Cell Lung Cancer|Large Cell Lung Cancer|Malignant Pleural Effusion|Recurrent Non-small Cell Lung Cancer|Squamous Cell Lung Cancer|Stage IIIB Non-small Cell Lung Cancer|Stage IV Non-small Cell Lung Cancer July 2005 Phase 2
    NCT00004081 Beth Israel Deaconess Medical Center|Dana-Farber Cancer Institute Ovarian Cancer|Peritoneal Cavity Cancer July 1999 Phase 2
    NCT01771289 Peking University People's Hospital Non-small Cell Lung Cancer January 2013 Phase 2
    NCT02964455 Sun Yat-sen University Esophageal Squamous Cell Carcinoma November 2016 Phase 1
    NCT00258388 NCIC Clinical Trials Group|Canadian Cancer Trials Group Prostate Cancer June 2005 Phase 2
    NCT00319514 Gachon University Gil Medical Center Advanced Non-Small Cell Lung Cancer April 2004 Phase 2
    NCT01064479 M.D. Anderson Cancer Center|OSI Pharmaceuticals|Sanofi Head and Neck Cancer|Squamous Cell Carcinoma of the Head and Neck February 2010 Phase 2
    NCT00424606 Hellenic Oncology Research Group|University Hospital of Crete Breast Cancer June 2001 Phase 3
    NCT00133224 Cell Genesys Prostate Cancer July 2005 Phase 3
    NCT00669773 National University Hospital, Singapore Breast Cancer February 2007 Phase 2
    NCT00089609 National Cancer Institute (NCI)|National Institutes of Health Clinical Center (CC) Prostatic Neoplasms August 2004 Phase 2
    NCT00303888 Yale University|National Cancer Institute (NCI) Fallopian Tube Cancer|Ovarian Cancer|Primary Peritoneal Cavity Cancer May 2006 Phase 1
    NCT00315211 Aultman Hospital|GlaxoSmithKline Mediastinal Neoplasms November 2004 Phase 2
    NCT01958580 Albert Einstein College of Medicine, Inc.|National Cancer Institute (NCI) Stage IA Uterine Sarcoma|Stage IB Uterine Sarcoma|Stage IC Uterine Sarcoma|Stage IIA Uterine Sarcoma|Stage IIB Uterine Sarcoma|Stage IIIA Uterine Sarcoma|Stage IIIB Uterine Sarcoma|Stage IIIC Uterine Sarcoma|Stage IVA Uterine Sarcoma|Stage IVB Uterine Sarcoma|Uterine Corpus Leiomyosarcoma June 2013
    NCT00490646 R-Pharm Metastatic Breast Cancer February 2008 Phase 2
    NCT00399087 AEterna Zentaris Neoplasms November 2004 Phase 1
    NCT01951157 PharmaMar Non-Small Cell Lung Cancer (NSCLC) October 2013 Phase 2
    NCT01718626 Hebei Tumor Hospital Gastric Cancer October 2012 Phase 2
    NCT00970684 Nathan Pennell, MD, PhD|National Cancer Institute (NCI)|Case Comprehensive Cancer Center Lung Cancer September 2009 Phase 2
    NCT00431613 Hellenic Oncology Research Group|University Hospital of Crete Non Small Cell Lung Cancer March 2006 Phase 2
    NCT02231164 Boehringer Ingelheim Carcinoma, Non-Small-Cell Lung October 2014 Phase 3
    NCT00525408 Cadila Pharnmaceuticals Hormone Refractory Prostate Cancer November 2007 Phase 2
    NCT00288054 Southwest Oncology Group|National Cancer Institute (NCI) Lung Cancer April 2006 Phase 1
    NCT00519285 Sanofi|Regeneron Pharmaceuticals Prostatic Neoplasms|Neoplasm Metastasis August 2007 Phase 3
    NCT02913196 Weill Medical College of Cornell University|Janssen Scientific Affairs, LLC Prostate Cancer Metastatic December 2016 Phase 1
    NCT00086957 City of Hope Medical Center|National Cancer Institute (NCI) Breast Cancer January 2004 Phase 1|Phase 2
    NCT00660699 Washington University School of Medicine Cholangiocarcinoma Cancer|Gallbladder Cancer|Pancreatic Cancer|Ampullary Cancer September 2002 Phase 2
    NCT00268671 Sanofi Head and Neck Neoplasms August 2003 Phase 1|Phase 2
    NCT00217815 NeuTec Pharma Cancer of the Breast September 2005 Phase 1|Phase 2
    NCT00757172 Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI)|Amgen Adenocarcinoma of the Gastroesophageal Junction|Esophageal Cancer January 2009 Phase 2
    NCT00173888 National Taiwan University Hospital Non-small Cell Lung Cancer July 2003 Phase 2
    NCT01110486 AbbVie (prior sponsor, Abbott)|AbbVie Advanced Solid Tumors March 2010 Phase 1
    NCT01308567 Sanofi Prostate Cancer May 2011 Phase 3
    NCT00528866 Radiation Therapy Oncology Group|National Cancer Institute (NCI)|NRG Oncology Prostate Cancer April 2008 Phase 2
    NCT00527124 National Cancer Institute (NCI) Adenocarcinoma of the Prostate|Stage IV Prostate Cancer November 2007 Phase 2
    NCT00005800 H. Lee Moffitt Cancer Center and Research Institute|National Cancer Institute (NCI)|Aventis Pharmaceuticals Breast Cancer April 1999 Phase 2
    NCT02586025 Hoffmann-La Roche Breast Cancer March 14, 2016 Phase 3
    NCT00002662 Aventis Pharmaceuticals|National Cancer Institute (NCI) Breast Cancer August 1994 Phase 3
    NCT01313390 University College, London Head and Neck Cancer June 2009 Phase 1|Phase 2
    NCT01382706 University of Southern California|National Cancer Institute (NCI)|GlaxoSmithKline Recurrent Bladder Cancer|Stage III Bladder Cancer|Stage IV Bladder Cancer|Transitional Cell Carcinoma of the Bladder June 13, 2011 Phase 2
    NCT01497041 Korean South West Oncology Group Carcinoma, Non-Small-Cell Lung|Carcinoma, Squamous|Carcinoma, Large Cell February 2011 Phase 2
    NCT00934856 Hoffmann-La Roche Breast Cancer July 2009 Phase 1|Phase 2
    NCT00148902 GlaxoSmithKline Solid Tumor Cancer April 2003 Phase 1
    NCT00283062 Sanofi Prostatic Neoplasms December 2005 Phase 3
    NCT00030641 Genta Incorporated|National Cancer Institute (NCI) Lung Cancer October 2001 Phase 2|Phase 3
    NCT00077857 Hoffmann-La Roche Breast Cancer July 2003 Phase 2
    NCT00079170 National Cancer Institute (NCI) Breast Cancer January 2004
    NCT02124902 Washington University School of Medicine Triple Negative Breast Neoplasms July 7, 2014 Phase 2
    NCT00446030 Sanofi Breast Neoplasms March 2007 Phase 2
    NCT00191139 Eli Lilly and Company Non-small Cell Lung Cancer March 2003 Phase 2
    NCT02484677 Assistance Publique Hopitaux De Marseille Patients With Head and Neck Cancer (ORL) June 2015 Phase 4
    NCT01129206 Ohio State University Comprehensive Cancer Center|National Comprehensive Cancer Network|Spectrum Pharmaceuticals, Inc Adenocarcinoma of the Esophagus|Adenocarcinomas of the Gastroesophageal Junction|Recurrent Esophageal Cancer|Squamous Cell Carcinoma of the Esophagus|Stage IV Esophageal Cancer July 2010 Phase 2
    NCT00169182 Groupe Oncologie Radiotherapie Tete et Cou|Sanofi Larynx Cancer|Hypopharynx Cancer December 2000 Phase 3
    NCT00193128 SCRI Development Innovations, LLC|Sanofi-Synthelabo|Aventis Pharmaceuticals Esophagus Cancer April 2004 Phase 1|Phase 2
    NCT00104624 UNICANCER Breast Cancer May 2005 Phase 2
    NCT00097851 Medigen Biotechnology Corporation Carcinoma, Non-Small-Cell Lung February 2004 Phase 2
    NCT00771953 University of Maryland|Tragara Pharmaceuticals, Inc. Lung Cancer|Non Small Cell Lung Cancer November 2008 Phase 2
    NCT00721747 Grupo Oncológico Gallego|Pivotal S.L. Breast Cancer January 2008 Phase 2
    NCT00527761 M.D. Anderson Cancer Center|Aventis Pharmaceuticals Metastatic Melanoma August 2004 Phase 1
    NCT00268710 Sanofi|Canadian Urologic Oncology Group Prostatic Neoplasms February 2004 Phase 2
    NCT00243113 Aichi Cancer Center|National Cancer Institute (NCI) Head and Neck Cancer June 2004 Phase 2
    NCT01155791 Sandy Srinivas|Stanford University Urologic Neoplasms|Prostate Cancer|Prostate Cancer Metastatic Disease April 2010 Phase 1
    NCT00813332 Simcere Pharmaceutical Co., Ltd Advanced NSCLC|Recurrent NSCLC October 2008 Phase 4
    NCT00225056 Oncology Specialties, Alabama Metastatic Breast Cancer October 2003 Phase 2
    NCT00372736 NCIC Clinical Trials Group|Canadian Cancer Trials Group Unspecified Adult Solid Tumor, Protocol Specific June 2006 Phase 1
    NCT00826852 Sanofi Lung Neoplasms October 2003 Phase 2
    NCT00957125 Thomas Hatschek|Karolinska University Hospital Breast Cancer September 2008 Phase 2
    NCT00258375 NCIC Clinical Trials Group|Canadian Cancer Trials Group Breast Cancer June 2005 Phase 2
    NCT00022022 Istituto Nazionale per lo Studio e la Cura dei Tumori|National Cancer Institute (NCI) Lung Cancer December 2000 Phase 3
    NCT00114205 University of Virginia|National Cancer Institute (NCI) Metastatic Cancer July 2003 Phase 1
    NCT00047801 Telik Carcinoma, Non-small-cell Lung October 2002 Phase 1|Phase 2
    NCT01671319 University of Wisconsin, Madison|Amgen Female Breast Cancer June 2011 Phase 2
    NCT00227708 UNICANCER|National Cancer Institute (NCI) Lung Cancer June 2005 Phase 2
    NCT00816543 Sanofi Gastric Cancer December 2008 Phase 2
    NCT01927744 M.D. Anderson Cancer Center|Astellas Pharma Inc|OSI Pharmaceuticals|Kadoorie Foundation Head and Neck Cancer December 2013 Phase 2
    NCT00949247 Case Comprehensive Cancer Center|National Cancer Institute (NCI) Breast Cancer December 2009 Early Phase 1
    NCT01985724 Hellenic Oncology Research Group|University Hospital of Crete Breast Cancer October 2007 Phase 3
    NCT00114192 University of Virginia|National Cancer Institute (NCI) Lung Cancer June 2004 Phase 2
    NCT02923258 Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University|Fudan University Head and Neck Squamous Cell Carcinoma November 2016 Phase 2|Phase 3
    NCT00257348 University of California, Irvine|Aventis Pharmaceuticals Cervical Cancer March 2004 Phase 2
    NCT00657423 Xijing Hospital|Yantai Medgenn Ltd. Lung Neoplasms April 2008 Phase 3
    NCT00080080 Point Therapeutics Lung Cancer Phase 2
    NCT00471159 Pfizer Breast Neoplasms August 2007 Phase 2
    NCT00084786 Memorial Sloan Kettering Cancer Center|National Cancer Institute (NCI) Unspecified Adult Solid Tumor, Protocol Specific March 2004 Phase 1
    NCT00937417 Southwest Oncology Group|National Cancer Institute (NCI) Breast Cancer|Head and Neck Cancer|Lung Cancer|Prostate Cancer|Unspecified Adult Solid Tumor, Protocol Specific September 2008 Phase 1
    NCT00327340 OncoGenex Technologies Prostate Cancer July 2006 Phase 2
    NCT00620100 Sanofi Breast Neoplasms September 2004 Phase 2
    NCT00002901 City of Hope Medical Center|National Cancer Institute (NCI) Breast Cancer|Head and Neck Cancer|Lung Cancer|Ovarian Cancer|Unspecified Adult Solid Tumor, Protocol Specific December 1996 Phase 1
    NCT00660816 Case Comprehensive Cancer Center|National Cancer Institute (NCI) Lung Cancer January 2008 Phase 2
    NCT00193271 SCRI Development Innovations, LLC|Aventis Pharmaceuticals Prostate Cancer August 2004 Phase 2
    NCT01862328 Millennium Pharmaceuticals, Inc.|Takeda Solid Tumors July 1, 2013 Phase 1
    NCT00032825 National Cancer Institute (NCI)|National Institutes of Health Clinical Center (CC) Prostatic Neoplasms March 19, 2002 Phase 1
    NCT00441740 Hellenic Oncology Research Group|University Hospital of Crete Non Small Cell Lung Cancer April 2004 Phase 3
    NCT00321633 University College London Hospitals|National Cancer Institute (NCI) brca1 Mutation Carrier|brca2 Mutation Carrier|Breast Cancer|Hereditary Breast/Ovarian Cancer (brca1, brca2) September 2005 Phase 2
    NCT00193011 SCRI Development Innovations, LLC|Aventis Pharmaceuticals Breast Cancer March 2002 Phase 3
    NCT00772863 Sanofi Ovarian Neoplasms September 2003 Phase 2
    NCT00359671 Merck Sharp & Dohme Corp. Advanced Solid Tumors December 2006 Phase 1
    NCT01810913 Radiation Therapy Oncology Group|National Cancer Institute (NCI)|NRG Oncology Stage III Squamous Cell Carcinoma of the Hypopharynx|Stage III Squamous Cell Carcinoma of the Larynx|Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity|Stage III Squamous Cell Carcinoma of the Oropharynx|Stage III Verrucous Carcinoma of the Larynx|Stage III Verrucous Carcinoma of the Oral Cavity|Stage IV Squamous Cell Carcinoma of the Hypopharynx|Stage IVA Squamous Cell Carcinoma of the Larynx|Stage IVA Squamous Cell Carcinoma of the Lip and Oral Cavity|Stage IVA Squamous Cell Carcinom March 2013 Phase 2|Phase 3
    NCT01312324 Samsung Medical Center Locally Advanced Stage III or IV Thymic Cancer February 2007 Phase 2
    NCT00551759 Eastern Cooperative Oncology Group|National Cancer Institute (NCI) Esophageal Cancer June 2008 Phase 2
    NCT02387216 Merrimack Pharmaceuticals Non-Small Cell Lung Cancer|NSCLC|Adenocarcinoma|Squamous Cell Carcinoma|Heregulin|Large Cell Carcinoma February 2015 Phase 2
    NCT00085228 European Organisation for Research and Treatment of Cancer - EORTC Prostate Cancer April 2004 Phase 2
    NCT00075465 Groupe Cooperateur Multidisciplinaire en Oncologie (GERCOR)|National Cancer Institute (NCI) Gastric Cancer April 2001 Phase 2
    NCT00589420 University of Pennsylvania|National Cancer Institute (NCI) Prostate Cancer October 2006 Phase 2
    NCT02447406 Samsung Medical Center Advanced Gastric Adenocarcinoma April 30, 2015 Phase 1|Phase 2
    NCT00238199 OHSU Knight Cancer Institute|Sanofi Pancreatic Cancer June 2002 Phase 2
    NCT00916097 Sanofi Head and Neck Neoplasms July 2002 Phase 2
    NCT00127088 Gustave Roussy, Cancer Campus, Grand Paris Prostate Cancer October 2004 Phase 2
    NCT00538525 King Faisal Specialist Hospital & Research Center Breast Cancer September 2007
    NCT01917279 Binghe Xu|Hoffmann-La Roche|Chinese Academy of Medical Sciences Breast Neoplasms|Neoplasms by Site|Neoplasm Metastasis|Breast Diseases|Skin Diseases October 2013 Phase 3
    NCT00357149 Sanofi Head and Neck Neoplasms January 2003 Phase 2
    NCT00953420 Baylor College of Medicine|Texas Children's Hospital|The Methodist Hospital System|Center for Cell and Gene Therapy, Baylor College of Medicine|M.D. Anderson Cancer Center Nasopharyngeal Carcinoma November 2009 Phase 2
    NCT00401180 The Cleveland Clinic|National Cancer Institute (NCI) Unspecified Adult Solid Tumor, Protocol Specific June 2002 Phase 1
    NCT00075517 Groupe Cooperateur Multidisciplinaire en Oncologie (GERCOR)|National Cancer Institute (NCI) Lung Cancer September 2003 Phase 2
    NCT01367028 Austrian Breast & Colorectal Cancer Study Group|Hoffmann-La Roche|Cephalon Breast Cancer June 2011 Phase 2
    NCT00191243 Eli Lilly and Company Breast Cancer March 2002 Phase 2
    NCT00425750 Vanderbilt-Ingram Cancer Center|National Cancer Institute (NCI) Head and Neck Cancer August 2005 Phase 2
    NCT00546364 R-Pharm Breast Neoplasms February 2008 Phase 2
    NCT00273338 Novacea Prostate Cancer January 2006 Phase 3
    NCT00642018 Eli Lilly and Company Prostate Cancer March 2008 Phase 2
    NCT00193245 SCRI Development Innovations, LLC|AstraZeneca|Aventis Pharmaceuticals|GlaxoSmithKline Lung Cancer November 2000 Phase 2
    NCT00004139 Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI) Lung Cancer September 1999 Phase 2
    NCT00520845 Vanderbilt-Ingram Cancer Center|National Cancer Institute (NCI) Lung Cancer October 2007 Phase 2
    NCT02182622 Martin Gutierrez|Novartis|Hackensack University Medical Center Prostate Cancer July 2014 Phase 1
    NCT00190489 Japan Clinical Oncology Group|Ministry of Health, Labour and Welfare, Japan Breast Cancer|Neoplasm Metastasis January 1999 Phase 3
    NCT00066677 Fox Chase Cancer Center Pancreatic Cancer October 2003 Phase 2
    NCT00015938 Southwest Oncology Group|National Cancer Institute (NCI) Breast Cancer May 2001 Phase 2
    NCT00156312 University of Michigan Cancer Center Breast Cancer July 2003
    NCT00313781 Pfizer Prostatic Neoplasms May 2006 Phase 2
    NCT00488982 University of California, San Francisco|Genzyme, a Sanofi Company Prostate Cancer April 2007 Phase 2
    NCT00813072 PharmaEngine Stomach Neoplasms|Esophageal Neoplasms November 2007 Phase 2
    NCT00193323 SCRI Development Innovations, LLC|Aventis Pharmaceuticals Lung Cancer August 2001 Phase 2
    NCT00293332 University of California, San Francisco|National Cancer Institute (NCI) Lung Cancer December 2005 Phase 2
    NCT00003066 Herbert Irving Comprehensive Cancer Center|National Cancer Institute (NCI) Breast Cancer February 1997 Phase 2
    NCT00026078 Grupo Oncologico Cooperativo del Sur|National Cancer Institute (NCI) Breast Cancer March 2001 Phase 2
    NCT00148291 West Japan Thoracic Oncology Group Lung Cancer June 1999 Phase 3
    NCT00002775 Herbert Irving Comprehensive Cancer Center|National Cancer Institute (NCI) Prostate Cancer February 1998 Phase 1|Phase 2
    NCT00004243 City of Hope Medical Center|National Cancer Institute (NCI) Unspecified Adult Solid Tumor, Protocol Specific March 2000 Phase 1
    NCT00114816 Finnish Breast Cancer Group|Hoffmann-La Roche|Sanofi|AstraZeneca Breast Cancer January 2004 Phase 3
    NCT00004223 Eastern Cooperative Oncology Group|National Cancer Institute (NCI) Bladder Cancer|Transitional Cell Cancer of the Renal Pelvis and Ureter|Urethral Cancer December 1999 Phase 2
    NCT00066768 National Cancer Institute (NCI) Recurrent Non-small Cell Lung Cancer|Stage IIIB Non-small Cell Lung Cancer|Stage IV Non-small Cell Lung Cancer July 2003 Phase 1
    NCT00761241 Benaroya Research Institute|Sanofi Pancreatic Cancer September 2008 Phase 2
    NCT03070886 NRG Oncology|National Cancer Institute (NCI) Stage I Prostate Adenocarcinoma|Stage II Prostate Adenocarcinoma|Stage III Prostate Adenocarcinoma January 16, 2017 Phase 2|Phase 3
    NCT02494921 Rahul Aggarwal|University of California, San Francisco Prostate Cancer September 2015 Phase 1|Phase 2
    NCT02268695 Groupe Oncologie Radiotherapie Tete et Cou|Grupo Español de Tratamiento de Tumores de Cabeza y Cuello|AIO-Studien-gGmbH Head and Neck Squamous Cell Carcinoma October 2014 Phase 2
    NCT00193232 SCRI Development Innovations, LLC|Aventis Pharmaceuticals|Millennium Pharmaceuticals, Inc. Prostate Cancer May 2004 Phase 2
    NCT00003864 Eastern Cooperative Oncology Group|National Cancer Institute (NCI) Esophageal Cancer July 1999 Phase 2
    NCT00193570 SCRI Development Innovations, LLC|GlaxoSmithKline|Genentech, Inc. Cancer February 2002 Phase 1
    NCT01012141 Centre Jean Perrin Metastatic Prostate Cancer September 2009 Phase 2
    NCT00020046 National Institutes of Health Clinical Center (CC) Stage IV Prostate Cancer|Adenocarcinoma of the Prostate|Recurrent Prostate Cancer December 1999 Phase 2
    NCT00415285 Georgia Center for Oncology Research & Education|Sanofi Breast Neoplasms December 2006 Phase 2
    NCT01038661 Sanofi Lung Neoplasms November 2009 Phase 3
    NCT00054184 CTI BioPharma Lung Cancer January 2003 Phase 3
    NCT00016185 Barbara Ann Karmanos Cancer Institute|National Cancer Institute (NCI) Unspecified Adult Solid Tumor, Protocol Specific March 2001 Phase 1
    NCT00039520 Fox Chase Cancer Center|National Cancer Institute (NCI) Breast Cancer January 2002 Phase 2
    NCT00801411 National Cancer Centre, Singapore|National Cancer Institute (NCI) Breast Cancer October 2008 Phase 2
    NCT00212082 National University Hospital, Singapore Metastatic Breast Cancer April 2002 Phase 2
    NCT00178269 University of Rochester Cervix Neoplasm January 2005 Phase 2
    NCT00050596 Bristol-Myers Squibb Prostate Cancer November 2002 Phase 2
    NCT00004886 European Organisation for Research and Treatment of Cancer - EORTC Unspecified Adult Solid Tumor, Protocol Specific December 1999 Phase 1
    NCT00404066 George Albert Fisher|GlaxoSmithKline|Sanofi|Stanford University Breast Cancer|Metastatic Breast Cancer October 2006 Phase 2
    NCT00004923 Yale University|National Cancer Institute (NCI) Unspecified Adult Solid Tumor, Protocol Specific April 1999 Phase 1|Phase 2
    NCT01396655 Seoul National University Hospital Breast Cancer July 2006 Phase 2
    NCT02889666 Shanghai Jiao Tong University School of Medicine|Shanghai 10th People's Hospital|Jilin University|Jiangxi Provincial Cancer Hospital|Shanghai Tongji Hospital, Tongji University School of Medicine Recurrent Non-small Cell Lung Cancer January 2008 Phase 1
    NCT00452920 University of Miami Cervical Cancer September 2003 Phase 1|Phase 2
    NCT02016417 Cancer Hospital of Guangxi Medical University Nasopharyngeal Carcinoma May 2014 Phase 2
    NCT00003560 Herbert Irving Comprehensive Cancer Center|National Cancer Institute (NCI) Endometrial Cancer|Fallopian Tube Cancer|Ovarian Cancer|Primary Peritoneal Cavity Cancer May 1998 Phase 2
    NCT02099396 China Association of Osteosarcoma Chemotherapy Lobaplatin and Gemcitabine in Combination, Second-line Treatments on Advanced Osteosarcoma April 2014 Phase 2|Phase 3
    NCT02703961 Fourth Military Medical University Cervical Cancer February 2016 Phase 3
    NCT01331928 Taipei Veterans General Hospital, Taiwan Gastric Cancer January 2011 Phase 2
    NCT02460367 NewLink Genetics Corporation Non-small Cell Lung Cancer|Progression of Non-small Cell Lung Cancer|Non-small Cell Lung Cancer Recurrent January 2016 Phase 1|Phase 2
    NCT00583622 M.D. Anderson Cancer Center Ovarian Cancer December 2007 Phase 2
    NCT00744497 Bristol-Myers Squibb Prostatic Neoplasms October 2008 Phase 3
    NCT01131429 Chinese PLA General Hospital Neoplasms, Lung|Carcinoma, Non-Small Cell Lung|Drug Therapy|Genes, EGFR June 2010 Phase 2
    NCT00003908 Southwest Oncology Group|National Cancer Institute (NCI) Head and Neck Cancer November 1999 Phase 2
    NCT00774241 Hoffmann-La Roche Breast Cancer January 2010 Phase 4
    NCT01256567 Eli Lilly and Company Breast Cancer|Metastatic Breast Cancer December 2010 Phase 1
    NCT00006104 Vanderbilt-Ingram Cancer Center|National Cancer Institute (NCI) Breast Cancer September 1998 Phase 2
    NCT01907529 Hebei Medical University Fourth Hospital Stage III Breast Cancer August 2018 Phase 2|Phase 3
    NCT00482807 University of Nebraska|National Cancer Institute (NCI) Prostate Cancer August 2004 Phase 1
    NCT00309985 ECOG-ACRIN Cancer Research Group|National Cancer Institute (NCI)|Eastern Cooperative Oncology Group Metastatic Hormone-sensitive Prostate Cancer July 2006 Phase 3
    NCT00376792 Scandinavian Prostate Cancer Group|National Cancer Institute (NCI) Prostate Cancer October 2005 Phase 3
    NCT00452985 Sanofi Ovarian Neoplasms February 2002
    NCT02395172 EMD Serono Research & Development Institute, Inc.|Merck KGaA|EMD Serono Carcinoma, Non-Small-Cell Lung March 2015 Phase 3
    NCT00006120 Groupe Cooperateur Multidisciplinaire en Oncologie (GERCOR)|National Cancer Institute (NCI) Breast Cancer May 2000 Phase 2
    NCT01660542 Yonsei University Locally Advanced Breast Cancer April 2011 Phase 4
    NCT00352378 National Cancer Center, Korea Breast Cancer June 2002 Phase 3
    NCT00005857 City of Hope Medical Center|National Cancer Institute (NCI) Prostate Cancer August 2000 Phase 2
    NCT00434668 University Hospital, Antwerp|Universiteit Antwerpen|Sanofi Non-small Cell Lung Cancer December 2005 Phase 2
    NCT00471432 NCIC Clinical Trials Group|Canadian Cancer Trials Group Bladder Cancer|Breast Cancer|Kidney Cancer|Lung Cancer|Ovarian Cancer|Prostate Cancer|Unspecified Adult Solid Tumor, Protocol Specific March 2003 Phase 1
    NCT02450539 Eli Lilly and Company Non-Small Cell Lung Cancer Stage IV August 2015 Phase 2
    NCT00006682 Washington Hospital Center|National Cancer Institute (NCI) Breast Cancer February 2000 Phase 2
    NCT00040807 Eastern Cooperative Oncology Group|National Cancer Institute (NCI) Head and Neck Cancer October 2002 Phase 2
    NCT00651326 NCIC Clinical Trials Group|Canadian Cancer Trials Group Prostate Cancer March 2008 Phase 3
    NCT00593697 Finnish Breast Cancer Group Breast Neoplasms January 2008 Phase 3
    NCT00425191 Sanofi Non-small Cell Lung Cancer July 2002 Phase 2
    NCT00088933 National Cancer Institute (NCI) Extensive Stage Small Cell Lung Cancer|Recurrent Colon Cancer|Recurrent Non-small Cell Lung Cancer|Recurrent Rectal Cancer|Recurrent Small Cell Lung Cancer|Stage IV Colon Cancer|Stage IV Non-small Cell Lung Cancer|Stage IV Rectal Cancer June 2004 Phase 1
    NCT01596868 Fourth Military Medical University Nasopharyngeal Squamous Cell Carcinoma|Toxicity Due to Radiotherapy May 2012 Phase 2
    NCT02685657 Russian Academy of Medical Sciences|Russian Society of Clinical Oncology Triple Negative Breast Cancer September 2016 Phase 2
    NCT00003781 OHSU Knight Cancer Institute Pain|Prostate Cancer December 1998 Phase 2
    NCT00537381 Centocor, Inc. Prostatic Neoplasms May 2007 Phase 2
    NCT00868998 Columbia University Biliary Cancer August 2005 Phase 2
    NCT00365365 Sanofi Breast Cancer August 2006 Phase 2
    NCT02465736 Sun Yat-sen University Esophageal Squamous Cell Carcinoma|Esophageal Cancer|Oesophageal Cancer July 2015 Phase 3
    NCT00058253 National Cancer Institute (NCI) Recurrent Prostate Cancer|Stage IV Prostate Cancer|Unspecified Adult Solid Tumor, Protocol Specific February 2003 Phase 1
    NCT00535509 King Faisal Specialist Hospital & Research Center Breast Cancer June 2007
    NCT00087165 Princess Margaret Hospital, Canada|National Cancer Institute (NCI) Prostate Cancer January 2005 Phase 2
    NCT00148122 University of Michigan Cancer Center Head and Neck Cancer November 2002 Phase 2
    NCT00331097 National Cancer Institute, Naples Breast Cancer July 2003 Phase 3
    NCT01868022 GlaxoSmithKline Cancer October 9, 2013 Phase 1
    NCT01359397 The Netherlands Cancer Institute Metastatic Gastric Cancer|Adenocarcinoma of the Gastro-oesophageal Junction March 2011 Phase 2
    NCT00138242 Floyd & Delores Jones Cancer Institute at Virginia Mason Medical Center|National Cancer Institute (NCI) Fallopian Tube Cancer|Ovarian Cancer|Primary Peritoneal Cavity Cancer December 2004 Phase 2
    NCT01525771 Asan Medical Center Stage IV Gastric Cancer With Metastasis February 2011 Phase 1|Phase 2
    NCT00096304 Medical University of South Carolina|National Cancer Institute (NCI) Prostate Cancer June 2004 Phase 1
    NCT00966706 IRCCS San Raffaele Pancreatic Cancer June 2005 Phase 2
    NCT00066885 Novacea|Aventis Pharmaceuticals Carcinoma, Non-Small-Cell Lung June 2003 Phase 1|Phase 2
    NCT00121992 Spanish Breast Cancer Research Group|Sanofi Breast Neoplasms June 1999 Phase 3
    NCT00077311 Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI) Anemia|Drug/Agent Toxicity by Tissue/Organ|Lung Cancer|Neutropenia August 2004 Phase 2
    NCT00448682 University of Miami Gastric Cancer June 2005 Phase 2
    NCT00293371 University of California, San Francisco|National Cancer Institute (NCI) Prostate Cancer February 2005 Phase 1|Phase 2
    NCT00932893 Pfizer Carcinoma, Non-Small-Cell Lung September 2009 Phase 3
    NCT00217568 Fred Hutchinson Cancer Research Center|National Cancer Institute (NCI) Ovarian Cancer|Peritoneal Cavity Cancer May 2005 Phase 2
    NCT00281970 Sidney Kimmel Comprehensive Cancer Center|National Cancer Institute (NCI) Lung Cancer August 2004 Phase 2
    NCT02402842 Centre Hospitalier Universitaire de Besancon Anal Canal Carcinoma September 2014 Phase 2
    NCT00499122 University of Miami Breast Cancer October 6, 2008 Phase 2
    NCT00015886 Wake Forest University Health Sciences|National Cancer Institute (NCI) Breast Cancer January 1997 Phase 2
    NCT00436839 Sanofi Prostatic Neoplasms January 2007 Phase 3
    NCT00238615 Stanford University|Aventis Pharmaceuticals Lung Cancer|Carcinoma, Non-Small-Cell Lung March 2003 Phase 2
    NCT00026156 Southwest Oncology Group|National Cancer Institute (NCI) Lung Cancer November 2001 Phase 2
    NCT00004864 Montefiore Medical Center|National Cancer Institute (NCI) Unspecified Adult Solid Tumor, Protocol Specific July 1999 Phase 1
    NCT00769470 Translational Oncology Research International|National Cancer Institute (NCI)|University of California, Los Angeles Breast Cancer April 2009 Phase 2
    NCT00415116 The Cleveland Clinic|National Cancer Institute (NCI) Unspecified Adult Solid Tumor, Protocol Specific August 2004 Phase 1
    NCT00271323 Sanofi Non-Small-Cell Lung Carcinoma May 2005 Phase 2
    NCT00073983 Sarcoma Alliance for Research through Collaboration Sarcoma October 2006 Phase 2
    NCT02551055 Millennium Pharmaceuticals, Inc.|Takeda Neoplasms, Advanced or Metastatic September 2015 Phase 1
    NCT01065870 Columbia University Pancreatic Cancer Stage II|Pancreatic Cancer Stage III December 2009 Phase 2|Phase 3
    NCT00333775 Hoffmann-La Roche Breast Cancer March 2006 Phase 3
    NCT02256436 Merck Sharp & Dohme Corp. Urothelial Cancer October 22, 2014 Phase 3
    NCT00005868 European Organisation for Research and Treatment of Cancer - EORTC Lung Cancer March 2000 Phase 2
    NCT00002866 NCIC Clinical Trials Group|Canadian Cancer Trials Group Breast Cancer|Neutropenia August 1996 Phase 1
    NCT00326378 Samsung Medical Center|Sanofi Carcinoma, Non-Small-Cell Lung October 2005 Phase 3
    NCT00004884 European Organisation for Research and Treatment of Cancer - EORTC Pancreatic Cancer July 1999 Phase 2
    NCT01565109 Institut Sainte Catherine Gastric Adenocarcinoma March 2009 Phase 2
    NCT01012297 National Cancer Institute (NCI) Recurrent Uterine Corpus Sarcoma|Stage IIIA Uterine Sarcoma|Stage IIIB Uterine Sarcoma|Stage IIIC Uterine Sarcoma|Stage IVA Uterine Sarcoma|Stage IVB Uterine Sarcoma|Uterine Corpus Leiomyosarcoma November 2009 Phase 3
    NCT01362374 Genentech, Inc. Neoplasms July 11, 2011 Phase 1
    NCT00003562 Hope Cancer Institute, Inc.|National Cancer Institute (NCI) Lung Cancer July 1998 Phase 2
    NCT00911820 Dana-Farber Cancer Institute|Massachusetts General Hospital|SCRI Development Innovations, LLC|Texas Oncology Cancer Center|Genentech, Inc. Esophageal Cancer|Gastric Cancer|Stomach Cancer July 2009 Phase 2
    NCT01204697 Hoffmann-La Roche Non-Squamous Non-Small Cell Lung Cancer November 2010 Phase 2
    NCT00083005 National Institutes of Health Clinical Center (CC)|National Cancer Institute (NCI) Prostate Cancer March 2004 Phase 2
    NCT00436293 Sanofi Nasopharyngeal Neoplasms December 2002 Phase 2
    NCT00514267 Astellas Pharma Inc Prostate Cancer|Tumors May 2007 Phase 1|Phase 2
    NCT00074139 Case Comprehensive Cancer Center|National Cancer Institute (NCI) Breast Cancer September 2003 Phase 1
    NCT00869258 Columbia University Pancreatic Cancer Stage IVA June 2005 Phase 2
    NCT01073683 Rabin Medical Center|Davidoff Cancer Center Larynx Cancer April 2010 Phase 2
    NCT01879085 Melissa Burgess, MD|Merck Sharp & Dohme Corp.|University of Pittsburgh Sarcoma June 2013 Phase 1|Phase 2
    NCT00637910 Fatebenefratelli and Ophthalmic Hospital|Mario Negri Institute for Pharmacological Research|Niguarda Hospital Non Small Cell Lung Cancer (NSCLC) November 2007 Phase 3
    NCT00554918 University Hospital Birmingham|National Cancer Institute (NCI) Metastatic Cancer|Prostate Cancer February 2005 Phase 2
    NCT01216124 Fudan University|Chinese Anti-Cancer Association Triple Negative Local Advanced Breast Cancer
    NCT00398489 Technische Universität München|National Cancer Institute (NCI) Breast Cancer October 2006 Phase 2
    NCT02897050 Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University Breast Cancer September 2016 Phase 2
    NCT00193115 SCRI Development Innovations, LLC|Aventis Pharmaceuticals Breast Cancer March 2004 Phase 2
    NCT00576901 Hoffmann-La Roche Breast Cancer November 2007 Phase 2
    NCT00189137 University of Michigan Cancer Center Sarcoma, Soft Tissue August 2004 Phase 2
    NCT00459836 Proacta, Incorporated Unspecified Adult Solid Tumor, Protocol Specific February 2007 Phase 1
    NCT00391092 Hoffmann-La Roche Breast Cancer September 2006 Phase 3
    NCT00379015 Translational Research Informatics Center, Kobe, Hyogo, Japan Breast Cancer January 2006 Phase 2
    NCT00416533 Wake Forest University Health Sciences|National Cancer Institute (NCI) Prostate Cancer August 2004 Phase 2
    NCT00242762 AstraZeneca Head and Neck Cancer July 2003 Phase 2
    NCT01547741 NSABP Foundation Inc|National Cancer Institute (NCI) Breast Cancer April 2012 Phase 3
    NCT00402545 Dana-Farber Cancer Institute|Brigham and Women's Hospital|Bristol-Myers Squibb Head and Neck Neoplasms January 2007 Phase 1
    NCT00004264 University of Wisconsin, Madison|National Cancer Institute (NCI) Drug/Agent Toxicity by Tissue/Organ|Lung Cancer July 1997 Phase 1|Phase 2
    NCT01588431 Anand B. Karnad|The University of Texas Health Science Center at San Antonio Carcinoma, Squamous Cell of Head and Neck December 2011 Phase 2
    NCT01186731 INSYS Therapeutics Inc Pancreatic Cancer April 2010 Phase 2
    NCT00046826 Whittingham Cancer Center|National Cancer Institute (NCI) Prostate Cancer September 2001 Phase 2
    NCT00811447 Sanofi Stomach Neoplasms November 2008 Phase 3
    NCT00568971 Fudan University Gastric Cancer April 2007 Phase 2
    NCT00261703 Sanofi Head and Neck Neoplasms December 2002 Phase 2|Phase 3
    NCT02997332 Gustave Roussy, Cancer Campus, Grand Paris|French National Cancer Institute Head and Neck Cancers March 30, 2017 Phase 1
    NCT01536223 Zhejiang Cancer Hospital|Second Affiliated Hospital, School of Medicine, Zhejiang University|Zhejiang University|Zhejiang Provincial People’s Hospital|Sir Run Run Shaw Hospital|Wenzhou Medical University Chemoradiation|Nasopharyngeal Carcinoma April 2012 Phase 3
    NCT01533207 Gynecologic Oncology Group|National Cancer Institute (NCI) Stage I Uterine Sarcoma|Uterine Corpus Leiomyosarcoma June 2012 Phase 3
    NCT01188408 INSYS Therapeutics Inc Prostate Cancer June 2010 Phase 2
    NCT00310154 Wake Forest University Health Sciences|National Cancer Institute (NCI) Lung Cancer November 2003 Phase 1
    NCT00449020 University of Miami Lung Cancer January 2004 Phase 2
    NCT01774578 NewLink Genetics Corporation Non-small Cell Lung Cancer|Progression of Non-small Cell Lung Cancer|Non-small Cell Lung Cancer Recurrent February 2013 Phase 2|Phase 3
    NCT00068341 Jonsson Comprehensive Cancer Center|National Cancer Institute (NCI)|Aventis Pharmaceuticals|Genentech, Inc. Breast Cancer July 2003 Phase 2
    NCT00004066 Memorial Sloan Kettering Cancer Center|National Cancer Institute (NCI) Ovarian Cancer|Sarcoma|Small Intestine Cancer June 1999 Phase 2
    NCT00620971 Hellenic Oncology Research Group|University Hospital of Crete Non Small Cell Lung Cancer January 2008 Phase 2
    NCT01957436 UNICANCER|Janssen-Cilag Ltd.|European Organisation for Research and Treatment of Cancer - EORTC|Ipsen Prostate Cancer Adenocarcinoma Metastatic October 2013 Phase 3
    NCT03101046 UNICANCER|National Cancer Institute, France|Institut du Cancer de Montpellier - Val d'Aurelle|Institut Bergonié Prostate Carcinoma|Castration-resistant Prostate Cancer|Circulating Tumor Cells|Chemotherapy October 1, 2017 Phase 2
    NCT00155259 National Taiwan University Hospital Breast Cancer October 2004 Phase 2
    NCT00430001 Danish Breast Cancer Cooperative Group|Hoffmann-La Roche|Sanofi Breast Cancer May 2005 Phase 3
    NCT00090610 Duke University|Aventis Pharmaceuticals Ovarian Cancer October 2003 Phase 2
    NCT02479178 BIND Therapeutics Urothelial Carcinoma|Cholangiocarcinoma|Cervical Cancer|Squamous Cell Carcinoma of Head and Neck June 2015 Phase 2
    NCT00569673 Gynecologic Oncology Group|National Cancer Institute (NCI) Fallopian Tube Cancer|Ovarian Cancer|Primary Peritoneal Cavity Cancer March 2008 Phase 2
    NCT01478308 New Mexico Cancer Care Alliance Prostate Cancer June 2011 Phase 2
    NCT00226239 University of Pittsburgh|Bristol-Myers Squibb Cancer October 2005 Phase 2
    NCT00216008 H. Lee Moffitt Cancer Center and Research Institute|Aventis Pharmaceuticals Esophageal Adenocarcinomas|Adenocarcinomas of the Gastroesophageal Junction July 2005 Phase 2
    NCT00101127 Gynecologic Oncology Group|National Cancer Institute (NCI) Sarcoma December 2003 Phase 2
    NCT00191672 Eli Lilly and Company Breast Neoplasms December 2003 Phase 2
    NCT00104715 UNICANCER|National Cancer Institute (NCI) Prostate Cancer October 2004 Phase 3
    NCT02003209 National Cancer Institute (NCI) Estrogen Receptor Positive|HER2/Neu Positive|Progesterone Receptor Positive|Stage IB Breast Cancer|Stage IIA Breast Cancer|Stage IIB Breast Cancer|Stage IIIA Breast Cancer|Stage IIIB Breast Cancer|Stage IIIC Breast Cancer January 15, 2014 Phase 3
    NCT01461746 Asan Medical Center|Boryung Pharmaceutical Co., Ltd Endometrial Cancer October 2011 Phase 2
    NCT00625937 Yonsei University|National Cancer Institute (NCI) Head and Neck Cancer November 2006 Phase 2
    NCT00845910 Hoffmann-La Roche Breast Cancer May 2009 Phase 2
    NCT00431080 Hellenic Oncology Research Group|University Hospital of Crete Breast Cancer August 2004 Phase 3
    NCT00052845 Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI) Prostate Cancer November 2002 Phase 2
    NCT00485979 Sanofi Breast Neoplasms June 2007 Phase 2
    NCT02975934 Clovis Oncology, Inc.|Foundation Medicine Metastatic Castration Resistant Prostate Cancer January 2017 Phase 3
    NCT00288080 Radiation Therapy Oncology Group|National Cancer Institute (NCI)|NRG Oncology Prostate Cancer December 2005 Phase 3
    NCT00119314 University of Medicine and Dentistry of New Jersey|National Cancer Institute (NCI)|Rutgers, The State University of New Jersey Carcinoma of Unknown Primary July 2004 Phase 2
    NCT01558011 National Health Research Institutes, Taiwan|Taipei Veterans General Hospital, Taiwan|Tri-Service General Hospital|Mackay Memorial Hospital|National Cheng-Kung University Hospital Gastric Adenocarcinoma March 2012 Phase 2
    NCT01312350 Samsung Medical Center Hypopharyngeal Cancer November 2010 Phase 2
    NCT00524459 Roswell Park Cancer Institute|National Cancer Institute (NCI) Breast Cancer May 2007 Phase 2
    NCT02345772 Western Regional Medical Center HER2-positive Breast Cancer|ER-positive Breast Cancer July 2014
    NCT02088515 Jiangsu Simcere Pharmaceutical Co., Ltd. Squamous Cell Carcinoma December 2013 Phase 4
    NCT00445861 Swiss Group for Clinical Cancer Research Esophageal Cancer January 2007 Phase 1|Phase 2
    NCT00390676 Adherex Technologies, Inc.|US Oncology Research Neoplasms November 2006 Phase 1
    NCT00796458 A.O.U. San Giovanni Battista di Torino, Italy|National Cancer Institute (NCI) Pain|Prostate Cancer April 2005 Phase 3
    NCT00615602 Hellenic Oncology Research Group|University Hospital of Crete Breast Cancer October 2004 Phase 3
    NCT00879619 John P. Fruehauf|Sanofi|University of California, Irvine Prostate Cancer|Adenocarcinoma of the Prostate|Recurrent Prostate Cancer|Stage I Prostate Cancer|Stage III Prostate Cancer|Stage IV Prostate Cancer July 2009 Phase 1|Phase 2
    NCT00217529 Fred Hutchinson Cancer Research Center Fallopian Tube Cancer|Ovarian Cancer|Peritoneal Cavity Cancer June 2004 Phase 1|Phase 2
    NCT00391274 Eli Lilly and Company Non-Small Cell Lung Cancer October 2006 Phase 3
    NCT02512380 Chinese Academy of Medical Sciences Gastric Adenocarcinoma July 2015 Phase 3
    NCT00112697 UNICANCER|National Cancer Institute (NCI) Pancreatic Cancer December 2002 Phase 2
    NCT01642771 China Breast Cancer Clinical Study Group Breast Cancer June 2012 Phase 3
    NCT00733889 Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)|Merck Sharp & Dohme Corp.|Sanofi Esophageal Carcinoma December 2006 Phase 2
    NCT01049425 West German Study Group|Sanofi|Amgen Primary Breast Cancer|Her2 Non-overexpressing January 2009 Phase 3
    NCT00319618 AstraZeneca Metastatic Breast Cancer June 2003 Phase 2
    NCT00021255 Sanofi|Cancer International Research Group (CIRG) Breast Neoplasms April 2001 Phase 3
    NCT00020332 National Cancer Institute (NCI) Breast Cancer October 2000 Phase 1|Phase 2
    NCT00028483 Seattle Genetics, Inc. Breast Cancer October 2000 Phase 2
    NCT00720304 Case Comprehensive Cancer Center|National Cancer Institute (NCI) Head and Neck Cancer November 2007 Phase 2
    NCT00214058 University of Wisconsin, Madison|Aventis Pharmaceuticals Ovarian Carcinoma|Primary Peritoneal Carcinoma August 2002 Phase 2
    NCT00520676 Eli Lilly and Company Non-Small Cell Lung Cancer October 2007 Phase 3
    NCT00359333 National Health Research Institutes, Taiwan|Mackay Memorial Hospital|Tri-Service General Hospital|China Medical University Hospital|Kaohsiung Veterans General Hospital.|Taichung Veterans General Hospital|Buddhist Tzu Chi General Hospital Sarcoma|Malignant Gastrointestinal Stromal Tumor December 2006 Phase 2
    NCT01234025 Ionis Pharmaceuticals, Inc. Castrate-Resistant Prostate Cancer November 2010 Phase 1|Phase 2
    NCT00949624 Arog Pharmaceuticals, Inc. Advanced Solid Tumors December 2005 Phase 1
    NCT00978549 Cambridge University Hospitals NHS Foundation Trust|National Cancer Institute (NCI) Adenocarcinoma of the Gastroesophageal Junction|Esophageal Cancer|Gastric Cancer|Nausea and Vomiting|Pain April 2008 Phase 3
    NCT00043576 Novacea|Aventis Pharmaceuticals Prostate Cancer August 2002 Phase 2|Phase 3
    NCT00051571 Seattle Genetics, Inc. Carcinoma, Non-Small-Cell Lung Phase 2
    NCT00623558 Seoul National University Hospital|Clinical Research Center for Solid Tumor, Korea Head and Neck Neoplasm April 2008 Phase 2
    NCT00010140 International Collaborative Cancer Group|National Cancer Institute (NCI) Breast Cancer August 1997 Phase 3
    NCT01515748 Sanofi Gastric Cancer January 2012 Phase 3
    NCT01216644 Krankenhaus Nordwest Gastric Cancer July 2010 Phase 2|Phase 3
    NCT00282087 Sarcoma Alliance for Research through Collaboration Leiomyosarcoma|Uterine Neoplasm January 2006 Phase 2
    NCT00247481 AstraZeneca Breast Cancer September 2002 Phase 2
    NCT00203502 University of Arkansas|Genentech, Inc. Breast Cancer September 2005 Phase 2
    NCT00084318 Radiation Therapy Oncology Group|National Cancer Institute (NCI)|NRG Oncology Head and Neck Cancer April 2004 Phase 2
    NCT00532727 Institute of Cancer Research, United Kingdom|King's College London|Cancer Research UK|Breakthrough Breast Cancer Breast Cancer January 2008 Phase 3
    NCT01812018 Peng Yuan|Chinese Academy of Medical Sciences Soft Tissue Sarcoma November 2012 Phase 2
    NCT00250874 Zeneus Pharma Metastatic Breast Cancer December 2003 Phase 2
    NCT02413320 University of Kansas Medical Center Triple-negative Breast Cancer July 2015 Phase 2
    NCT00633568 European Lung Cancer Working Party Non-small Cell Lung Carcinoma January 2007 Phase 3
    NCT00003998 University of Glasgow|National Cancer Institute (NCI) Ovarian Cancer|Primary Peritoneal Cavity Cancer October 1998 Phase 3
    NCT00045227 National Cancer Institute (NCI) Prostate Cancer August 2002 Phase 2
    NCT00005627 Dana-Farber Cancer Institute|National Cancer Institute (NCI) Prostate Cancer March 1999 Phase 1
    NCT00191152 Eli Lilly and Company Breast Cancer|Breast Neoplasms|Cancer of the Breast February 2002 Phase 3
    NCT02659020 Eli Lilly and Company Soft Tissue Sarcoma March 2016 Phase 1|Phase 2
    NCT02453009 Santa Chiara Hospital Prostatic Neoplasms October 2014 Phase 2
    NCT00705874 Progen Pharmaceuticals Cancer May 2006 Phase 1
    NCT00645866 Mayo Clinic|National Cancer Institute (NCI) Breast Cancer April 2003 Phase 2
    NCT00190476 Japan Clinical Oncology Group|Ministry of Health, Labour and Welfare, Japan Non-small-cell Lung Cancer April 2003 Phase 3
    NCT00004001 Southwest Oncology Group|National Cancer Institute (NCI)|Cancer and Leukemia Group B|North Central Cancer Treatment Group Prostate Cancer October 1999 Phase 3
    NCT02654587 OSE Immunotherapeutics|Orion Corporation, Orion Pharma Non Small Cell Lung Cancer February 2016 Phase 3
    NCT01257139 Rennes University Hospital Non Small-cell Lung Cancer January 2010 Phase 3
    NCT01690325 West German Study Group|Roche Pharma AG|Sanofi Breast Cancer September 2012 Phase 2
    NCT00600249 Centre Jean Perrin|Merck Sharp & Dohme Corp.|Sanofi Breast Cancer January 2008 Phase 2
    NCT01862081 Genentech, Inc. Breast Cancer, Non-small Lung Cancer July 16, 2013 Phase 1
    NCT01192165 GlaxoSmithKline Cancer September 2010 Phase 1
    NCT02179671 AstraZeneca|Quintiles, Inc. Locally Advanced or Metastatic Non-Small-Cell Lung Cancer (Stage IIIB-IV) July 2014 Phase 2
    NCT01354522 Peking Union Medical College Hospital Breast Cancer May 2011 Phase 3
    NCT00464646 NSABP Foundation Inc|Genentech, Inc.|International Drug Development Institute Breast Cancer May 2007 Phase 2
    NCT00450892 European Organisation for Research and Treatment of Cancer - EORTC|GlaxoSmithKline Breast Cancer February 2007 Phase 1|Phase 2
    NCT00167401 University of Rochester Carcinoma, Non-Small-Cell Lung February 2002 Phase 2
    NCT00712881 Cephalon|Teva Pharmaceutical Industries Breast Cancer October 2008 Phase 2
    NCT00117572 University of Chicago Cancer of the Pharynx|Cancer of the Larynx|Cancer of the Nasal Cavity|Paranasal Sinus Neoplasms|Cancer of the Oral Cavity November 2004 Phase 3
    NCT00002707 NSABP Foundation Inc|National Cancer Institute (NCI) Breast Cancer December 1995 Phase 3
    NCT02402712 Hoffmann-La Roche Breast Cancer May 6, 2015 Phase 3
    NCT00201435 Norwegian Breast Cancer Group Breast Neoplasm March 2005 Phase 2|Phase 3
    NCT00079287 Japan Multinational Trial Organization|National Cancer Institute (NCI) Lung Cancer March 2001 Phase 3
    NCT00994968 Yonsei University|National Cancer Institute (NCI) Breast Cancer July 2009 Phase 2
    NCT00498797 Sanofi|Genzyme, a Sanofi Company Prostate Cancer|Metastatic|Hormone Refractory December 2005 Phase 2
    NCT01221753 Dana-Farber Cancer Institute Squamous Cell Carcinoma of the Head and Neck|Human Papilloma Virus July 2011 Phase 2
    NCT03006432 Federation Francophone de Cancerologie Digestive|UNICANCER|Groupe Cooperateur Multidisciplinaire en Oncologie (GERCOR) OESOPHAGO-GASTRIC CARCINOMA December 2016 Phase 3
    NCT00213694 University Hospital, Rouen Metastatic Prostate Cancer November 2003 Phase 2
    NCT02105675 Sotio a.s. Prostate Cancer|Prostate Cancer Metastatic February 2012 Phase 2
    NCT00003782 NSABP Foundation Inc|National Cancer Institute (NCI) Breast Cancer March 1999 Phase 3
    NCT01999933 Mei Shi|Fourth Military Medical University Cervical Cancer|Toxicity Due to Radiotherapy November 2013 Phase 2|Phase 3
    NCT00283829 University of Washington|Sanofi Prostate Cancer September 2002 Phase 1|Phase 2
    NCT00072930 MedImmune LLC Prostate Cancer December 2003 Phase 2
    NCT01652820 Spanish Lung Cancer Group|Aventis Pharmaceuticals Non Small-cell Lung Cancer October 2001 Phase 2
    NCT00004175 Northwestern University|National Cancer Institute (NCI) Breast Cancer November 1998 Phase 2
    NCT01763671 Intergroupe Francophone de Cancerologie Thoracique Non-squamous Non-small Cell Lung Cancer May 2013 Phase 3
    NCT00243204 Point Therapeutics Carcinoma, Non-Small Cell Lung January 2006 Phase 3
    NCT00365417 NSABP Foundation Inc|Genentech, Inc.|Hoffmann-La Roche|International Drug Development Institute Breast Cancer August 2006 Phase 2
    NCT01614938 Fudan University Nasopharyngeal Carcinoma August 2010 Phase 2
    NCT01295086 Odense University Hospital|Aalborg Universitetshospital|Aarhus University Hospital|Rigshospitalet, Denmark Adenocarcinoma March 2011
    NCT00017563 OHSU Knight Cancer Institute|National Cancer Institute (NCI) Prostate Cancer September 2000 Phase 2
    NCT03066154 The Netherlands Cancer Institute Prostatic Neoplasms September 2016 Phase 1
    NCT00002544 Arbeitsgemeinschaft fur Internistische Onkologie|National Cancer Institute (NCI) Breast Cancer May 1993 Phase 3
    NCT00734851 Duke University|Pfizer|Sanofi Prostate Cancer December 2008 Phase 2
    NCT00165399 Dana-Farber Cancer Institute Adenocarcinoma of the Prostate|Prostate Cancer March 2004 Phase 2
    NCT00252707 AstraZeneca Non-Small Cell Lung Cancer September 2003 Phase 3
    NCT00194740 University of Washington|Aventis Pharmaceuticals Breast Neoplasm November 1997 Phase 2
    NCT00006215 Amgen|National Cancer Institute (NCI) Lung Cancer October 1999 Phase 2
    NCT01479504 Guangxi Medical University|People's Hospital of Guangxi|303rd Hospital of the People's Liberation Army|Nanning Second People's Hospital|Guangxi Traditional Chinese Medical University|Guilin Medical College|Guangxi Naxishan Hospital|Liuzhou Worker's Hospital|Liuzhou People's Hospital|Liuzhou Hospital of Traditional Chinese Medicine|Liuzhou Cancer Hospital|Liuzhou Railway hospital|First People's Hospital of Yulin|The Red Cross hospital of YuLin|Guigang People's Hospital|The Red Cross hospital of Wuzhou Nasopharyngeal Carcinoma November 2011 Phase 3
    NCT02776163 Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University Salivary Gland Tumors|Head and Neck Cancer June 2016 Phase 2
    NCT00110214 National Cancer Institute (NCI) Adenocarcinoma of the Prostate|Hormone-resistant Prostate Cancer|Recurrent Prostate Cancer|Stage IV Prostate Cancer April 2005 Phase 3
    NCT00374985 Johannes Gutenberg University Mainz Esophageal Neoplasms|Stomach Neoplasms October 2005 Phase 1|Phase 2
    NCT01192230 Fudan University Carcinoma, Non-Small-Cell Lung June 2009 Phase 2
    NCT00031629 Gynecologic Oncology Group|National Cancer Institute (NCI) Recurrent Uterine Corpus Sarcoma|Uterine Corpus Leiomyosarcoma January 2005 Phase 2
    NCT00082472 Zivena NSCLC January 2004 Phase 1|Phase 2
    NCT00927589 Genentech, Inc. Solid Cancers July 2009 Phase 1
    NCT02718482 Italian Sarcoma Group OSTEOSARCOMA April 2016 Phase 2
    NCT01443078 Memorial Sloan Kettering Cancer Center|Eli Lilly and Company|United States Department of Defense Lung Cancer October 2011 Phase 2
    NCT01154920 M.D. Anderson Cancer Center|Dana-Farber Cancer Institute Head and Neck Squamous Cell Carcinoma July 2010 Phase 2
    NCT00911716 Cancer Trials Ireland Breast Cancer October 2008
    NCT01574716 Morphotek Metastatic Soft Tissue Sarcoma May 2012 Phase 2
    NCT00268372 Southwest Oncology Group|National Cancer Institute (NCI) Head and Neck Cancer December 2005 Phase 3
    NCT01084330 Novartis Pharmaceuticals|Novartis Advanced Gastric Cancer|Gastro-esophageal Junction Cancer April 2010 Phase 2
    NCT00183924 University of Southern California|Aventis Pharmaceuticals Prostate Adenocarcinoma March 2001 Phase 2
    NCT00687297 PrECOG, LLC.|AstraZeneca Lung Cancer|Non Small Cell Lung Cancer April 2008 Phase 2
    NCT01472029 AIO-Studien-gGmbH|Roche Pharma AG Adenocarcinoma of the Gastroesophageal Junction|Adenocarcinoma of the Stomach December 2011 Phase 2
    NCT01207011 Sumitomo Dainippon Pharma Co., Ltd. Lung Cancer October 2010 Phase 3
    NCT00055731 UNICANCER|National Cancer Institute (NCI) Prostate Cancer November 2002 Phase 3
    NCT00050167 M.D. Anderson Cancer Center|Roche Pharma AG Breast Cancer November 2002 Phase 1
    NCT03067792 Yonsei University Inoperable Gastric Cancer December 2014 Phase 3
    NCT01869192 University of Colorado, Denver Malignant Neoplasm of Female Breast March 5, 2003 Phase 2
    NCT00129935 Spanish Breast Cancer Research Group|Sanofi|Hoffmann-La Roche|Pfizer Breast Cancer February 2004 Phase 3
    NCT00475670 Hoffmann-La Roche Breast Cancer October 2005 Phase 2
    NCT01557959 Wake Forest University Health Sciences|National Cancer Institute (NCI)|OSI Pharmaceuticals Adenocarcinoma of the Lung|Adenosquamous Cell Lung Cancer|Bronchoalveolar Cell Lung Cancer|Large Cell Lung Cancer|Non-small Cell Lung Cancer|Recurrent Non-small Cell Lung Cancer|Squamous Cell Lung Cancer|Stage IIIB Non-small Cell Lung Cancer|Stage IV Non-small Cell Lung Cancer July 2007 Phase 2
    NCT02115204 West German Study Group|AGO Germany Breast Cancer June 2000 Phase 3
    NCT01604863 Human Genome Sciences Inc., a GSK Company|GlaxoSmithKline Cancer June 2012 Phase 1
    NCT00313690 University of Southern California Lung Cancer April 2006 Phase 1|Phase 2
    NCT00721513 Wake Forest University Health Sciences|National Cancer Institute (NCI) Head and Neck Cancer September 2008 Phase 2
    NCT00003810 Eastern Cooperative Oncology Group|National Cancer Institute (NCI) Pancreatic Cancer April 1999 Phase 2
    NCT01792050 NewLink Genetics Corporation Metastatic Breast Cancer February 2013 Phase 2
    NCT00771563 University Hospital, Antwerp|Universiteit Antwerpen Non-Small Cell Lung Cancer June 2008 Phase 3
    NCT02076594 Gruppo Italiano per lo studio dei Carcinomi dell'Apparato Digerente|Regione Lombardia Locally Advanced Unresectable Gastric Cancer|Metastatic Gastric Cancer January 2013 Phase 3
    NCT00835471 Dutch Society of Physicians for Pulmonology and Tuberculosis Carcinoma, Non-Small-Cell Lung March 2009 Phase 2
    NCT00045448 Memorial Sloan Kettering Cancer Center|National Cancer Institute (NCI) Unspecified Adult Solid Tumor, Protocol Specific April 2002 Phase 1
    NCT01083615 OncoGenex Technologies|Teva Pharmaceuticals USA Castrate-Resistant Prostate Cancer|Hormone Refractory Prostate Cancer March 2010 Phase 3
    NCT01160705 Cancer Trials Ireland Metastatic Cancer|Prostate Cancer November 2009
    NCT00176527 University of Medicine and Dentistry of New Jersey|National Cancer Institute (NCI)|Rutgers, The State University of New Jersey Prostate Cancer November 2002 Phase 2
    NCT02307227 Centro di Riferimento Oncologico - Aviano Breast Neoplasms April 2006 Phase 2
    NCT00636441 Duke University|United States Department of Defense Early-Stage Breast Cancer April 2008 Phase 2
    NCT00406302 Wolfgang Hilbe|Merck Sharp & Dohme Corp.|Sanofi|TAKO - Tiroler Arbeitskreis Onkologie|Medical University of Vienna Carcinoma, Non-small-cell Lung January 2007 Phase 2
    NCT01424709 Tongji University Non-small Cell Lung Cancer December 2010 Phase 2
    NCT01168973 Eli Lilly and Company|ImClone LLC Non-Small Cell Lung Cancer December 2010 Phase 3
    NCT01530295 Hanjong Ahn|Asan Medical Center Prostate Cancer July 2008
    NCT01338753 Clinica Universidad de Navarra, Universidad de Navarra|Roche Farma, S.A Breast Neoplasms October 2009 Phase 2
    NCT01503905 Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University Breast Cancer Nos Premenopausal December 2011
    NCT03177174 Luo yanrong|Chinese PLA General Hospital Drug-Related Side Effects and Adverse Reactions June 12, 2017
    NCT01783587 Dana-Farber Cancer Institute|National Comprehensive Cancer Network Squamous Cell Carcinoma of the Head and Neck February 2013 Phase 1
    NCT00766246 Pharmatech|Genentech, Inc.|Sanofi Non-small Cell Lung Cancer Stage IIIB|Non-small Cell Lung Cancer Stage IV October 2008 Phase 2
    NCT00174629 Sanofi Lung Neoplasms June 2001 Phase 3
    NCT01884259 Arbeitsgemeinschaft medikamentoese Tumortherapie Squamous Cell Carcinoma of the Hypopharynx Stage III|Squamous Cell Carcinoma of the Hypopharynx Stage IV|Squamous Cell Carcinoma of the Larynx Stage III|Squamous Cell Carcinoma of the Larynx Stage IV|Squamous Cell Carcinoma of the Oropharynx Stage III|Squamous Cell Carcinoma of the Oropharynx Stage IV|Squamous Cell Carcinoma of the Oral Cavity Stage III|Squamous Cell Carcinoma of the Oral Cavity Stage IV May 2013 Phase 2
    NCT00005810 Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI) Prostate Cancer March 2000 Phase 2
    NCT02613026 307 Hospital of PLA Breast Neoplasms July 2009 Phase 3
    NCT00617968 Sanofi Breast Neoplasms October 2003 Phase 2
    NCT00559754 Hoffmann-La Roche Breast Cancer December 2007 Phase 2
    NCT01314833 Fudan University|Chinese Anti-Cancer Association Breast Cancer June 2010 Phase 3
    NCT00003953 Case Comprehensive Cancer Center|National Cancer Institute (NCI) Breast Cancer February 1999 Phase 2
    NCT02177552 Rigshospitalet, Denmark Esophageal Neoplasms|Stomach Neoplasms June 2014 Phase 2
    NCT00314977 Radboud University|Sanofi|Amgen Breast Cancer February 2006 Phase 3
    NCT00798252 Bristol-Myers Squibb Advanced Cancer March 2009 Phase 1
    NCT02126969 University of Kentucky Head and Neck Cancer|Larynx October 2014 Phase 2
    NCT02786641 Sun Yat-sen University Nasopharyngeal Carcinoma August 2016 Phase 3
    NCT02512315 Sun Yat-sen University Nasopharyngeal Carcinoma August 2015 Phase 3
    NCT00938470 Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI) Adenocarcinoma of the Gastroesophageal Junction|Esophageal Cancer|Gastric Cancer January 2010 Phase 2
    NCT00508664 ClinAssess|Merck Sharp & Dohme Corp.|Sanofi|University of Leipzig Squamous Cell Carcinoma of the Hypopharynx|Larynx Carcinoma July 2007 Phase 2
    NCT02324088 UNICANCER Inflammatory Breast Cancer October 2000 Phase 3
    NCT00963807 National Cancer Institute (NCI) Recurrent Non-Small Cell Lung Carcinoma|Stage IB Non-Small Cell Lung Carcinoma|Stage IIA Non-Small Cell Lung Carcinoma|Stage IIB Non-Small Cell Lung Carcinoma|Stage IIIA Non-Small Cell Lung Cancer|Stage IV Non-Small Cell Lung Cancer September 2009 Phase 2
    NCT00014196 Southwest Oncology Group|National Cancer Institute (NCI) Lung Cancer March 2001 Phase 2
    NCT02111577 Sotio a.s. Metastatic Castrate Resistant Prostate Cancer April 2014 Phase 3
    NCT00545688 Hoffmann-La Roche Breast Cancer June 2006 Phase 2
    NCT01633541 University of Michigan Cancer Center Laryngeal Cancer March 2012 Phase 2
    NCT01222052 Martin-Luther-Universität Halle-Wittenberg|German Breast Group Breast Cancer January 2002 Phase 3
    NCT01270373 Instituto Nacional de Cancer, Brazil|Sanofi Breast Cancer August 2010 Phase 2
    NCT02339532 UNICANCER Breast Cancer January 2015 Phase 2
    NCT02419742 Hoffmann-La Roche Breast Cancer August 18, 2015 Phase 4
    NCT02005549 Hoffmann-La Roche Breast Cancer February 2006 Phase 2
    NCT02564263 Merck Sharp & Dohme Corp. Esophageal Carcinoma|Esophagogastric Junction Carcinoma December 1, 2015 Phase 3
    NCT00014456 Dartmouth-Hitchcock Medical Center|National Cancer Institute (NCI) Bladder Cancer|Breast Cancer|Carcinoma of Unknown Primary|Esophageal Cancer|Gastric Cancer|Head and Neck Cancer|Lung Cancer|Melanoma (Skin)|Ovarian Cancer|Pancreatic Cancer|Prostate Cancer|Sarcoma March 2000 Phase 1
    NCT03015727 Zhejiang Cancer Hospital|Zhejiang Provincial People’s Hospital|The Central Hospital of Lishui City|Jinhua Central Hospital|First Affiliated Hospital of Wenzhou Medical Univeristy|Ningbo Medical Center Lihuili Eastern Hospital|People's Hospital of Quzhou Locally Advanced Nasopharyngeal Carcinoma December 2016 Phase 3
    NCT00531271 Celgene Corporation Metastatic Breast Cancer November 2007 Phase 1|Phase 2
    NCT00003587 Southwest Oncology Group|National Cancer Institute (NCI) Lung Cancer October 1998 Phase 2
    NCT02157116 Duke University|Sanofi Non-small Cell Lung Cancer May 2006 Phase 2
    NCT00236899 Eli Lilly and Company Metastatic Breast Cancer (MBC) September 2005 Phase 3
    NCT01245959 Sun Yat-sen University|Fudan University|West China Hospital|Huazhong University of Science and Technology|Beijing Cancer Hospital|Zhejiang Cancer Hospital|Central South University|Jiangsu Cancer Institute & Hospital|First People's Hospital of Foshan|The Third Affiliated Hospital of Harbin Medical University|Cancer Hospital of Guangxi Medical University|Jiangxi Provincial Cancer Hospital|Guangzhou Medical University Nasopharyngeal Carcinoma January 2011 Phase 3
    NCT03001726 Shanghai Zhongshan Hospital Gastric Cancer January 2017 Phase 3
    NCT00073866 Northwestern University|National Cancer Institute (NCI) Lung Cancer June 2003 Phase 1|Phase 2
    NCT00005958 Amgen|National Cancer Institute (NCI) Bladder Cancer|Transitional Cell Cancer of the Renal Pelvis and Ureter October 1999 Phase 2
    NCT00191490 Eli Lilly and Company|Aventis Pharmaceuticals Carcinoma, Non-Small-Cell Lung July 2002 Phase 2
    NCT03099382 Jiangsu HengRui Medicine Co., Ltd. Esophageal Carcinoma May 10, 2017 Phase 3
    NCT00004082 Beth Israel Deaconess Medical Center|National Cancer Institute (NCI) Endometrial Cancer|Fallopian Tube Cancer|Ovarian Cancer|Primary Peritoneal Cavity Cancer July 1999 Phase 1
    NCT00003037 Memorial Sloan Kettering Cancer Center|National Cancer Institute (NCI) Lung Cancer April 1997 Phase 1|Phase 2
    NCT02513342 Nanjing NingQi Medicine Science and Technology Co., Ltd. Advanced Lung Squamous Carcinoma March 2015 Phase 4
    NCT00941135 Fundacion Miguel Servet|Salutis Research, SL|Unidad de Genética Clínica (Clínica Universitaria de Navarra) Laryngeal Neoplasms May 2009 Phase 2
    NCT01967875 China Medical University, China Stomach Neoplasms July 2013 Phase 2
    NCT01149902 University of Yamanashi Head and Neck Cancer July 2010 Phase 1
    NCT01059188 Swiss Group for Clinical Cancer Research Lung Cancer May 3, 2010 Phase 2
    NCT00093795 NSABP Foundation Inc|National Cancer Institute (NCI) Breast Cancer October 2004 Phase 3
    NCT02575547 Zhao Chong|Wuhan University|Fudan University|Fujian Cancer Hospital|Zhejiang Cancer Hospital|First Affiliated Hospital of Guangxi Medical University|The First Affiliated Hospital of Xiamen University|Cancer Hospital of Guizhou Province|Hainan People's Hospital|First People's Hospital of Foshan|Sun Yat-sen University Nasopharyngeal Carcinoma|Malnutrition May 2015
    NCT00016107 National Cancer Institute (NCI) Adenocarcinoma of the Prostate|Hormone-resistant Prostate Cancer|Recurrent Prostate Cancer|Stage IV Prostate Cancer June 2001 Phase 2
    NCT00487786 OncoGenex Technologies Neoplasms June 2007 Phase 1
    NCT00308750 Eli Lilly and Company Non-small Cell Lung Cancer March 2006 Phase 2
    NCT00113386 Radiation Therapy Oncology Group|National Cancer Institute (NCI)|Southwest Oncology Group|Cancer and Leukemia Group B|Eastern Cooperative Oncology Group|North Central Cancer Treatment Group Lung Cancer April 2005 Phase 3
    NCT00448760 University of Miami Esophageal Cancer October 2004 Phase 2
    NCT02605915 Hoffmann-La Roche HER2-Positive Metastatic Breast Cancer|HER2-Negative Metastatic Breast Cancer|Locally Advanced or Early Breast Cancer December 31, 2015 Phase 1
    NCT02568839 Thomas Hatschek|Karolinska University Hospital Early-Stage Breast Carcinoma|HER-2 Positive Breast Cancer November 2014 Phase 2|Phase 3
    NCT02283424 Chinese PLA General Hospital Neoplasms, Therapy-Associated October 2014 Phase 4
    NCT00193427 SCRI Development Innovations, LLC|Aventis Pharmaceuticals|Eli Lilly and Company Lung Cancer April 2004 Phase 2
    NCT00012220 Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI) Pancreatic Cancer January 2001 Phase 2
    NCT00003915 University of Massachusetts, Worcester Prostate Cancer May 1999 Phase 2
    NCT00816855 Fudan University Nasopharyngeal Carcinoma February 2007 Phase 2
    NCT00964704 Hoffmann-La Roche Breast Cancer March 2011 Phase 2
    NCT00816816 Fudan University Nasopharyngeal Carcinoma February 2007 Phase 2
    NCT02478125 Sidney Kimmel Comprehensive Cancer Center|Prostate Cancer Foundation Prostate Cancer July 2015 Phase 1
    NCT00434031 National Cancer Institute, Naples Breast Cancer September 2007 Phase 2
    NCT01217060 M.D. Anderson Cancer Center Esophageal Cancer October 2010 Phase 1|Phase 2
    NCT00493870 US Oncology Research|Sanofi Breast Cancer May 2007 Phase 3
    NCT00630032 UNICANCER Breast Cancer September 2007 Phase 3
    NCT00004888 National Cancer Institute (NCI) Recurrent Breast Cancer|Stage IV Breast Cancer January 2001 Phase 2
    NCT01003964 National Cancer Center, Korea Non Small Cell Lung Cancer February 2009 Phase 2
    NCT01708993 Canadian Cancer Trials Group|Oncolytics Biotech Non Small Cell Lung Cancer October 15, 2012 Phase 2
    NCT00525200 Daniela Kandioler|Medical University of Vienna|Austrian Society Of Surgical Oncology Esophageal Cancer June 2007 Phase 3
    NCT01784549 IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy|Azienda Sanitaria Locale di Cagliari|Azienda Ospedaliera San Gerardo di Monza|Ospedale Santa Croce-Carle Cuneo|Azienda Ospedaliera S. Maria della Misericordia|Istituto Tumori Giovanni Paolo II, BARI|Azienda Ospedaliera dei Colli|Azienda Ospedaliera Santa Maria Degli Angeli|Azienda Ospedaliera San Camillo Forlanini|Azienda Ospedaliera San Giovanni Battista|Azienda Ospedaliera Universitaria Integrata Verona|Azienda Sanitaria Locale n.2 Savonese|ASL TO4, Chivasso|Azienda Provinciale per i Servizi Sanitari, Provincia Autonoma di Trento|Istituto Clinico Humanitas|Azienda Ospedaliera Sant'Andrea, Roma|Azienda Ospedaliera, Ospedale Civile di Legnano|Azienda Ospedaliera Spedali Riuniti di Livorno, Livorno Non Small Cell Lung Cancer July 2012 Phase 2
    NCT02479217 Hoffmann-La Roche Metastatic Breast Cancer, Colon Cancer July 2006
    NCT00270894 Accelerated Community Oncology Research Network|Aventis Pharmaceuticals Breast Neoplasm November 2005 Phase 2
    NCT00149214 Eli Lilly and Company Breast Cancer September 2005 Phase 2
    NCT00031187 Seattle Genetics, Inc. Prostatic Neoplasms October 2000 Phase 2
    NCT00665392 Groupe Cooperateur Multidisciplinaire en Oncologie (GERCOR) Head and Neck Cancer February 2008 Phase 2
    NCT00008125 University of Pittsburgh|National Cancer Institute (NCI) Unspecified Adult Solid Tumor, Protocol Specific March 1998 Phase 1
    NCT00872625 Centre Antoine Lacassagne Breast Cancer April 2007 Phase 1
    NCT00003888 European Organisation for Research and Treatment of Cancer - EORTC Head and Neck Cancer April 1999 Phase 3
    NCT00454649 Pfizer Neoplasms December 2005 Phase 1
    NCT00238147 University of Washington Esophageal Cancer September 2004 Phase 1
    NCT02510781 Hospital Affiliated to Military Medical Science, Beijing Breast Neoplasms January 2015 Phase 2
    NCT01498289 Southwest Oncology Group|National Cancer Institute (NCI) Adenocarcinoma of the Gastroesophageal Junction|Esophageal Cancer|Gastric Cancer February 2012 Phase 2
    NCT00291005 Sanofi Prostatic Neoplasms August 2004 Phase 2
    NCT00352118 Masonic Cancer Center, University of Minnesota|National Cancer Institute (NCI) Head and Neck Cancer March 2006 Phase 2
    NCT00433589 European Organisation for Research and Treatment of Cancer - EORTC|Agendia|Breast International Group|Roche Pharma AG|Novartis|Sanofi Breast Cancer December 2006 Phase 3
    NCT00379717 AZ-VUB|Sanofi Non-Small-Cell Lung Carcinoma November 2006 Phase 1|Phase 2
    NCT02326285 AIO-Studien-gGmbH|AstraZeneca Non-squamous Non-small Cell Lung Cancer Stage II|Non-squamous Non-small Cell Lung Cancer Stage IIIA|Non-squamous Non-small Cell Lung Cancer Stage IIIB|Activating EGFR Mutation|NSCLC November 2015 Phase 2|Phase 3
    NCT01504256 AIO-Studien-gGmbH|Neovii Biotech Gastric Adenocarcinoma With Peritoneal Carcinomatosis|Siewert Type II Adenocarcinoma of Esophagogastric Junction With Peritoneal Carcinomatosis|Siewert Type III Adenocarcinoma of Esophagogastric Junction With Peritoneal Carcinomatosis October 2011 Phase 2
    NCT00599131 University of Michigan Cancer Center Cancer of Larynx August 2007 Phase 2
    NCT00848718 Merck Sharp & Dohme Corp. Locally Advanced, Metastatic Solid Tumors March 2009 Phase 1
    NCT03123770 Zhejiang University|Second Affiliated Hospital, School of Medicine, Zhejiang University|First Affiliated Hospital of Zhejiang University|Sir Run Run Shaw Hospital|Women's Hospital School Of Medicine Zhejiang University|Zhejiang Cancer Hospital|Zhejiang Provincial People’s Hospital|Zhejiang Provincial Hospital of TCM|First People's Hospital of Hangzhou|Hangzhou Hospital of Traditional Chinese Medicine|First Affiliated Hospital of Wenzhou Medical Univeristy|Ningbo No. 1 Hospital|Jinhua Central Hospital Breast Cancer December 2016 Phase 4
    NCT01754623 H. Lee Moffitt Cancer Center and Research Institute Pancreatic Cancer February 2013 Phase 2
    NCT02980965 Fudan University Breast Cancer Female May 2013 Phase 3
    NCT00277043 New Mexico Cancer Care Alliance Supportive|Ill-defined Sites June 2002 Phase 3
    NCT02229149 US Oncology Research|Genentech, Inc. Breast Neoplasms|Malignant Tumor of the Breast December 2014 Phase 2
    NCT00933517 Centre Jean Perrin Pathological Response Rate September 2009 Phase 2
    NCT00047840 Genzyme, a Sanofi Company|Sanofi Non-Small Cell Lung Cancer (NSCLC, Locally Advanced or Metastatic, Second-line October 2002 Phase 2
    NCT02908477 Mayo Clinic Oropharynx Cancer August 2016 Phase 3
    NCT01603420 Proton Collaborative Group Prostate Cancer July 2012 Phase 2|Phase 3
    NCT01472016 AbbVie (prior sponsor, Abbott)|AbbVie Advanced Solid Tumors October 6, 2011 Phase 1
    NCT02005783 Shanghai Jiao Tong University School of Medicine Grade 3/4 Neutropenia|Febrile Neutropenia October 2013 Phase 2
    NCT02861573 Merck Sharp & Dohme Corp. Metastatic Castration-Resistant Prostate Cancer November 17, 2016 Phase 1
    NCT00817583 Fudan University Nasopharyngeal Carcinoma January 2009 Phase 2
    NCT00268476 Medical Research Council Prostate Cancer September 2005 Phase 2|Phase 3
    NCT02403531 Mian XI|Sun Yat-sen University Neoplasms May 2015 Phase 2
    NCT00682383 Mt. Sinai Medical Center, Miami|Amgen Unresectable Locally Advanced NSCLC September 2003 Phase 2
    NCT00539630 Sanofi Carcinoma, Squamous Cell November 2002 Phase 3
    NCT01985841 Hellenic Oncology Research Group Breast Cancer October 2011 Phase 2
    NCT01356368 National Guard Health Affairs Non-Small Cell Lung Cancer May 2010 Phase 2
    NCT00334815 National Cancer Institute (NCI) Adenocarcinoma of the Lung|Adenosquamous Cell Lung Cancer|Bronchoalveolar Cell Lung Cancer|Large Cell Lung Cancer|Squamous Cell Lung Cancer|Stage IIIA Non-small Cell Lung Cancer|Stage IIIB Non-small Cell Lung Cancer June 2006
    NCT00130780 Memorial Sloan Kettering Cancer Center Carcinoma, Non-Small-Cell Lung August 2005 Phase 2
    NCT00539669 Sanofi Ovarian Neoplasms March 2003 Phase 2
    NCT01275677 National Cancer Institute (NCI) Estrogen Receptor Negative|Estrogen Receptor Positive|HER2/Neu Positive|Progesterone Receptor Negative|Progesterone Receptor Positive|Recurrent Breast Carcinoma|Stage IA Breast Cancer|Stage IB Breast Cancer|Stage IIA Breast Cancer|Stage IIB Breast Cancer|Stage IIIA Breast Cancer|Stage IIIC Breast Cancer January 6, 2011 Phase 3
    NCT00191438 Eli Lilly and Company Breast Neoplasms October 2002 Phase 3
    NCT00020709 National Cancer Institute (NCI) Adenocarcinoma of the Lung|Bronchoalveolar Cell Lung Cancer|Large Cell Lung Cancer|Squamous Cell Lung Cancer|Stage IIIA Non-small Cell Lung Cancer|Stage IIIB Non-small Cell Lung Cancer June 2001 Phase 3
    NCT00095875 Dana-Farber Cancer Institute|National Cancer Institute (NCI) Head and Neck Cancer August 2004 Phase 3
    NCT02611960 Merck Sharp & Dohme Corp. Nasopharyngeal Neoplasms April 18, 2016 Phase 2
    NCT02353260 Wei Guo|Xuzhou Central Hospital|Shanghai 9th People's Hospital Head and Neck Cancer December 2014 Phase 2
    NCT01551589 LANG Jin-yi|The Second People's Hospital of Sichuan Esophageal Squamous Cell Carcinoma March 2012 Phase 3
    NCT03144947 Gruppo Oncologico Italiano di Ricerca Clinica|University Hospital of Parma: Department of Biomedical, Biotechnological and Translational Sciences, Pathological Anatomy and Histology Unit|University Hospital of Parma:Laboratory of Viral Immunopathology, Unit of Infectious Diseases and Hepatology|University Hospital of Parma:Statistica medica ed epidemiologia clinica-UO Ricerca e Innovazione|Clirest s.r.l.|Mipharm SpA|Arithmos srl|Temas srl Cancer, Breast November 29, 2016 Phase 2
    NCT01301729 Hoffmann-La Roche Breast Cancer March 2011 Phase 4
    NCT00887536 NSABP Foundation Inc|Genentech, Inc.|US Oncology Research Breast Cancer May 2009 Phase 3
    NCT02766335 Southwest Oncology Group|National Cancer Institute (NCI) Recurrent Squamous Cell Lung Carcinoma|Stage IV Squamous Cell Lung Carcinoma June 2014 Phase 2
    NCT00310089 National Cancer Institute (NCI) Breast Cancer January 2006
    NCT02048540 Chinese PLA General Hospital Locally Advanced Gastric Carcinoma February 2009 Phase 1|Phase 2
    NCT00737438 Memorial Sloan Kettering Cancer Center|Genentech, Inc.|Weill Medical College of Cornell University Esophageal Cancer|Gastric Cancer August 2008 Phase 2
    NCT01107639 Swiss Group for Clinical Cancer Research Adenocarcinoma of the Gastroesophageal Junction|Esophageal Cancer April 2010 Phase 3
    NCT01929811 Shanghai Jiao Tong University School of Medicine pCR Rate|BCT Rate|Safety October 2013 Phase 2
    NCT00005086 University of Chicago|National Cancer Institute (NCI) Bladder Cancer August 1999 Phase 2
    NCT02001168 Xinjiang Medical University Non-small Cell Lung Cancer October 2013 Phase 3
    NCT01467115 Drexel University College of Medicine|Drexel University Head and Neck Cancer March 2010 Phase 2
    NCT02569242 Ono Pharmaceutical Co. Ltd|Bristol-Myers Squibb Esophageal Cancer December 2015 Phase 3
    NCT01106872 University of Iowa|Genentech, Inc. Sarcoma|Soft Tissue Sarcoma|Locally Advanced Sarcoma|Unresectable Sarcoma|Metastatic Sarcoma September 2010 Phase 1|Phase 2
    NCT02838225 Peking Union Medical College Hospital Breast Cancer January 2009 Phase 2
    NCT00408408 NSABP Foundation Inc|National Cancer Institute (NCI) Breast Cancer November 2006 Phase 3
    NCT00864175 Incyte Corporation Metastatic Breast Cancer July 2007 Phase 1|Phase 2
    NCT03017404 Hebei Medical University Fourth Hospital Breast Cancer May 2015
    NCT01940497 Hoffmann-La Roche Breast Cancer November 16, 2013 Phase 3
    NCT00054587 UNICANCER Breast Cancer June 2001 Phase 3
    NCT01284335 Eli Lilly and Company Advanced Solid Tumors July 2008 Phase 1
    NCT00466440 Eli Lilly and Company Prostate Cancer June 2007 Phase 2
    NCT00198393 Intergroupe Francophone de Cancerologie Thoracique|AstraZeneca|Sanofi Carcinoma, Non-Small-Cell Lung November 2004 Phase 2
    NCT00509366 Duke University|Eli Lilly and Company Non Small Cell Lung Cancer May 2007 Phase 2
    NCT00479856 GlaxoSmithKline Relapsed Breast Cancer|Neoplasms, Breast November 2007 Phase 2
    NCT02037997 Fudan University Non Small Cell Lung Cancer December 2013 Phase 2
    NCT02555358 Qun Zhao|Jiangsu HengRui Medicine Co., Ltd.|Hebei Medical University Gastric Cancer November 2014 Phase 3
    NCT01395758 ArQule Metastatic Non-Small Cell Lung Cancer July 2011 Phase 2
    NCT00054054 Southwest Oncology Group|National Cancer Institute (NCI) Head and Neck Cancer April 2003 Phase 2
    NCT02921984 Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University Salivary Gland Tumors|Head and Neck Cancer September 2013 Phase 1
    NCT01196429 National Cancer Institute (NCI) Ovarian Clear Cell Cystadenocarcinoma|Stage III Ovarian Cancer|Stage IV Ovarian Cancer August 2010 Phase 2
    NCT02599324 Pharmacyclics LLC. Renal Cell Carcinoma (RCC)|Urothelial Carcinoma|Gastric Adenocarcinoma|Colorectal Adenocarcinoma (CRC) November 2015 Phase 1|Phase 2
    NCT02560051 The University of Texas Health Science Center, Houston Prostatic Neoplasms November 2015 Phase 2
    NCT00976989 Hoffmann-La Roche Breast Cancer November 2009 Phase 2
    NCT00868491 Institute of Oncology Ljubljana Head and Neck Cancer March 2008 Phase 2
    NCT01914900 Fondazione IRCCS Istituto Nazionale dei Tumori, Milano Locally Advanced Resectable Oral Cavity Squamous Cell Cancer June 2012 Phase 2
    NCT00203372 Translational Oncology Research International|Genentech, Inc. Breast Cancer May 2005 Phase 2
    NCT00737373 Krankenhaus Nordwest Gastric Cancer|Adenocarcinoma of the Esophagogastric Junction August 2007 Phase 2
    NCT00665457 University of Nebraska|National Cancer Institute (NCI) Breast Cancer April 2004 Phase 2
    NCT02716974 Sidney Kimmel Comprehensive Cancer Center Prostate Cancer June 2016 Phase 2
    NCT02132949 Hoffmann-La Roche Breast Cancer July 14, 2014 Phase 2
    NCT02495896 University of Southern California|National Cancer Institute (NCI)|Vasgene Therapeutics, Inc Head and Neck Squamous Cell Carcinoma|Metastatic Pancreatic Adenocarcinoma|Non-Resectable Cholangiocarcinoma|Pancreatic Adenocarcinoma|Recurrent Gallbladder Carcinoma|Recurrent Non-Small Cell Lung Carcinoma|Stage III Pancreatic Cancer|Stage IIIA Gallbladder Cancer|Stage IIIA Non-Small Cell Lung Cancer|Stage IIIB Gallbladder Cancer|Stage IIIB Non-Small Cell Lung Cancer|Stage IV Gallbladder Cancer|Stage IV Non-Small Cell Lung Cancer|Stage IV Pancreatic Cancer|Unresectable Gallbladder Carcinoma|Unr September 2015 Phase 1
    NCT00004913 Northwestern University|National Cancer Institute (NCI) Unspecified Adult Solid Tumor, Protocol Specific January 2000 Phase 1
    NCT00454779 Amgen Metastatic or Recurrent Squamous Cell Carcinoma of Head and Neck January 2007 Phase 2
    NCT01828112 Novartis Pharmaceuticals|Novartis Non-Small Cell Lung Cancer June 2013 Phase 3
    NCT00003633 Herbert Irving Comprehensive Cancer Center|National Cancer Institute (NCI) Prostate Cancer August 1998 Phase 1
    NCT00622349 European Lung Cancer Working Party Carcinoma, Non-Small-Cell Lung February 2004 Phase 3
    NCT02302807 Hoffmann-La Roche Bladder Cancer January 13, 2015 Phase 3
    NCT00936936 M.D. Anderson Cancer Center Testicular Cancer June 2009 Phase 2
    NCT01640782 Mario Negri Institute for Pharmacological Research|Aventis Pharmaceuticals|Gruppo Italiano per lo studio dei Carcinomi dell'Apparato Digerente|Gruppo Oncologico Italiano di Ricerca Clinica|Gruppo Oncologico del Nord-Ovest|Italian Trial in Medical Oncology|Southern Italy Cooperative Oncology Group|Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori|Oncotech Adenocarcinoma of the Stomach|Adenocarcinoma of the Gastroesophageal Junction February 2005 Phase 3
    NCT03084237 Shanghai Henlius Biotech Breast Cancer November 2016 Phase 3
    NCT01622361 Asan Medical Center|Korean Breast Cancer Study Group Breast Cancer June 2012 Phase 3
    NCT00115414 Amgen Breast Cancer|Fever|Neutropenia Phase 2
    NCT03006575 Sun Yat-sen University Non-small Cell Lung Cancer January 2016 Phase 2
    NCT02573506 Sun Yat-sen University Non-small Cell Lung Cancer August 2015 Phase 2
    NCT00446225 Spanish Lung Cancer Group Non-Small Cell Lung Cancer February 2007 Phase 3
    NCT00896181 Stanford University Stage II Lymphoepithelioma of the Nasopharynx|Stage II Squamous Cell Carcinoma of the Nasopharynx|Stage III Lymphoepithelioma of the Nasopharynx|Stage III Squamous Cell Carcinoma of the Nasopharynx|Stage IV Lymphoepithelioma of the Nasopharynx|Stage IV Squamous Cell Carcinoma of the Nasopharynx January 2009 Phase 2
    NCT02760667 George Washington University Head and Neck Cancer June 2015 Phase 2
    NCT01572038 Hoffmann-La Roche Breast Neoplasms June 1, 2012 Phase 3
    NCT00003679 Scottish Cancer Therapy Network|National Cancer Institute (NCI) Breast Cancer November 1998 Phase 3
    NCT00525759 Sheffield Teaching Hospitals NHS Foundation Trust Breast Cancer July 2007 Phase 2
    NCT01160419 Ludwig-Maximilians - University of Munich|Sanofi Gastric Cancer December 2009 Phase 2
    NCT00820547 UNICANCER Breast Cancer January 2009 Phase 2
    NCT01099436 Borstkanker Onderzoek Groep|Dutch Cancer Society|Amgen|Sanofi|Novartis Breast Cancer April 2010 Phase 3
    NCT00295893 City of Hope Medical Center|National Cancer Institute (NCI) Breast Cancer September 2005 Phase 2
    NCT02252042 Merck Sharp & Dohme Corp. Head and Neck Squamous Cell Cancer November 17, 2014 Phase 3
    NCT03211117 Mayo Clinic|National Cancer Institute (NCI) Thyroid Gland Undifferentiated (Anaplastic) Carcinoma July 9, 2017 Phase 2
    NCT00044993 Introgen Therapeutics|National Cancer Institute (NCI) Breast Cancer February 2002 Phase 2
    NCT00849615 Krankenhaus Nordwest Gastric Cancer|Adenocarcinoma of the Esophagogastric Junction February 2009 Phase 2
    NCT01822613 Novartis Pharmaceuticals|Novartis Esophageal Squamous Cell Carcinoma July 26, 2013 Phase 1
    NCT02846428 Hoffmann-La Roche Breast Cancer March 2004 Phase 2
    NCT02208583 Tianjin Medical University Cancer Institute and Hospital Hormone Refractory Prostate Cancer June 2014
    NCT00132301 VA Office of Research and Development|Sanofi Prostate Cancer June 2006 Phase 3
    NCT02577341 Sun Yat-sen University Non-small-cell Lung Cancer August 2015 Phase 2
    NCT01646034 The Netherlands Cancer Institute Breast Cancer September 2014 Phase 3
    NCT02322281 Clovis Oncology, Inc. Non-small Cell Lung Cancer February 2015 Phase 3
    NCT00003406 Cancer Treatment Centers of America|National Cancer Institute (NCI) Chronic Myeloproliferative Disorders|Leukemia|Lymphoma|Multiple Myeloma and Plasma Cell Neoplasm|Myelodysplastic Syndromes|Precancerous/Nonmalignant Condition|Unspecified Adult Solid Tumor, Protocol Specific October 1997 Phase 1|Phase 2
    NCT00617656 Spanish Lung Cancer Group LUNG CANCER February 2008 Phase 3
    NCT01920061 Pfizer Neoplasm September 10, 2013 Phase 1
    NCT00005960 Amgen|National Cancer Institute (NCI) Pain|Prostate Cancer October 1999 Phase 2
    NCT00950300 Hoffmann-La Roche Breast Cancer October 2009 Phase 3
    NCT00004164 Dana-Farber Cancer Institute|National Cancer Institute (NCI) Head and Neck Cancer August 1999 Phase 2
    NCT01714037 Debiopharm International SA|INC Research Non-small Cell Lung Cancer August 2012 Phase 1
    NCT02900742 Shanghai University of Traditional Chinese Medicine|Shanghai Chest Hospital|Shanghai Pulmonary Hospital, Shanghai, China Cancer March 2013 Phase 3
    NCT02450656 The Netherlands Cancer Institute|AstraZeneca|Boehringer Ingelheim Colorectal Neoplasms|Gastrointestinal Neoplasms|Pancreatic Neoplasms|Carcinoma, Non-Small-Cell Lung June 2015 Phase 1|Phase 2
    NCT01224405 University of Turin, Italy Advanced Prostate Cancer April 2010 Phase 3
    NCT02019277 Hoffmann-La Roche Breast Cancer December 2013 Phase 3
    NCT02641847 Fudan University Triple Negative Breast Cancer|Breast Cancer July 2015 Phase 2|Phase 3
    NCT02661971 Krankenhaus Nordwest Stomach Cancer|Gastroesophageal Junction Cancer June 2016 Phase 2|Phase 3
    NCT00003519 Eastern Cooperative Oncology Group|National Cancer Institute (NCI)|Southwest Oncology Group|North Central Cancer Treatment Group|Cancer and Leukemia Group B Breast Cancer August 1998 Phase 3
    NCT00540800 National Cancer Institute, Naples Breast Cancer February 2004 Phase 3
    NCT02105636 Bristol-Myers Squibb|Ono Pharmaceutical Co. Ltd Squamous Cell Carcinoma of the Head and Neck May 2014 Phase 3
    NCT02627807 Sun Yat-sen University Nasopharyngeal Neoplasms December 2015
    NCT02076477 Sichuan Cancer Hospital and Research Institute|Mianyang Central Hospital|Cancer Hospital of Guizhou Province Oligo-metastatic Stage IV Non-small Cell Lung Cancer January 2014 Phase 3
    NCT02627248 Shandong University Breast Cancer October 2015 Phase 4
    NCT00006038 Memorial Sloan Kettering Cancer Center|National Cancer Institute (NCI) Esophageal Cancer|Gastric Cancer February 2000 Phase 2
    NCT00600496 AstraZeneca Breast Cancer|Breast Neoplasms|Colon Cancer|Colonic Cancer|Colon Neoplasms|Lung Cancer|Melanoma|Kidney Cancer December 14, 2007 Phase 1
    NCT02194166 Hoffmann-La Roche Breast Cancer July 18, 2014 Phase 3
    NCT01120184 Hoffmann-La Roche|Genentech, Inc. Breast Cancer July 2010 Phase 3
    NCT00564733 University of Washington|National Cancer Institute (NCI) Malignant Pleural Effusion|Stage IIIB Non-small Cell Lung Cancer|Stage IV Non-small Cell Lung Cancer October 2007 Phase 2
    NCT02049905 CytRx Metastatic, Locally Advanced or Unresectable Soft Tissue Sarcoma January 2014 Phase 3
    NCT00028873 European Organisation for Research and Treatment of Cancer - EORTC Breast Cancer September 2001 Phase 2
    NCT00499109 H. Lee Moffitt Cancer Center and Research Institute|Sanofi Non-Small Cell Lung Cancer May 2007 Phase 3
    NCT03137771 NRG Oncology|National Cancer Institute (NCI) Recurrent Non-Small Cell Lung Carcinoma|Stage IV Non-Small Cell Lung Cancer April 7, 2017 Phase 2
    NCT01351415 Hoffmann-La Roche Non-Squamous Non-Small Cell Lung Cancer June 2011 Phase 3
    NCT00502567 AstraZeneca Advanced Solid Tumor January 2005 Phase 1
    NCT00004125 Eastern Cooperative Oncology Group|National Cancer Institute (NCI)|North Central Cancer Treatment Group|Southwest Oncology Group|Cancer and Leukemia Group B Breast Cancer October 1999 Phase 3
    NCT00003172 Eastern Cooperative Oncology Group|National Cancer Institute (NCI) Gastric Cancer December 1997 Phase 2
    NCT00588770 National Cancer Institute (NCI) Recurrent Hypopharyngeal Squamous Cell Carcinoma|Recurrent Laryngeal Squamous Cell Carcinoma|Recurrent Laryngeal Verrucous Carcinoma|Recurrent Lip and Oral Cavity Squamous Cell Carcinoma|Recurrent Metastatic Squamous Cell Carcinoma in the Neck With Occult Primary|Recurrent Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma|Recurrent Oral Cavity Verrucous Carcinoma|Recurrent Oropharyngeal Squamous Cell Carcinoma|Recurrent Salivary Gland Carcinoma|Salivary Gland Squamous Cell Carcinoma|Squam August 8, 2008 Phase 3
    NCT00215930 H. Lee Moffitt Cancer Center and Research Institute|Eli Lilly and Company|Aventis Pharmaceuticals Carcinoma, Non-Small-Cell Lung February 2004 Phase 2
    NCT03201861 RenJi Hospital Tubular Breast Cancer|Mucinous Breast Cancer|Invasive Duct Carcinoma of Breast July 20, 2017 Phase 2
    NCT02365805 Fundación Pública Andaluza para la gestión de la Investigación en Sevilla Breast Cancer April 2014 Phase 2
    NCT00053911 UNICANCER Breast Cancer November 2002 Phase 3
    NCT00033683 Institute of Cancer Research, United Kingdom|National Cancer Institute (NCI) Breast Cancer February 2001 Phase 2
    NCT01959490 Case Comprehensive Cancer Center|National Cancer Institute (NCI) Stage II Breast Cancer|Stage IIIA Breast Cancer|Stage IIIB Breast Cancer|Stage IIIC Breast Cancer September 2013 Phase 2
    NCT00004906 Hackensack University Medical Center|National Cancer Institute (NCI) Breast Cancer October 1999 Phase 2
    NCT02578368 Krankenhaus Nordwest|German Research Foundation|Arbeitsgemeinschaft fur Internistische Onkologie Gastric Cancer February 2016 Phase 3
    NCT02047201 Lithuanian University of Health Sciences Head and Neck Squamous Cell Carcinoma June 2013 Phase 2
    NCT01454934 Eisai Inc. Non-Small Cell Lung Cancer (NSCLC) September 2011 Phase 3
    NCT00863512 Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI) Lung Cancer March 2009 Phase 3
    NCT00881166 Astex Pharmaceuticals Malignant Disease November 2007 Phase 1
    NCT02472964 Mylan Inc.|Mylan GmbH Breast Cancer July 2012 Phase 3
    NCT00478699 Spanish Lung Cancer Group Non-small-cell Lung Cancer June 2007 Phase 3
    NCT00625898 NSABP Foundation Inc|Cancer International Research Group (CIRG)|Hoffmann-La Roche|Genentech, Inc. Breast Cancer April 2008 Phase 3
    NCT00405405 Sidney Kimmel Cancer Center at Thomas Jefferson University|Genentech, Inc.|Thomas Jefferson University Head and Neck Cancer|Parotid Gland Cancer|Thyroid Gland Cancer|Melanoma|Stage IV Head and Neck Cancer December 2006 Phase 1
    NCT00004873 Swiss Group for Clinical Cancer Research Gastric Cancer August 1999 Phase 2
    NCT00242203 Washington University School of Medicine|Novartis|Pfizer Breast Neoplasms October 2002 Phase 2
    NCT01516996 The Second People's Hospital of Sichuan|Biotech Pharmaceutical Co., Ltd. Oropharyngeal Cancer|Hypopharyngeal Cancer March 2012 Phase 2
    NCT02399306 Sichuan Cancer Hospital and Research Institute|Wuhan University|Xiangya Hospital of Central South University|Shanxi Province Cancer Hospital|Shandong Tumor Hospital|Henan Cancer Hospital|Beijing Cancer Hospital|Hebei Medical University Fourth Hospital Esophageal Squamous Cell Carcinoma|Enteral Nutrition Therapy|Chemoradiotherapy March 2015 Phase 3
    NCT02358863 Georgetown University Esophageal Cancer|Gastric Cancer February 2015
    NCT00042835 National Cancer Institute (NCI) Adenocarcinoma of the Lung|Bronchoalveolar Cell Lung Cancer|Large Cell Lung Cancer|Squamous Cell Lung Cancer|Stage IIIA Non-small Cell Lung Cancer|Stage IIIB Non-small Cell Lung Cancer May 2002 Phase 1
    NCT00146549 Dana-Farber Cancer Institute|Massachusetts General Hospital|Brigham and Women's Hospital|North Shore Medical Center|GlaxoSmithKline Breast Cancer|Stage IV Breast Cancer August 2001 Phase 3
    NCT02031601 Qilu Hospital of Shandong University Non-Small-Cell Lung Cancer January 2014 Phase 4
    NCT01641406 Auxilio Mutuo Cancer Center Infiltrating Duct and Lobular Carcinoma In Situ|Invasive Lobular Breast Carcinoma|Inflammatory Breast Carcinoma March 2011 Phase 2
    NCT01710176 Italian Sarcoma Group|GROUPE SARCOMES FRANÇAIS|Grupo Espanol de Investigacion en Sarcomas Localized High-risk Soft Tissue Sarcomas of the Extremities and Trunk Wall in Adults June 1, 2011 Phase 3
    NCT01935947 National Cancer Institute (NCI) Recurrent Non-Small Cell Lung Carcinoma|Stage IIIA Non-Small Cell Lung Cancer|Stage IIIB Non-Small Cell Lung Cancer|Stage IV Non-Small Cell Lung Cancer May 2013 Phase 2
    NCT03057366 Millennium Pharmaceuticals, Inc.|Takeda Advanced Solid Tumors, Neoplasms, Advanced Solid May 11, 2017 Phase 1
    NCT02434614 Wei Jiang|Wuzhou Red Cross Hospital|Guangxi Naxishan Hospital|Liuzhou People's Hospital|Guigang People's Hospital|Affiliated Hospital of Youjiang Medical University for Nationalities|Nanning Monority Hospital|Guilin Medical University, China Nasopharyngeal Carcinoma March 2015 Phase 3
    NCT00883480 Spanish Lung Cancer Group Non-Small Cell Lung Cancer June 2005
    NCT00667251 Novartis Pharmaceuticals|NCIC Clinical Trials Group|Novartis Breast Cancer October 7, 2008 Phase 3
    NCT02621970 Sun Yat-sen University|Affiliated Tumor Hospital of Guangzhou Medical University|The First Affiliated Hospital of Guangzhou Medical University|The First Affiliated Hospital of Guangdong Pharmaceutical University Nasopharyngeal Carcinoma January 2016 Phase 3
    NCT02725424 Chinese Academy of Medical Sciences Gastric Cancer August 2015 Phase 2
    NCT02494713 The University of Texas Health Science Center, Houston Prostate Cancer October 2015 Phase 2
    NCT02122185 University of Chicago|National Cancer Institute (NCI) Brenner Tumor|Malignant Ascites|Malignant Pleural Effusion|Ovarian Clear Cell Cystadenocarcinoma|Ovarian Endometrioid Adenocarcinoma|Ovarian Mixed Epithelial Carcinoma|Ovarian Serous Cystadenocarcinoma|Ovarian Undifferentiated Adenocarcinoma|Recurrent Fallopian Tube Cancer|Recurrent Ovarian Epithelial Cancer|Recurrent Ovarian Germ Cell Tumor|Recurrent Primary Peritoneal Cavity Cancer|Stage IIIA Fallopian Tube Cancer|Stage IIIA Ovarian Epithelial Cancer|Stage IIIA Ovarian Germ Cell Tumor|Stage II June 2014 Phase 2
    NCT03043807 Sidney Kimmel Comprehensive Cancer Center Prostate Cancer February 22, 2017 Phase 2
    NCT02568033 The Cooper Health System Non Small Cell Lung Cancer October 2013 Early Phase 1
    NCT02985255 HealthCare Global Enterprise Ltd. Tongue Neoplasms|Squamous Cell Carcinoma|Anterior Tongue Squamous Cell Carcinoma April 2016 Phase 2
    NCT00681993 Sidney Kimmel Comprehensive Cancer Center Breast Cancer April 2008
    NCT01779206 West German Study Group Breast Cancer May 2012 Phase 2|Phase 3
    NCT00003231 Swiss Group for Clinical Cancer Research Lung Cancer April 1997 Phase 2
    NCT02366494 Medical College of Wisconsin Prostate Cancer March 2015
    NCT00274898 Groupe Cooperateur Multidisciplinaire en Oncologie (GERCOR)|National Cancer Institute (NCI) Lung Cancer May 2004 Phase 2
    NCT02777788 Shanghai University of Traditional Chinese Medicine|Shanghai Chest Hospital|Shanghai Pulmonary Hospital, Shanghai, China Cancer September 2014 Phase 2|Phase 3
    NCT02117024 Heat Biologics Non Small Cell Lung Cancer July 2014 Phase 2
    NCT00718913 Hellenic Oncology Research Group|University Hospital of Crete Gastric Cancer April 2008 Phase 2
    NCT01690702 German Breast Group|Celgene|Amgen Breast Cancer September 2012 Phase 3
    NCT00112294 Eli Lilly and Company|ImClone LLC Non-Small-Cell Lung Carcinoma December 2004 Phase 3
    NCT00003103 Memorial Sloan Kettering Cancer Center Bladder Cancer|Breast Cancer|Colorectal Cancer|Esophageal Cancer|Head and Neck Cancer|Kidney Cancer|Lung Cancer|Ovarian Cancer|Prostate Cancer|Unspecified Adult Solid Tumor, Protocol Specific August 1997 Phase 1|Phase 2
    NCT01779050 Washington University School of Medicine Breast Neoplasms December 19, 2013 Phase 2
    NCT02131064 Hoffmann-La Roche Breast Neoplasms June 2014 Phase 3
    NCT00565851 National Cancer Institute (NCI) Clear Cell Adenocarcinoma|Fallopian Tube Clear Cell Adenocarcinoma|Fallopian Tube Endometrioid Adenocarcinoma|Fallopian Tube Mucinous Adenocarcinoma|Fallopian Tube Serous Adenocarcinoma|Mucinous Adenocarcinoma|Ovarian Brenner Tumor|Ovarian Clear Cell Adenocarcinofibroma|Ovarian Endometrioid Adenocarcinoma|Ovarian Seromucinous Carcinoma|Ovarian Serous Adenocarcinoma|Primary Peritoneal Serous Adenocarcinoma|Recurrent Fallopian Tube Carcinoma|Recurrent Ovarian Carcinoma|Recurrent Primary Peritoneal December 6, 2007 Phase 3
    NCT02331251 Western Regional Medical Center Advanced Cancer|Breast Cancer|Sarcoma|Pancreatic Cancer|Small Cell Lung Cancer|Ovarian December 2014 Phase 1|Phase 2
    NCT00062270 University of Alabama at Birmingham|National Cancer Institute (NCI) Lung Cancer May 2003 Phase 1|Phase 2
    NCT01137994 GlaxoSmithKline Neoplasms, Breast October 2011 Phase 2
    NCT02514681 Japan Breast Cancer Research Group|Chugai Pharmaceutical HER2-positive Locally Advanced or Metastatic Breast Cancer October 2015 Phase 3
    NCT01204996 Centocor, Inc. Cancer May 2010 Phase 1
    NCT02931890 The Netherlands Cancer Institute Gastric Cancer October 2016 Phase 2
    NCT01358877 Hoffmann-La Roche|Genentech, Inc.|Breast International Group Breast Cancer November 8, 2011 Phase 3
    NCT00637897 Wake Forest University Health Sciences|National Cancer Institute (NCI) Breast Cancer March 2008 Phase 1
    NCT00609336 University of Washington|National Cancer Institute (NCI) Adenocarcinoma of the Pancreas|Stage IA Pancreatic Cancer|Stage IB Pancreatic Cancer|Stage IIA Pancreatic Cancer|Stage IIB Pancreatic Cancer January 2008 Phase 2
    NCT02486718 Hoffmann-La Roche Non-Small Cell Lung Cancer October 31, 2015 Phase 3
    NCT02122770 Millennium Pharmaceuticals, Inc.|Takeda Advanced Solid Tumors April 1, 2014 Phase 1
    NCT02379585 Western Regional Medical Center Breast Cancer January 2013 Phase 1|Phase 2
    NCT00476827 Duke University|Genentech, Inc. Breast Cancer May 2007 Phase 2
    NCT00736814 Yonsei University|National Cancer Institute (NCI) Lung Cancer June 2008 Phase 2
    NCT00781612 Genentech, Inc.|F. Hoffmann-La Roche Breast Cancer October 31, 2008 Phase 2
    NCT02393248 Incyte Corporation Malignant Solid Tumour|Carcinoma, Non-Small-Cell Lung|Stomach Neoplasms|Urothelial Carcinoma|Endometrial Neoplasms|Multiple Myeloma|MPN|Breast Cancer|Cholangiocarcinoma January 2015 Phase 1|Phase 2
    NCT03061058 The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School Stomach Neoplasms|Chemotherapy Effect|Chemotherapeutic Toxicity September 1, 2014 Phase 3
    NCT00288002 German Breast Group|National Cancer Institute (NCI) Breast Cancer January 2005 Phase 3
    NCT02145078 Barbara Ann Karmanos Cancer Institute|National Cancer Institute (NCI) Recurrent Non-small Cell Lung Cancer|Stage IV Non-small Cell Lung Cancer June 2014
    NCT01964391 Hoffmann-La Roche Breast Cancer February 21, 2014 Phase 3
    NCT02485834 Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI) Adenocarcinoma of the Gastroesophageal Junction|Gastric Adenocarcinoma|Gastric Cancer August 2015 Phase 2
    NCT03161353 MedSIR Breast Cancer June 26, 2017 Phase 2
    NCT01880385 Association Tunisienne de lutte Contre le Cancer|Hoffmann-La Roche|Sanofi Inflammatory Breast Cancer March 2011 Phase 1
    NCT02607423 ECOG-ACRIN Cancer Research Group|National Cancer Institute (NCI)|Eastern Cooperative Oncology Group Stage IIIA Non-Small Cell Lung Cancer November 2015 Phase 2
    NCT00462696 Institut Bergonié|National Cancer Institute (NCI) Breast Cancer February 2006
    NCT00514293 Raghu Nandan, M.D., Inc|National Cancer Institute (NCI) Lung Cancer January 2007 Phase 2
    NCT02909751 Vejle Hospital Breast Cancer September 2016 Phase 2
    NCT00705549 Hellenic Oncology Research Group|University Hospital of Crete Non-Small-Cell Lung Cancer February 2008 Phase 2
    NCT00017095 European Organisation for Research and Treatment of Cancer - EORTC|Swedish Breast Cancer Group|Swiss Group for Clinical Cancer Research|Anglo Celtic Cooperative Oncology Group Breast Cancer March 2001 Phase 3
    NCT00454636 Hoffmann-La Roche Gastric Cancer March 2007 Phase 2
    NCT01501487 Agendia|University of South Florida|University of Miami|Morton Plant Mease Health Care|Florida Hospital|Plano Cancer Center|Ohio State University Comprehensive Cancer Center|University of Oklahoma|University of South Alabama Breast Cancer October 2011 Phase 4
    NCT00498953 European Organisation for Research and Treatment of Cancer - EORTC Head and Neck Cancer May 2007 Phase 1|Phase 2
    NCT01093235 Cambridge University Hospitals NHS Foundation Trust|National Cancer Institute (NCI) Breast Cancer|Cardiac Toxicity|Perioperative/Postoperative Complications April 2009 Phase 3
    NCT01304784 Merrimack Pharmaceuticals HER-2 Gene Amplification January 2011 Phase 1
    NCT00544414 City of Hope Medical Center|National Cancer Institute (NCI) Head and Neck Cancer April 2000 Phase 2
    NCT00113399 Radiation Therapy Oncology Group|National Cancer Institute (NCI) Head and Neck Cancer April 2005 Phase 3
    NCT02940990 Shanghai Chest Hospital NSCLC|SBRT|GM-CSF November 2016 Phase 2
    NCT01966471 Hoffmann-La Roche Breast Cancer January 31, 2014 Phase 3
    NCT00024167 M.D. Anderson Cancer Center|National Cancer Institute (NCI) Prostate Cancer April 2002 Phase 3
    NCT00324805 National Cancer Institute (NCI)|Cancer and Leukemia Group B|NCIC Clinical Trials Group|North Central Cancer Treatment Group|Southwest Oncology Group Stage IB Non-Small Cell Lung Carcinoma AJCC v7|Stage IIA Non-Small Cell Lung Carcinoma AJCC v7|Stage IIB Non-Small Cell Lung Carcinoma AJCC v7|Stage IIIA Non-Small Cell Lung Cancer AJCC v7 June 1, 2007 Phase 3
    NCT02099188 Fondazione IRCCS Istituto Nazionale dei Tumori, Milano|Regione Lombardia Unresectable Sinonasal Tumors November 2013 Phase 2
    NCT02099175 Fondazione IRCCS Istituto Nazionale dei Tumori, Milano|Regione Lombardia Sinonasal Tumors November 2013 Phase 2
    NCT02039336 The Netherlands Cancer Institute|Pfizer Colorectal Cancer January 2014 Phase 1|Phase 2
    NCT02509286 University Hospital Freiburg|Clinical Trials Unit Freiburg Esophageal Adenocarcinoma (UICC TNM7)|Adenocarcinoma of the Esophagogastric Junction January 2016 Phase 3
    NCT00999700 Gruppo Oncologico del Nord-Ovest Squamous Cell Carcinoma of the Head and Neck September 2009 Phase 3
    NCT02915744 Nektar Therapeutics Metastasis|Breast Cancer November 2016 Phase 3
    NCT02383212 Regeneron Pharmaceuticals|Sanofi Advanced Cancer|Advanced Malignancies January 2015 Phase 1
    NCT02664935 University of Birmingham|Cancer Research UK|AstraZeneca|Pfizer|Experimental Cancer Medicine Centre Network Non-Small Cell Lung Cancer|Carcinoma, Squamous Cell|Adenocarcinoma March 2015 Phase 2
    NCT02154490 Southwest Oncology Group|National Cancer Institute (NCI) Recurrent Squamous Cell Lung Carcinoma|Stage IV Squamous Cell Lung Carcinoma June 2014 Phase 2|Phase 3
    NCT02009449 ARMO BioSciences Melanoma|Prostate Cancer|Ovarian Cancer|Renal Cell Carcinoma|Colorectal Carcinoma|Pancreatic Carcinoma|Non-small Cell Lung Carcinoma|Solid Tumors|Breast Cancer November 2013 Phase 1
    NCT02344472 Prof. W. Janni|Roche Pharma AG|DETECT study group|University of Ulm Metastatic Breast Cancer September 2015 Phase 3
    NCT00027859 Eastern Cooperative Oncology Group|National Cancer Institute (NCI)|Southwest Oncology Group|Cancer and Leukemia Group B Prostate Cancer May 2003 Phase 3
    NCT00193284 SCRI Development Innovations, LLC|AstraZeneca|Aventis Pharmaceuticals Head and Neck Cancer October 2003 Phase 2
    NCT02753140 Daping Hospital and the Research Institute of Surgery of the Third Military Medical University Carcinoma, Squamous Cell of Head and Neck April 2016 Phase 2
    NCT00006261 Case Comprehensive Cancer Center|National Cancer Institute (NCI) Breast Cancer May 2000 Phase 2
    NCT01220128 GlaxoSmithKline Neoplasms, Breast April 1, 2011 Phase 2
    NCT00567554 German Breast Group|AGO Study Group Breast Cancer October 2007 Phase 3
    NCT02624973 Haukeland University Hospital|Helse Vest|Pfizer|AstraZeneca Breast Cancer April 2016 Phase 2
    NCT02574078 Bristol-Myers Squibb Non-Small Cell Lung Cancer November 13, 2015 Phase 1|Phase 2
    NCT00014352 Memorial Sloan Kettering Cancer Center|National Cancer Institute (NCI) Prostate Cancer|Thromboembolism September 2000 Phase 2
    NCT01376310 GlaxoSmithKline Cancer March 28, 2011 Phase 2
    NCT00963729 Imperial College London|National Cancer Institute (NCI) Breast Cancer September 2008 Phase 3
    NCT00392938 University of Washington|National Cancer Institute (NCI) Metastatic Cancer|Prostate Cancer December 2005
    NCT00309920 Heinrich-Heine University, Duesseldorf|National Cancer Institute (NCI) Breast Cancer January 2004
    NCT00989690 Istituto Scientifico H. San Raffaele|National Cancer Institute (NCI) Lung Cancer February 2008 Phase 3
    NCT00311636 Gruppo Italiano Mammella (GIM)|National Cancer Institute (NCI) Breast Cancer September 2003 Phase 3
    NCT00047099 Ludwig-Maximilians - University of Munich|National Cancer Institute (NCI) Breast Cancer August 2001 Phase 3
    NCT00030654 Radiation Therapy Oncology Group|National Cancer Institute (NCI)|Eastern Cooperative Oncology Group|Cancer and Leukemia Group B|Southwest Oncology Group|NRG Oncology Prostate Cancer October 2002 Phase 3
    NCT00083083 American College of Radiology Imaging Network|National Cancer Institute (NCI)|Radiation Therapy Oncology Group Lung Cancer March 2005 Phase 2
    NCT00003159 Medical Research Council|European Organisation for Research and Treatment of Cancer - EORTC|National Cancer Institute (NCI) Lung Cancer August 1997 Phase 3
    NCT00646659 European Organisation for Research and Treatment of Cancer - EORTC Head and Neck Cancer February 2008 Phase 2
    NCT00629278 Azienda Ospedaliera - Universitaria di Modena|National Cancer Institute (NCI) Breast Cancer December 2007 Phase 3
    NCT00276744 Sidney Kimmel Comprehensive Cancer Center|National Cancer Institute (NCI) Pancreatic Cancer October 2005 Phase 2
    NCT00755313 University of California, San Francisco|National Cancer Institute (NCI) Breast Cancer|Chemotherapeutic Agent Toxicity|Cognitive/Functional Effects|Fatigue|Long-term Effects Secondary to Cancer Therapy in Adults|Neurotoxicity|Psychosocial Effects of Cancer and Its Treatment May 2007
    NCT00012311 Herbert Irving Comprehensive Cancer Center|National Cancer Institute (NCI) Breast Cancer January 2000 Phase 2
    NCT02998528 Bristol-Myers Squibb Non Small Cell Lung Cancer January 13, 2017 Phase 3
    NCT00513383 Massachusetts General Hospital|Brigham and Women's Hospital|Amgen Squamous Cell Carcinoma of the Head and Neck April 2006 Phase 1
    NCT02393833 International Breast Cancer Study Group Breast Cancer June 2002 Phase 3
    NCT01209520 University of Miami Lung Cancer|Non Small Cell Lung Carcinoma|Hypermethylation July 2009
    NCT00811993 Hoffmann-La Roche Neoplasms February 2009 Phase 1
    View MoreCollapse
    References
    Preparing Stock Solutions
    Concentration Volume (DMSO) Mass 1 mg 5 mg 10 mg
    1 mM 1.2378 mL 6.1890 mL 12.3781 mL
    5 mM 0.2476 mL 1.2378 mL 2.4756 mL
    10 mM 0.1238 mL 0.6189 mL 1.2378 mL
    Cell Assay
    [1]

    Docetaxel is dissolved in DMSO (100 mM) and stored, and then diluted with appropriate media before use[1].

    Single-drug concentration-response curves are assessed. Seeding is done at a density of 2,000 cells/well for PC-3 and LNCaP, in 96-well plates. Cells are treated with each single drug and their combination for 72 h at different drug concentrations. Docetaxel is used at concentrations of 0.1-1,000 nM. GLU is used at concentrations of 0.1-300 µm. Cytotoxicity is assessed at the end of drug exposure using SRB assay. Following 72 h exposure the cells are fixed with 10% trichloroacetic acid (150 µL) for 1 h at 4°C. Then, cells are stained for 10 min at room temperature with 0.4% SRB dissolved in 1% acetic acid. The plates are then air dried for 24 h and the dye is made soluble with 150 µL Tris (10 mM, PH 7.4) for 5 min on a shaker at 1,600 rpm. Absorbance is then measured at 545 nM using microplate reader. Results are expressed as the relative percentage of absorbance compared to control[1]. MCE has not independently confirmed the accuracy of these methods. They are for reference only.

    Animal Administration
    [3][4]

    Docetaxel is dissolved in a solution to store 10 mg/mL and further diluted with saline just before each injection (Mice)[3].
    Docetaxel is dissolved in DMSO and then diluted with PEG 400, followed by saline (Rat)[4].

    Mice[3]
    Five-week-old male Balb/c mice are used. Docetaxel (0, 10, 20, 30, 40, 60, and 80 mg/kg per week) is given once a week for 3 weeks for mice. Because more than 30 mg/kg per week of Docetaxel causes body weight loss in mice, 20 mg/kg per week of Docetaxel is judged to be the maximum nontoxic dose. Docetaxel (20 mg/kg per week) is given to mice once a week for 3 weeks at one of the following different points (2, 10, 14, or 22 HALO). Seventy-two hours after the final dosing of the agent, the intestinal mucosa of the small intestine (proximal 8 cm) is removed, fixed in 20 N Mildform solution (containing 8% formaldehyde in a buffered solution), and embedded in paraffin blocks, and sections of 5 μm are put on glass slides. Apoptosis is detected using the terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling (TUNEL) method, using the Apop Tag Peroxidase In Situ Apoptosis Detection Kit.
    Rat[4]
    Male Sprague-Dawley rats with body weight between 230-250 g and age between 6-7 weeks are used. About 25 SD rats are divided into five groups receiving Docetaxel (7 mg/kg, i.v.), PIP (35 mg/kg, p.o.) and their combined administration (DOX+PIP) as well as PIP (3.5 mg/kg, p.o.) and PIP (3.5 mg/kg, i.v.). A day before the drug administrations, the rats are anesthetized with an intramuscular injection of a cocktail containing 60 mg/kg ketamine and 6 mg/kg xylazine (injection volume, 0.2 mL). Right jugular vein is cannulated with a polyethylene tubing (0.5 mm ID, 1 mm) for blood collection. MCE has not independently confirmed the accuracy of these methods. They are for reference only.

    References
    M.Wt

    807.88

    Formula

    C₄₃H₅₃NO₁₄

    CAS No.

    114977-28-5

    Storage
    Powder -20°C 3 years
      4°C 2 years
    In solvent -80°C 6 months
      -20°C 1 month
    Shipping

    Room temperature in continental US; may vary elsewhere

    Solvent & Solubility

    DMSO: ≥ 35 mg/mL

    * "<1 mg/mL" means slightly soluble or insoluble. "≥" means soluble, but saturation unknown.

    Purity: 99.80%

    Inquiry Online

    Your information is safe with us. * Required Fields.

    Product name

     

    Salutation

    Applicant name *

     

    Email address *

    Phone number

     

    Organization name *

    Country *

     

    Requested quantity *

    Remarks

    Bulk Inquiry

    Inquiry Information

    Product Name:
    Docetaxel
    Cat. No.:
    HY-B0011
    Quantity: